
<!-- saved from url=(0088)https://www.sec.gov/Archives/edgar/data/1328143/000110465921124979/tm2129361d1_ex2-1.htm -->
<html><head><meta http-equiv="Content-Type" content="text/html; charset=windows-1252"><script src="chrome-extension://ddbjnfjiigjmcpcpkmhogomapikjbjdk/base.js"></script></head><body style="font: 10pt Times New Roman, Times, Serif" data-new-gr-c-s-check-loaded="14.1131.0" data-gr-ext-installed=""><document>
<type>EX-2.1
<sequence>2
<filename>tm2129361d1_ex2-1.htm
<description>EXHIBIT 2.1
<text>


     <title></title>



                           <p style="margin: 0pt"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>Exhibit 2.1</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><font><b>EXECUTION
COPY</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</p>

<p style="border-top: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>AGREEMENT AND PLAN OF MERGER</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">by and among:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-size: 10pt"><b>ADAMAS PHARMACEUTICALS,&nbsp;INC.,</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-size: 10pt">&nbsp;</font></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-size: 10pt"><b>SUPERNUS PHARMACEUTICALS,&nbsp;INC.,</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-size: 10pt">and</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-size: 10pt">&nbsp;</font></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-size: 10pt"><b>SUPERNUS REEF,&nbsp;INC.</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Dated as of October&nbsp;<font style="font-size: 10pt">10,
2021</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="border-top: Black 2.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font><b>TABLE
OF CONTENTS</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><font><b>Page</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Article&nbsp;1 DEFINITIONS</font> </td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 15%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 75%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 10%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;1.1</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitions</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Article&nbsp;2 THE OFFER</font> </td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.1</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Offer.</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.2</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Actions.</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">16</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Article&nbsp;3 MERGER TRANSACTION</font> </td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">17</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.1</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger
    of Purchaser into the Company</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">17</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.2</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of the Merger</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">17</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.3</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing;
    Effective Time.</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">17</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.4</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
    of Incorporation and Bylaws; Directors and Officers</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">18</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.5</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
    of Shares.</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">18</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.6</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surrender
    of Certificates; Stock Transfer Books.</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.7</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dissenters’
    Rights</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">21</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.8</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treatment
    of Company Options, Company RSU Awards and Company ESPP.</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">22</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.9</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further
    Action</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">23</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Article&nbsp;4 REPRESENTATIONS AND WARRANTIES OF THE COMPANY</font> </td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">24</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.1</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
    Organization; Subsidiaries, Etc.</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">24</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.2</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
    of Incorporation and Bylaws</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">24</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.3</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authority;
    Binding Nature of Agreement</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">25</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.4</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization,
    Etc.</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">25</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.5</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Contravention;
    Consents</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">26</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.6</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC
    Filings; Financial Statements.</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">26</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.7</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Absence
    of Changes</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">29</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.8</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
    Property.</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">29</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.9</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Privacy
    and Security</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">30</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.10</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contracts.</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">31</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.11</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Undisclosed Liabilities</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">33</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.12</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Litigation</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">34</td></tr>
  </tbody></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1in"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font>(continued)</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Page</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 15%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.13</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 75%; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance
    with Laws</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">34</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.14</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulatory
    Matters; Product Liability and Recalls.</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">34</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.15</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
    Business Practices</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">37</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.16</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governmental
    Authorizations</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">37</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.17</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
    Matters</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">38</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.18</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    Matters; Benefit Plans</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">39</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.19</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Environmental
    Matters</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">41</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.20</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real
    Property.</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">41</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.21</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    to Assets</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">41</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.22</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">41</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.23</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;203
    of the DGCL</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">42</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.24</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger
    Approval</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">42</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.25</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion
    of Financial Advisor</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">42</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.26</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brokers
    and Other Advisors</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">42</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Article&nbsp;5 REPRESENTATIONS AND WARRANTIES OF PARENT AND PURCHASER</font> </td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">42</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.1</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
    Organization</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">42</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.2</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchaser</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">43</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.3</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authority;
    Binding Nature of Agreement</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">43</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.4</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Contravention;
    Consents</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">43</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.5</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">44</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.6</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Litigation</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">44</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.7</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solvency</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">44</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.8</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership
    of Company Common Stock; Absence of Certain Arrangements</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">44</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.9</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brokers
    and Other Advisors</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">45</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.10</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sufficient
    Funds</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">45</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.11</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acknowledgement
    by Parent and Purchaser.</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">45</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Article&nbsp;6 CERTAIN COVENANTS OF THE COMPANY</font> </td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">46</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.1</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Access
    and Investigation</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">46</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.2</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operation
    of the Business.</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">47</td></tr>
  </tbody></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1in"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font>(continued)</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><font><b>Page</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 15%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.3</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 75%; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Solicitation.</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">50</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Article&nbsp;7 ADDITIONAL COVENANTS OF THE PARTIES</font> </td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">51</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.1</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Board Recommendation.</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">51</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.2</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filings,
    Consents and Approvals.</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">52</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.3</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continuing
    Employee Benefits</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">55</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.4</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification
    of Officers and Directors.</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">56</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.5</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securityholder
    Litigation</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">58</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.6</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further
    Assurances</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">58</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.7</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
    Announcements; Disclosure</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">59</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.8</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Takeover
    Laws</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">59</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.9</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;16
    Matters</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">59</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.10</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule&nbsp;14d-10
    Matters</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">59</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.11</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchaser
    Stockholder Consent</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">60</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.12</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    Exchange Delisting; Deregistration</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">60</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.13</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Agreements and Understandings</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">60</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Article&nbsp;8 CONDITIONS PRECEDENT TO THE MERGER</font> </td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">60</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.1</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Restraints</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">60</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.2</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consummation
    of Offer</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">60</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Article&nbsp;9 TERMINATION</font> </td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">60</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;9.1</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">60</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;9.2</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of Termination</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-top: 0; margin-bottom: 0"></p>
                                                                            <p style="margin-top: 0; margin-bottom: 0">62</p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;9.3</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses;
    Termination Fee.</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">63</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Article&nbsp;10 MISCELLANEOUS PROVISIONS</font> </td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">64</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;10.1</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">64</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;10.2</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Waiver</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">64</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;10.3</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Survival</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">65</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;10.4</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entire
    Agreement; Counterparts</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">65</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;10.5</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applicable
    Laws; Jurisdiction; Specific Performance; Remedies.</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">65</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;10.6</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assignment</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">66</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;10.7</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    Third Party Beneficiaries</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">67</td></tr>
</tbody></table>

<p style="margin: 0">&nbsp;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font>(continued)</font></p>


<p style="margin: 0">&nbsp;</p>

<p style="text-align: right; margin: 0"><b>Page</b></p>

<p style="margin: 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tbody><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 15%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;10.8</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 75%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 10%">67</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;10.9</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Severability</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">68</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;10.10</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligation
    of Parent</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">68</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;10.11</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
    Taxes</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">69</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;10.12</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interpretations</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">69</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;10.13</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    Disclosure Schedule References</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">70</td></tr>
  </tbody></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><u>Exhibits</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" border="0" style="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<tbody><tr style="vertical-align: top">
  <td style="padding-left: 10pt; text-indent: -10pt; width: 9%">Exhibit&nbsp;A</td>
  <td style="padding-left: 10pt; text-indent: -10pt; width: 91%">Surviving Corporation Certificate of Incorporation</td></tr>

<tr style="vertical-align: top">
  <td style="padding-left: 10pt; text-indent: -10pt">Exhibit&nbsp;B</td>
  <td style="padding-left: 10pt; text-indent: -10pt">Surviving Corporation Bylaws</td></tr>
</tbody></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><u>Annexes</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" border="0" style="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<tbody><tr style="vertical-align: top">
  <td style="padding-left: 10pt; text-indent: -10pt; width: 9%">Annex I</td>
  <td style="padding-left: 10pt; text-indent: -10pt; width: 91%">Conditions to the Offer</td></tr>

<tr style="vertical-align: top">
  <td style="padding-left: 10pt; text-indent: -10pt">Annex II&nbsp;</td>
  <td style="padding-left: 10pt; text-indent: -10pt">Form&nbsp;of Contingent Value Rights Agreement</td></tr>
</tbody></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<!-- Field: Split-Segment; Name: 1 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>AGREEMENT AND PLAN OF MERGER</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">This <font style="font-variant: small-caps">Agreement
and Plan of Merger</font> (this “<u>Agreement</u>”) is made and entered into as of October&nbsp;10, 2021 (the “<u>Agreement
Date</u>”), by and among Supernus Pharmaceuticals,&nbsp;Inc., a Delaware corporation (“<u>Parent</u>”), Supernus Reef,&nbsp;Inc.,
a Delaware corporation and a wholly owned subsidiary of Parent (“<u>Purchaser</u>”), and Adamas Pharmaceuticals,&nbsp;Inc.,
a Delaware corporation (the “<u>Company</u>”). Certain capitalized terms used in this Agreement shall have the meanings ascribed
to such terms in <u>Article&nbsp;1</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-variant: small-caps"><b>Recitals</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">WHEREAS, Parent has agreed to
cause Purchaser to commence a cash tender offer (as it may be amended from time to time as permitted under this Agreement, the “<u>Offer</u>”)
to acquire all of the outstanding shares of Company Common Stock (the “<u>Shares</u>”) for (i)&nbsp;$8.10 per share in cash
(the “<u>Cash Amount</u>”) <i>plus</i> (ii)&nbsp;two (2)&nbsp;contingent value right payments per Share (each, a “<u>CVR</u>”),
which shall represent the right to receive the Milestone Payments (as such term is defined in the CVR Agreement) (the Cash Amount plus
the CVRs, collectively, or any higher amount per share paid pursuant to the Offer, being the “<u>Offer Price</u>”), in cash,
net of applicable withholding Taxes and without interest, on the terms and subject to the conditions set forth in this Agreement;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">WHEREAS, as soon as practicable
following the consummation of the Offer, Purchaser will be merged with and into the Company (the “<u>Merger</u>”), with the
Company continuing as the surviving corporation in the Merger and as a wholly owned Subsidiary of Parent (the “<u>Surviving Corporation</u>”),
on the terms and subject to the conditions set forth in this Agreement, whereby, (i)&nbsp;each issued and outstanding Share (other than
the Excluded Shares and Dissenting Shares) shall be converted into the right to receive the Offer Price, in cash, net of applicable withholding
Taxes and without interest, (ii)&nbsp;each Converted Share shall represent the right to receive the Merger Consideration, in cash, net
of applicable withholding Taxes and without interest and (iii)&nbsp;the Company shall become a wholly owned Subsidiary of Parent as a
result of the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">WHEREAS, the board of
directors of the Company (the “<u>Company Board</u>”) has (i)&nbsp;determined that this Agreement and the Transactions,
including the Offer and the Merger, are fair to, and in the best interest of, the Company and its stockholders, (ii)&nbsp;approved
the execution, delivery and performance by the Company of this Agreement and the consummation of the Transactions, including the
Offer and the Merger, (iii)&nbsp;resolved that the Merger shall be effected under Section&nbsp;251(h)&nbsp;of the DGCL and
(iv)&nbsp;resolved to recommend that the stockholders of the Company tender their Shares to Purchaser pursuant to the Offer (the
 “<u>Company Board Recommendation</u>”).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">WHEREAS, the board of directors
of each of Parent and Purchaser have (i)&nbsp;determined that this Agreement and the Transactions are in the best interests of Parent
and Purchaser, respectively, and (ii)&nbsp;approved the execution, delivery and performance of this Agreement and the consummation of
the Transactions, including the Offer and the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">WHEREAS, each of Parent, Purchaser
and the Company hereby acknowledges and agrees that the Merger shall be effected under Section&nbsp;251(h)&nbsp;of the DGCL and shall,
subject to satisfaction of the conditions set forth in this Agreement, be consummated as soon as practicable following the Offer Acceptance
Time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<!-- Field: Page; Sequence: 6 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">NOW THEREFORE, in consideration
of the foregoing and the mutual covenants and agreements herein contained, and intending to be legally bound hereby, Parent, Purchaser
and the Company hereby agree as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase">Article&nbsp;1</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">DEFINITIONS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;1.1	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Definitions</u>.
For purposes of this Agreement (including this <u>Article&nbsp;1</u>):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Acceptable
Confidentiality Agreement</u>” means any agreement with the Company that is either (a)&nbsp;in effect as of the execution and
delivery of this Agreement or (b)&nbsp;executed, delivered and effective after the execution and delivery of this Agreement, in
either case containing provisions that require any counterparty thereto (and any of its Affiliates and Representatives) that receive
material non-public information of, or with respect to, the Company to keep such information confidential; <i>provided</i>, <i>however</i>,
that, in the case of clause&nbsp;(b), (i)&nbsp;the provisions contained therein are no less favorable in the aggregate to the
Company than the terms of the Non-Disclosure Agreement (it being agreed that such agreement need not contain any
 “standstill” or similar provisions that prohibit the making of any Acquisition Proposal) and (ii)&nbsp;such agreement
does not contain any provision that prohibits the Company from satisfying its obligations hereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Acquisition Proposal</u>”
means any proposal or offer from any Person (other than Parent and its Affiliates) or “group”, within the meaning of Section&nbsp;13(d)&nbsp;of
the Exchange Act, relating to, in a single transaction or series of related transactions, any (a)&nbsp;acquisition or license, outside
of the ordinary course of business, in respect of a material portion of the Company Products, (b)&nbsp;issuance or acquisition of 10%
or more of the outstanding Shares, (c)&nbsp;recapitalization, tender offer or exchange offer that if consummated would result in any Person
or group beneficially owning 10% or more of the outstanding Shares or (d)&nbsp;merger, consolidation, amalgamation, share exchange, business
combination, recapitalization, liquidation, dissolution or similar transaction involving the Company that if consummated would result
in any Person or group beneficially owning 10% or more of the outstanding Shares, in each case other than the Transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Affiliate</u>”
means, as to any Person, any other Person that, directly or indirectly, controls, or is controlled by, or is under common control with,
such Person. For this purpose, “control” (including, with its correlative meanings, “controlled by” and “under
common control with”) means the possession, directly or indirectly, of the power to direct or cause the direction of management
or policies of a Person, whether through the ownership of securities or partnership or other ownership interests, by contract or otherwise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Agreement</u>”
is defined in the Preamble to this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Agreement Date</u>”
is defined in the Preamble to this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 7; Options: NewSection; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Anti-Corruption Laws</u>”
mean the Foreign Corrupt Practices Act of 1977, the Anti-Kickback Act of 1986, the UK Bribery Act of 2012, and the Anti-Bribery
Laws of the People’s Republic of China or any applicable Laws of similar effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Antitrust
Laws</u>” mean the Sherman Act, the Clayton Act, the HSR Act, the Federal Trade Commission Act, state antitrust laws, and all
other applicable Laws (including non-U.S. Laws) issued by a Governmental Body that are designed or intended to preserve or protect
competition, prohibit and restrict agreements in restraint of trade or monopolization, attempted monopolization, restraints of trade
and abuse of a dominant position, or to prevent acquisitions, mergers or other business combinations and similar transactions, the
effect of which may be to lessen or impede competition or to tend to create or strengthen a dominant position or to create a
monopoly.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Balance Sheet</u>”
is defined in <u>Section&nbsp;4.21</u> of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Book-Entry Shares</u>”
mean non-certificated Shares represented by book-entry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Business Day</u>”
means a day except a Saturday, a Sunday or other day on which banks in the City of New York are authorized or required by Laws to be closed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Cash Amount</u>”
is defined in the Recitals of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Cause</u>” is
defined in <u>Section&nbsp;7.3(a)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Certificates</u>”
is defined in <u>Section&nbsp;3.6(b)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Certificated Shares</u>”
mean Shares evidenced by Certificates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Closing</u>”
is defined in <u>Section&nbsp;3.3(a)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Closing Date</u>”
is defined in <u>Section&nbsp;3.3(a)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Code</u>” means
the Internal Revenue Code of 1986.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Company</u>”
is defined in the Preamble to this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Company Adverse Change
Recommendation</u>” is defined in <u>Section&nbsp;7.1(a)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Company Associate</u>”
means each officer or other employee, or individual who is an independent contractor, consultant or director, of or to the Company or
any of its Subsidiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Company Board</u>”
is defined in the Recitals of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Company Board Recommendation</u>”
is defined in the Recitals of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Company Common Stock</u>”
means the common stock, $0.001 par value per share, of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Company Contract</u>”
means any Contract to which the Company or any of its Subsidiaries is a party.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Company Disclosure
Documents</u>” is defined in <u>Section&nbsp;4.6(g)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Company Disclosure
Schedule</u>” means the disclosure schedule that has been prepared by the Company in accordance with the requirements of this Agreement
and that has been delivered by the Company to Parent on the Agreement Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Company Employee Agreement</u>”
means each management, employment, severance, retention, transaction bonus, change in control, consulting, relocation, repatriation or
expatriation agreement or other Contract between: (a)&nbsp;the Company or any of its Subsidiaries and (b)&nbsp;any Company Associate (other
than any Company Associate that is part time or paid on an hourly basis), other than any such Contract that is terminable “at will”
(or following a notice period imposed by applicable Laws) without any obligation on the part of the Company or any of its Subsidiaries
to make any severance, termination, change in control or similar payment or to provide any benefit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Company Equity Plans</u>”
means the 2014 Equity Incentive Plan and the 2016 Inducement Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Company ESPP</u>”
means the 2014 Employee Stock Purchase Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Company IP</u>”
means all Intellectual Property Rights that are owned or purported to be owned by the Company or any of its Subsidiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Company Lease</u>”
means any Company Contract pursuant to which the Company or any of its Subsidiaries leases or subleases Leased Real Property from another
Person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Company Option</u>”
means an option to purchase Shares granted by the Company pursuant to the Company Equity Plans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Company Product</u>”
means <font style="background-color: white">GOCOVRI®&nbsp;(amantadine)</font> and OSMOLEX ER® (amantadine).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Company Related Parties</u>”
is defined in <u>Section&nbsp;9.3(c)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Company RSU Award</u>”
means an award of restricted stock units granted by the Company pursuant to the Company Equity Plans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Company SEC Documents</u>”
is defined in <u>Section&nbsp;4.6(a)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Company Stock Awards</u>”
means all Company Options, all Company RSU Awards and all Shares of restricted Company Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Consent</u>”
means any approval, consent, ratification, permission, waiver or authorization (including any Governmental Authorization).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Continuing
Employee</u>” means (a)&nbsp;each employee of the Company who is employed by the Company as of immediately prior to the
Effective Time to whom the Surviving Corporation extends an offer of continued employment (including at-will employment but
excluding employment for less than three (3)&nbsp;months following the Closing Date) with the Surviving Corporation which such
employee accepts on or prior to the Closing Date and (b)&nbsp;each Transition Employee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Contract</u>”
means any written, oral or other agreement, contract, subcontract, lease, understanding, instrument, bond, debenture, note, option, warrant,
warranty, purchase order, license, sublicense, insurance policy, benefit plan or legally binding commitment or undertaking of any nature
(except, in each case, ordinary course of business purchase orders).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Converted Shares</u>”
means the Shares converted pursuant to and in accordance with <u>Section&nbsp;3.5(a)(iii)</u>&nbsp;of the Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>COVID-19</u>”
means the coronavirus pandemic known as COVID-19.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>COVID-19 Measures</u>”
means any quarantine, “shelter in place,” “stay at home,” workforce reduction, social distancing, shut-down,
closure, sequester, safety or other Law, directive, guidelines or recommendations promulgated by any Governmental Body, including the
Centers for Disease Control and Prevention and the World Health Organization, or by any U.S. industry group, in each case, in connection
with or in response to COVID-19.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>CVR</u>” is
defined in the Recitals of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>CVR Agreement</u>”
means the Contingent Value Right Agreement in the form attached hereto as <u>Annex II</u> to be entered into between Parent and a rights
agent mutually agreeable to Parent and the Company (the “<u>Rights Agent</u>”), with such revisions thereto requested by such
Rights Agent that are not, individually or in the aggregate, detrimental to any Person entitled to the receipt of CVRs in the Transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Depository Agent</u>”
is defined in <u>Section&nbsp;3.6(a)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Determination Notice</u>”
is defined in Section&nbsp;7.1(b)&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>DGCL</u>” means
the Delaware General Corporation Law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Dissenting Shares</u>”
is defined in <u>Section&nbsp;3.7</u> of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>DOJ</u>” means
the U.S. Department of Justice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>DTC</u>” is
defined in <u>Section&nbsp;3.6(h)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Effect</u>”
means any change, effect, circumstance, fact, event or occurrence.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Effective Time</u>”
is defined in <u>Section&nbsp;3.3(b)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Employee Plan</u>”
means any salary, bonus, vacation, deferred compensation, incentive compensation, stock purchase, stock option, severance pay, termination
pay, death and disability benefits, hospitalization, medical, life or other insurance, flexible benefits, supplemental unemployment benefits,
profit-sharing, pension or retirement plan, policy, program, agreement or arrangement and each other employee benefit plan or arrangement
sponsored, maintained, contributed to or required to be contributed to by the Company for the benefit of any current or former employee
of the Company or with respect to which the Company has any liability but excluding regular wages and salary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Encumbrance</u>”
means any lien, pledge, hypothecation, charge, mortgage, security interest, encumbrance, claim, infringement, interference, option, right
of first refusal, preemptive right, community property interest or other similar restriction (including any restriction on the voting
of any security, any restriction on the transfer of any security or other asset, any restriction on the receipt of any income derived
from any asset, any restriction on the use of any asset and any restriction on the possession, exercise or transfer of any other attribute
of ownership of any asset).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>End Date</u>”
is defined in <u>Section&nbsp;9.1(b)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Entity</u>”
means any corporation (including any non-profit corporation), general partnership, limited partnership, limited liability partnership,
joint venture, estate, trust, company (including any company limited by shares, limited liability company or joint stock company), firm,
society or other enterprise, association, organization or entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Environmental Law</u>”
means any federal, state, local or foreign Law relating to pollution or protection of human health, worker health or the environment (including
ambient air, surface water, ground water, land surface or subsurface strata), including any law or regulation relating to emissions, discharges,
releases or threatened releases of Hazardous Materials, or otherwise relating to the manufacture, processing, distribution, use, treatment,
storage, disposal, transport or handling of Hazardous Materials.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>ERISA</u>” means
the Employee Retirement Income Security Act of 1974.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Exchange Act</u>”
means the Securities Exchange Act of 1934.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Excluded Shares</u>”
means the Shares to be cancelled pursuant to and in accordance with <u>Section&nbsp;3.5(a)(i)</u>&nbsp;and <u>Section&nbsp;3.5(a)(ii)</u>&nbsp;of
this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Expiration Date</u>”
is defined in <u>Section&nbsp;2.1(c)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Extension Deadline</u>”
is defined in <u>Section&nbsp;2.1(c)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>FDA</u>” means
the U.S. Food and Drug Administration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>FTC</u>” means
the U.S. Federal Trade Commission.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>GAAP</u>” is
defined in <u>Section&nbsp;4.6(b)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Governmental Authorization</u>”
means any (a)&nbsp;permit, license, certificate, franchise, permission, variance, clearance, registration, qualification or authorization
issued, granted, given or otherwise made available by or under the authority of any Governmental Body or pursuant to any Law or (b)&nbsp;right
under any Contract with any Governmental Body.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Governmental Body</u>”
means any: (a)&nbsp;nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction of any nature;
(b)&nbsp;federal, state, local, municipal, foreign or other government; or (c)&nbsp;governmental or quasi-governmental authority of any
nature including any governmental division, department, agency, commission, instrumentality, official, ministry, fund, foundation, center,
organization, unit, body or Entity and any court, arbitrator or other tribunal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Hazardous Materials</u>”
mean any waste, material, or substance that is listed, regulated or defined under any Environmental Law and includes any pollutant, chemical
substance, hazardous substance, hazardous waste, special waste, solid waste, asbestos, mold, radioactive material, polychlorinated biphenyls,
petroleum or petroleum-derived substance or waste.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>HIPAA</u>”
means the Health Insurance Portability and Accountability Act of 1996.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>HSR Act</u>”
means the Hart-Scott-Rodino Antitrust Improvements Act of 1976.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Inbound License</u>”
is defined in <u>Section&nbsp;4.8(c)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Indebtedness</u>”
means (a)&nbsp;any indebtedness for borrowed money (including the issuance of any debt security) to any Person other than the Company
or any of its Subsidiaries, (b)&nbsp;any obligations evidenced by notes, bonds, debentures or similar Contracts to any Person other than
the Company or any of its Subsidiaries, (c)&nbsp;any obligations in respect of letters of credit and bankers’ acceptances (other
than letters of credit used as security for leases), or (d)&nbsp;any guaranty of any such obligations described in clauses (a)&nbsp;through
(c)&nbsp;of any Person other than the Company or any of its Subsidiaries (other than, in any case, accounts payable to trade creditors
and accrued expenses, in each case, arising in the ordinary course of business and not evidenced by notes, bonds, debentures or similar
Contracts).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Indemnified Persons</u>”
is defined in <u>Section&nbsp;7.4(a)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Indemnifying Parties</u>”
is defined in <u>Section&nbsp;7.4(b)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Intellectual Property
Rights</u>” means and includes all past, present, and future rights of the following types, which may exist or be created under
the laws of any jurisdiction in the world: (a)&nbsp;rights associated with works of authorship, including exclusive exploitation rights,
copyrights, moral rights, software, databases, and mask works; (b)&nbsp;trademarks, service marks, trade dress, logos, trade names and
other source identifiers, domain names and URLs and similar rights and any goodwill associated therewith; (c)&nbsp;rights associated with
trade secrets, know how, inventions, invention disclosures, methods, processes, protocols, specifications, techniques and other forms
of technology; (d)&nbsp;patents and industrial property rights; (e)&nbsp;other proprietary rights in intellectual property of every kind
and nature; (f)&nbsp;rights of privacy and publicity; and (g)&nbsp;all registrations, renewals, extensions, combinations, statutory invention
registrations, provisionals, continuations, continuations-in-part, divisions, or reissues of, and applications for, any of the rights
referred to in clauses (a)&nbsp;through (f)&nbsp;(whether or not in tangible form and including all tangible embodiments of any of the
foregoing, such as samples, studies and summaries), along with all rights to prosecute and perfect the same through administrative prosecution,
registration, recordation or other administrative proceeding, and all causes of action and rights to sue or seek other remedies arising
from or relating to the foregoing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>IRS</u>” means
the U.S. Internal Revenue Service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Knowledge</u>”
with respect to an Entity means with respect to any matter in question the actual knowledge of, in the case of the Company, Neil McFarlane,
Christopher Prentiss, Vijay Shreedhar and Jason Christiansen, after reasonable inquiry, and in the case of any other Entity, such Entity’s
executive officers after reasonable inquiry. With respect to matters involving Intellectual Property Rights, “reasonable inquiry”
does not require that any of such Entity’s executive officers or their direct reports conduct or have conducted or obtain or have
obtained any freedom-to-operate opinions or similar opinions of counsel or any Registered IP clearance searches, and no knowledge of any
third party Registered IP that would have been revealed by such inquiries, opinions or searches will be imputed to such executive officers
or their direct reports.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Law</u>”
means any federal, state, local, municipal, foreign or other law (including common law), statute, constitution, principle of common
law, resolution, order, ordinance, code, edict, judgment, decree, rule, regulation, ruling or requirement issued, pronounced,
enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Body.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Leased Real Property</u>”
is defined in <u>Section&nbsp;4.20</u> of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Legal Proceeding</u>”
means any action, suit, charge, complaint, litigation, arbitration, proceeding (including any civil, criminal, administrative, investigative
or appellate proceeding), hearing, inquiry, audit, examination or investigation commenced, brought, conducted or heard by or before, or
otherwise involving, any court or other Governmental Body or any arbitrator or arbitration panel.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Material Adverse Effect</u>”
means any Effect which, individually or in the aggregate, (A)&nbsp;has had, or would reasonably be expected to have, a material adverse
effect on the business, assets, financial condition, results of operations or financial prospects of the Company and its Subsidiaries,
taken as a whole, or (B)&nbsp;would prevent the Company from consummating the Transactions on or before the End Date; <i>provided, </i>that
none of the following shall be deemed in and of themselves, either alone or in combination, to constitute, and none of the following shall
be taken into account in determining whether there is, or would reasonably be expected to be, a Material Adverse Effect:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Effect generally affecting the U.S. or foreign economies, financial or securities markets, or political, legislative, or regulatory conditions,
or the industries in which the Company and its Subsidiaries operate;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Effect arising out of or otherwise relating to fluctuations in the value of any currency exchange, interest or inflation rates or tariffs;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Effect arising out of or otherwise relating to any change (or proposed change) in, or any compliance with or action taken for the purpose
of complying with, any Law or GAAP (or interpretations of any Law or GAAP);</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Effect arising out of or otherwise relating to any act of terrorism, cyberterrorism (whether or not or sponsored by a Governmental
Body), outbreak of hostilities, acts of war, trade war, national or international calamity or any other similar event (or the
escalation of any of the foregoing);</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
acts of god, natural disasters, <i>force majeure</i> events, weather or environmental events, health emergencies, pandemics (including
COVID-19) or epidemics (or the escalation of any of the foregoing and any governmental or industry responses thereto), including any COVID-19
Measures;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
change in the market price or trading volume of the Company’s stock or change in the Company’s credit ratings;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
failure of the Company to meet internal or analysts’ expectations, projections, forecasts, guidance or estimates, including the
results of operations of the Company and its Subsidiaries, taken as a whole;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Effect or other matter resulting from the announcement of this Agreement and the Transactions, including any Transaction Legal Proceeding,
any Effect related to the identity of Parent, Purchaser or any of their Affiliates or Representatives, or facts and circumstances relating
thereto, or any loss or threatened loss of, or adverse change or threatened adverse change in, the relationship of the Company or any
of its Subsidiaries with any of their current or prospective suppliers, customers, wholesalers, service providers, distributors, licensors,
licensees, regulators, employees, creditors, stockholders or other third parties (other than for purposes of any representation or warranty
contained in <u>Section&nbsp;4.5</u> (<i>Non-Contravention</i>) but subject to disclosures in <u>Section&nbsp;4.5</u> of the Company Disclosure
Schedule);</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Effect arising out of or otherwise directly relating to (A)&nbsp;any action taken by the Company at the written direction or written approval
of Parent or Purchaser, or (B)&nbsp;any action specifically required to be taken by the Company or the failure of the Company to take
any action that the Company is specifically prohibited from taking by the terms of this Agreement (including due to Parent not granting
a consent requested by the Company pursuant to this Agreement);</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Effect arising out of or relating to Parent’s or Purchaser’s breach of this Agreement; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
actions taken by Parent, any of its Affiliates (including Purchaser) or their respective Representatives;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>provided, however,</i> that in the cases of
clauses (i)&nbsp;through (v)&nbsp;(other than COVID-19 Measures), such exclusion shall only be applicable to the extent such matter
does not have a materially disproportionate Effect on the Company and its Subsidiaries, taken as a whole, relative to other companies
in the industries in which the Company and its Subsidiaries operate that are of a similar size to the Company and its Subsidiaries, taken
as a whole, in which case such Effect shall be taken into account only to the extent of such materially disproportionate Effect on the
Company and its Subsidiaries, taken as a whole; <i>provided, further,</i> that in the cases of clauses&nbsp;(vi)&nbsp;and (vii), the underlying
causes of any such Effect may be considered in determining whether a Material Adverse Effect occurred to the extent not otherwise excluded
by another exception in this definition; and <i>provided, further</i>, that none of clauses (i)&nbsp;through (xi)&nbsp;are to be construed
as including the commencement or pendency of any Legal Proceeding against the Company or any of its Subsidiaries (except for the specific
Transaction Legal Proceeding exception in clause&nbsp;(viii)).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Material Company IP</u>”
means Company IP that claims the composition of matter of, or the method of making or using, any Company Product for an approved indication.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Material Contract</u>”
is defined in <u>Section&nbsp;4.10(a)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Merger</u>”
is defined in the Recitals of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Merger Consideration</u>”
is defined in <u>Section&nbsp;3.5(a)(iii)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Minimum Condition</u>”
is defined in <u>Annex I</u> to this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Nasdaq</u>”
means the Nasdaq Global Market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Non-Continuing
Employee</u>” is defined in <u>Section&nbsp;7.3(a)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Non-Continuing
Employee Severance Benefits</u>” is defined in <u>Section&nbsp;7.3(a)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Non-Disclosure Agreement</u>”
is defined in <u>Section&nbsp;6.1</u> of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Offer</u>” is
defined in the Recitals of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Offer Acceptance Time</u>”
is defined in <u>Section&nbsp;7.1(b)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Offer Commencement
Date</u>” means the date on which Purchaser commences the Offer, within the meaning of Rule&nbsp;14d-2 under the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Offer Conditions</u>”
is defined in <u>Section&nbsp;2.1(b)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Offer Documents</u>”
is defined in <u>Section&nbsp;2.1(e)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Offer Price</u>”
is defined in the Recitals of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Offer to Purchase</u>”
is defined in <u>Section&nbsp;2.1(b)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Option Consideration</u>”
is defined in <u>Section&nbsp;3.8(a)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Order</u>” means,
with respect to any Person, any order, judgment, decision, decree, injunction, ruling, writ, assessment or other similar requirement issued,
enacted, adopted, promulgated or applied by any Governmental Body of competent jurisdiction that is binding on or applicable to such Person
or its property.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Outbound License</u><b>”
</b>is defined in <u>Section&nbsp;4.8(c)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Packaging Materials</u>”
means any information (including prescription information such as labeling and package inserts, indications and safety instructions),
packaging (including any boxes or other containers) and similar materials in each case relating to the packaging of the Company Products
and including any material that is printed and employed in the packaging of the Company Products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Parent</u>”
is defined in the Preamble to this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Parent Material Adverse
Effect</u>” means any Effect that would, individually or in the aggregate, prevent, materially delay or materially impair the ability
of Parent or Purchaser to consummate the Transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Parent Related Parties</u>”
is defined in <u>Section&nbsp;9.3(b)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Parties</u>”
mean Parent, Purchaser and the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Paying Agent</u>”
is defined in <u>Section&nbsp;3.6(a)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Payment Fund</u>”
is defined in <u>Section&nbsp;3.6(a)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Permitted
Encumbrance</u>” means (a)&nbsp;any Encumbrance that arises out of Taxes either not delinquent or the validity of which is
being contested in good faith by appropriate proceedings, (b)&nbsp;any Encumbrance representing the rights of customers, suppliers,
service providers and subcontractors in the ordinary course of business under the terms of any Contracts to which the relevant party
is a party or under general principles of commercial or government contract Law (including mechanics’, materialmen’s,
carriers’, workmen’s, warehouseman’s, repairmen’s, landlords’ and similar liens granted or which arise
in the ordinary course of business), (c)&nbsp;in the case of any Contract, Encumbrances that are restrictions against the transfer
or assignment thereof that are included in the terms of such Contract or any license of Intellectual Property Rights, (d)&nbsp;any
Encumbrances for which appropriate reserves have been established in the consolidated financial statements of the Company and its
Subsidiaries, (e)&nbsp;any Inbound License and any Outbound License and (f)&nbsp;in the case of real property, Encumbrances that are
easements, rights-of-way, encroachments, restrictions, conditions and other similar Encumbrances incurred or suffered in the
ordinary course of business and which, individually or in the aggregate, do not and would not materially impair the use (or
contemplated use), utility or value of the applicable real property or otherwise materially impair the present or contemplated
business operations at such location, or zoning, entitlement, building and other land use regulations imposed by Governmental Bodies
having jurisdiction over such real property or that are otherwise set forth on a title report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Person</u>”
means any individual, Entity or Governmental Body.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Personal Data</u>”
mean (a)&nbsp;any information that identifies, or could reasonably be used to identify, any particular individual and (b)&nbsp;any other
information, including genetic material, that is protected by Privacy Obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Pre-Closing Period</u>”
is defined in <u>Section&nbsp;6.1</u> of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Privacy Obligations</u>”
means, as to any Person, all applicable Laws (including HIPAA), publicly-facing statements or privacy policies of such Person, self-regulatory
bodies to which such Person submits, industry codes of conduct, or contractual and fiduciary obligations of such Person to third parties
(including such Person’s employees), access, rectification, portability, deletion, restriction, automated decision making or objection
of any Person regarding Personal Data and all other valid and lawful requests related to data subject rights, in each case, concerning
the privacy, integrity, accuracy, protection, management, sharing, exchange or other Handling of Personal Data.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Product
Registrations</u>” means, with respect to the Company Products anywhere in the world, (a)&nbsp;any approvals, clearances,
registrations, licenses, biologics license applications, listings, permits, investigational new drug exemptions,&nbsp;INDs, new drug
applications, ODDs, breakthrough therapy designations, fast track designations, clinical trial authorizations or marketing
authorizations, including FDA drug listings, marketing authorization approvals and other national or regional marketing
authorizations or permits and CE marks, together with any supplements or amendments thereto (collectively, <font style="background-color: white">“<u>Registration
Approvals</u>”)</font>, whether pending or issued, to the Company or any of its Subsidiaries by the relevant Governmental Body
solely related to the research, development, manufacture, importation, distribution, marketing or sale of the Company Products over
which such Governmental Body has authority, (b)&nbsp;any rights that the Company or an Affiliate of the Company has in any
Registration Approval under any agreement pursuant to which any such Registration Approval is held in the name of a third party, and
(c)&nbsp;pricing and reimbursement approval (if applicable or available) and all national drug code numbers (if any) assigned to the
Company Products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Promotional Materials</u>”
means, collectively, any materials, including any sales, promotional and marketing materials or aids, advertising and display materials
(including journal and broadcast advertisements), websites and other social media and internet platforms, Company Product literature,
stationary, training materials and similar materials (including leave behind items, reprints, direct mailings, internet postings and sites),
in each case, in whatever medium (other than Packaging Materials) relating to the marketing, promotion and commercialization of the Company
Products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Purchaser</u>”
is defined in the Preamble to this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Registered IP</u>”
means all Intellectual Property Rights that are registered or issued under the authority of any Governmental Body, including all patents,
registered copyrights, registered mask works, and registered trademarks, service marks and trade dress, registered domain names and all
applications for any of the foregoing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Release</u>”
means any presence, emission, spill, seepage, leak, escape, leaching, discharge, injection, pumping, pouring, emptying, dumping, disposal,
migration, or release of Hazardous Materials from any source into or upon the environment, including the air, soil, improvements, surface
water, groundwater, the sewer, septic system, storm drain, publicly owned treatment works, or waste treatment, storage, or disposal systems.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Representatives</u>”
means, with respect to an Entity, its directors, officers, employees, attorneys, accountants, investment bankers, consultants, agents,
financial advisors, other advisors and other representatives.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>RSU Consideration</u>”
is defined in <u>Section&nbsp;3.8(b)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Sarbanes-Oxley Act</u>”
means the Sarbanes-Oxley Act of 2002.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Schedule&nbsp;14D-9</u>”
is defined in <u>Section&nbsp;2.2(a)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Schedule&nbsp;TO</u>”
is defined in <u>Section&nbsp;2.1(e)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>SEC</u>” means
the U.S. Securities and Exchange Commission.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Securities Act</u>”
means the Securities Act of 1933.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Shares</u>”
is defined in the Recitals of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Specified Agreement</u>”
is defined in <u>Section&nbsp;9.1(d)(i)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Stockholder List Date</u>”
is defined in <u>Section&nbsp;2.2(b)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Subsidiary</u>”
means, with respect to any Person, any Entity of which such Person directly or indirectly owns or purports to own, beneficially or of
record, (a)&nbsp;an amount of voting securities or other interests in such Entity that is sufficient to enable such Person to elect at
least a majority of the members of such Entity’s Board of Directors or equivalent governing body, or (b)&nbsp;at least 50% of the
outstanding equity or financial interests of such Entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Superior Offer</u>”
means a <i>bona fide</i> written Acquisition Proposal on terms that the Company Board (or a committee thereof) has determined in good
faith, after consultation with its financial advisor and outside legal counsel, would be more favorable, from a financial point of view,
to the stockholders of the Company (in their capacity as such) than the Transactions (taking into account any legal, regulatory, timing,
financing and other aspects of such Acquisition Proposal (including the capability of such Acquisition Proposal being consummated) and
any revisions to this Agreement made or proposed in writing by Parent prior to the time of such determination); <i>provided</i>, that
for purposes of the definition of “<u>Superior Offer</u>”, the references to “a material portion” and “10%
or more” in the definition of Acquisition Proposal shall be deemed to be references to “90% or more.”</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Surviving Corporation</u>”
is defined in the Recitals of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Takeover Laws</u>”
means any “moratorium,” “control share acquisition,” “fair price,” “supermajority,” “affiliate
transactions,” or “business combination statute or regulation” or other similar state anti-takeover Laws, but excluding
any Antitrust Laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Tax</u>” means
any tax of any kind whatsoever (including any income, franchise, capital gains, gross receipts, value-added, estimated, unemployment,
excise, ad valorem, transfer, stamp, sales, use, property, business, withholding or payroll tax), including any interest, penalty or
addition thereto, in each case imposed, assessed or collected by or under the authority of any Governmental Body.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Tax Return</u>”
means any return (including any information return), report, statement, declaration, estimate, schedule, notice, notification, form, election,
certificate or other document or information filed with or submitted to, or required to be filed with or submitted to, any Governmental
Body in connection with the determination, assessment, collection or payment of any Tax.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Termination Condition</u>”
is defined in <u>Annex I</u> to this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Termination Fee</u>”
is defined in <u>Section&nbsp;9.3(b)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Transactions</u>”
means (a)&nbsp;the execution and delivery of this Agreement and (b)&nbsp;all of the transactions contemplated by this Agreement and the
CVR Agreement, including the Offer and the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Transition Employee</u>”
means each employee of the Company who is employed by the Company as of immediately prior to the Effective Time to whom the Surviving
Corporation extends an offer of short-term employment (or other similar short-term services arrangement) with the Surviving Corporation
for a term of employment (or other service arrangement) with a duration of at least three (3)&nbsp;months following the Closing Date in
connection with transition or other integration matters, which such employee accepts on or prior to the Closing Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Transition Employee
Severance Benefits</u>” is defined in <u>Section&nbsp;7.3(a)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Trigger Event</u>”
is defined in <u>Section&nbsp;9.1(c)</u>&nbsp;of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">“<u>Willful Breach</u>”
means a deliberate act or a deliberate failure to act (including a failure to cure) by the Company, Parent or Purchaser, as the case may
be, which act or failure to act constitutes in and of itself a material breach of any agreement or covenant in this Agreement, regardless
of whether breaching this Agreement was the object of the act or failure to act (it being agreed by the Parties that Purchaser’s
failure to purchase all Shares validly tendered (and not validly withdrawn) when required to do so in accordance with the terms of this
Agreement shall be deemed to be a “<u>Willful Breach</u>”).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase">Article&nbsp;2</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">THE OFFER</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.1	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>The
Offer</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Commencement
of the Offer</u>. Provided that this Agreement shall not have been terminated in accordance with <u>Article&nbsp;9</u>, as promptly as
practicable after the Agreement Date (but in no event more than ten (10)&nbsp;Business Days after the Agreement Date), Purchaser shall
(and Parent shall cause Purchaser to) commence (within the meaning of Rule&nbsp;14d-2 under the Exchange Act) the Offer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Terms
and Conditions of the Offer</u>. The obligations of Purchaser to, and of Parent to cause Purchaser to, accept for payment, and pay
for, any Shares tendered pursuant to the Offer are subject to the terms and conditions of this Agreement, including the prior
satisfaction of the Minimum Condition and the satisfaction or waiver of the other conditions set forth in <u>Annex I</u>
(collectively, the “<u>Offer Conditions</u>”). The Offer shall be made by means of an offer to purchase (the
 “<u>Offer to Purchase</u>”) that contains the terms set forth in this Agreement, the Minimum Condition and the other
Offer Conditions. Purchaser expressly reserves the right to (i)&nbsp;increase the Offer Price, (ii)&nbsp;waive any Offer Condition
and (iii)&nbsp;make any other changes in the terms and conditions of the Offer not inconsistent with the terms of this Agreement; <i>provided,
however,</i> that unless otherwise provided by this Agreement, without the prior written consent of the Company, Purchaser shall not
(A)&nbsp;decrease the Offer Price, (B)&nbsp;change the form of consideration payable in the Offer, (C)&nbsp;decrease the maximum
number of Shares sought to be purchased in the Offer, (D)&nbsp;impose conditions or requirements to the Offer in addition to the
Offer Conditions, (E)&nbsp;amend or modify any of the Offer Conditions in a manner that adversely affects any holder of Shares or
that could, individually or in the aggregate, reasonably be expected to prevent or delay the consummation of the Offer or prevent,
delay or impair the ability of Parent or Purchaser to consummate the Offer, the Merger or the other Transactions, (F)&nbsp;amend,
modify, change or waive the Minimum Condition, the Termination Condition or the condition set forth in clause&nbsp;(g)&nbsp;of <u>Annex
I</u>, (G)&nbsp;terminate the Offer or accelerate, extend or otherwise change the Expiration, except as permitted under <u>Section&nbsp;2.1(c)</u>&nbsp;or <u>Section&nbsp;2.1(d)</u>,
(H)&nbsp;provide any “subsequent offering period” within the meaning of Rule&nbsp;14d-11 promulgated under the
Exchange Act or (I)&nbsp;amend or modify the terms of the CVRs or the CVR Agreement (other than in accordance with the definition
thereof).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Expiration
and Extension of the Offer</u>. The Offer shall initially be scheduled to expire at one (1)&nbsp;minute following 11:59 p.m.,
Eastern Time, on the date that is the twentieth (20<sup>th</sup>) Business Day following the Offer Commencement Date, determined as
set forth in Rule&nbsp;14d-1(g)(3)&nbsp;and Rule&nbsp;14e-1(a)&nbsp;under the Exchange Act, unless otherwise agreed to in
writing by Parent and the Company (such date or such subsequent date to which the expiration of the Offer is extended in accordance
with the terms of this Agreement, the “<u>Expiration Date</u>”). Subject to the Parties’ respective termination
rights under <u>Article&nbsp;9</u>: (i)&nbsp;if, as of the scheduled Expiration Date, any Offer Condition is not satisfied and has
not been waived, Purchaser may, in its discretion (and without the consent of the Company or any other Person), extend the Offer on
one or more occasions, for an additional period of up to ten (10)&nbsp;Business Days per extension, to permit such Offer Condition
to be satisfied; (ii)&nbsp;Purchaser shall (and Parent shall cause Purchaser to) extend the Offer from time to time for (A)&nbsp;any
period required by any Law, any interpretation or position of the SEC, the staff thereof or Nasdaq applicable to the Offer and
(B)&nbsp;periods of up to ten (10)&nbsp;Business Days per extension, until any waiting period (and any extension thereof) applicable
to the consummation of the Offer under the HSR Act shall have expired or been terminated; and (iii)&nbsp;if, as of the scheduled
Expiration Date, each Offer Condition (other than the Minimum Condition and other than any such conditions that by their nature are
to be satisfied at the expiration of the Offer) has been satisfied or waived and the Minimum Condition has not been satisfied, at
the request of the Company, Purchaser shall (and Parent shall cause Purchaser to) extend the Offer for an additional ten
(10)&nbsp;Business Day period to permit such the Minimum Condition to be satisfied; <i>provided</i>, <i>however</i>, in no event
shall Purchaser or Parent be required to (and Parent shall not be required to cause Purchaser to) extend the expiration of the Offer
pursuant to this clause&nbsp;(iii)&nbsp;for more than twenty (20) Business Days in the aggregate; <i>provided</i>, <i>further</i>,
in no event shall Purchaser (1)&nbsp;be required to extend the Offer beyond the earlier to occur of: (x)&nbsp;the valid termination
of this Agreement in compliance with <u>Article&nbsp;9</u> and (y)&nbsp;the first (1<sup>st</sup>) Business Day immediately
following the End Date (the earlier of clauses (x)&nbsp;and (y), the “<u>Extension Deadline</u>”) or (2)&nbsp;be
permitted to extend the Offer beyond the Extension Deadline without the prior written consent of the Company. Purchaser agrees that
it shall not, and Parent shall not permit or authorize Purchaser to, terminate or withdraw the Offer prior to any scheduled
Expiration Date without the prior written consent of the Company except in the event that this Agreement is terminated in accordance
with <u>Article&nbsp;9</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Termination
of Offer</u>. In the event that this Agreement is terminated pursuant to <u>Section&nbsp;9.1</u>, Purchaser shall (and Parent shall cause
Purchaser to) promptly (and, in any event, within twenty-four (24) hours of such termination), irrevocably and unconditionally terminate
the Offer and shall not acquire any Shares pursuant to the Offer. If the Offer is terminated or withdrawn by Purchaser, Purchaser shall
(and Parent shall cause Purchaser to) promptly return, and shall cause any depository acting on behalf of Purchaser to return, in accordance
with applicable Laws, all tendered Shares to the registered holders thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Offer
Documents</u>. As promptly as practicable on the date of commencement (within the meaning of Rule&nbsp;14d-2 under the Exchange Act)
of the Offer, Parent and Purchaser shall (i)&nbsp;file with the SEC a tender offer statement on Schedule&nbsp;TO with respect to the
Offer (together with all amendments and supplements thereto and including the exhibits thereto, the “<u>Schedule
TO</u>”) that will contain as an exhibit or incorporate by reference the Offer to Purchase, the form of the related letter of
transmittal and other customary ancillary documents in each case related to the Offer and (ii)&nbsp;cause the Offer to Purchase and
related documents to be disseminated to the holders of Shares. Each of Parent and Purchaser agrees to cause the Schedule&nbsp;TO and
all exhibits (including the Offer to Purchase), amendments or supplements thereto (collectively, the “<u>Offer
Documents</u>”) filed by either Parent or Purchaser with the SEC to comply in all material respects with the Exchange Act and
other applicable Laws, and to not contain any untrue statement of a material fact or omission of a material fact necessary in order
to make the statements made therein, in light of the circumstances under which they are made, not misleading. The Company shall
promptly furnish or otherwise make available to Parent and Purchaser or Parent’s legal counsel all information concerning the
Company and the Company’s stockholders that may be required in connection with any action contemplated by this <u>Section&nbsp;2.1(e)</u>&nbsp;so
as to enable each of Parent and Purchaser to comply with its obligations hereunder. Each of Parent, Purchaser and the Company agrees
to promptly correct any information provided by it for use in the Offer Documents if and to the extent that such information shall
have become false or misleading in any material respect, and Parent further agrees to take all steps necessary to cause the Offer
Documents as so corrected to be filed with the SEC and to be disseminated to the holders of Shares, in each case as and to the
extent required by applicable federal securities Laws. The Company and its counsel shall be given reasonable opportunity to review
and comment on the Offer Documents prior to the filing thereof with the SEC. Parent and Purchaser agree to provide the Company and
its counsel with prompt notice of any comments (whether written or oral) that Parent, Purchaser or their counsel may receive from
the SEC or its staff with respect to the Offer Documents (which notice shall include a copy of any written comments) and Parent and
Purchaser shall keep the Company and its counsel reasonably informed as to their proposed response to any such comments of the SEC
or its staff. Each of Parent and Purchaser shall respond promptly to any comments of the SEC or its staff with respect to the Offer
Documents or the Offer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Acceptance;
Payment Funds</u>. On the terms specified herein and subject only to the satisfaction or waiver (to the extent waivable by Parent or Purchaser)
of the Offer Conditions, Purchaser shall, and Parent shall cause Purchaser to, irrevocably accept for payment at the Offer Acceptance
Time and pay for, all of the Shares validly tendered (and not validly withdrawn) pursuant to the Offer as promptly as practicable after
the Offer Acceptance Time. Without limiting the generality of <u>Section&nbsp;10.10</u>, Parent shall cause to be provided to Purchaser
all of the funds necessary to purchase any Shares that Purchaser becomes obligated to purchase pursuant to the Offer, and shall cause
Purchaser to perform, on a timely basis, all of Purchaser’s obligations under this Agreement. Parent and Purchaser shall, and each
of Parent and Purchaser shall ensure that all of their respective Affiliates shall, tender any Shares held by them into the Offer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Adjustments</u>.
If, between the Agreement Date and the Offer Acceptance Time, the outstanding Shares are changed into a different number or class of shares
by reason of any stock split, division or subdivision of shares, stock dividend, reverse stock split, consolidation of shares, reclassification,
recapitalization or other similar transaction, then the Offer Price shall be appropriately adjusted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>CVR
Agreement</u>. At or prior to the Offer Acceptance Time, Parent shall duly authorize, execute and deliver, and shall ensure that the Rights
Agent duly authorizes, executes and delivers, the CVR Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;2.2	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Company
Actions</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedule&nbsp;14D-9</u>.
On the date that the Schedule TO is filed with the SEC, the Company shall file with the SEC and disseminate to the holders of Shares,
in each case as and to the extent required by applicable federal securities Laws, a Tender Offer Solicitation/Recommendation Statement
on Schedule&nbsp;14D-9 (together with any exhibits, amendments or supplements thereto, the “<u>Schedule&nbsp;14D-9</u>”)
that, subject to <u>Section&nbsp;7.1(b)</u>, shall reflect the Company Board Recommendation and include the notice and other information
required by Section&nbsp;262(d)(2)&nbsp;of the DGCL. The Company shall set the record date for the Company’s stockholders to receive
the notice of appraisal rights as the same date as the Stockholder List Date and shall disseminate the Schedule 14d-9 including such
notice of appraisal rights to the Company’s stockholders to the extent required by Section&nbsp;262(d)&nbsp;of the DGCL. The Company
agrees that it shall cause the Schedule&nbsp;14D-9 to comply in all material respects with the Exchange Act and other applicable
Laws and to not contain any untrue statement of a material fact or omission of a material fact necessary in order to make the statements
made therein, in light of the circumstances under which they are made, not misleading. Parent and Purchaser shall promptly furnish or
otherwise make available to the Company or its legal counsel all information concerning Parent and Purchaser and their stockholders that
may be required in connection with any action contemplated by this <u>Section&nbsp;2.2(a)</u>&nbsp;so as to enable the Company to comply
with its obligations hereunder. Each of Parent, Purchaser and the Company agrees to promptly correct any information provided by it for
use in the Schedule&nbsp;14D-9 if and to the extent that such information shall have become false or misleading in any material respect,
and the Company further agrees to take all steps necessary to cause the Schedule&nbsp;14D-9 as so corrected to be filed with the
SEC and to be disseminated to the holders of Shares, in each case as and to the extent required by applicable federal securities Laws.
Parent and its counsel shall be given reasonable opportunity to review and comment on the Schedule&nbsp;14D-9 prior to the filing
thereof with the SEC. The Company agrees to provide Parent and its counsel with prompt notice of any comments (whether written or oral)
that the Company or its counsel may receive from the SEC or its staff with respect to the Schedule&nbsp;14D-9 (which notice shall
include a copy of any written comments) and the Company shall provide Parent and its counsel a reasonable opportunity to participate
in the formulation of any response to any such comments of the SEC or its staff, including the opportunity to participate in any discussions
with the SEC or its staff concerning such comments. The Company shall respond promptly to any comments of the SEC or its staff with respect
to the Schedule&nbsp;14D-9. Notwithstanding anything to the contrary in this Agreement, the obligations of the parties in this <u>Section&nbsp;2.2(a)</u>&nbsp;shall
not apply if the Company Board effects a Company Adverse Change Recommendation or has formally determined to do so.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Stockholder
Lists</u>. The Company shall promptly (and in no event later than one (1)&nbsp;Business Day before the date the Offer Documents are
first disseminated) furnish Parent with, or shall cause to be promptly furnished to Parent, a list of its stockholders, mailing
labels and any available listing or computer file containing the names and addresses of all record holders of Shares and lists of
securities positions of Shares held in stock depositories, in each case accurate and complete as of the most recent practicable date
(the date of the list used to determine the Persons to whom the Offer Documents and the Schedule&nbsp;14D-9 are first
disseminated, the “<u>Stockholder List Date</u>”), and shall provide to Parent such additional information (including
updated lists of stockholders, mailing labels and lists of securities positions) and such other assistance as Parent may reasonably
request in connection with the Offer. Parent and Purchaser and their Representatives shall hold in confidence the information
contained in any such labels, lists and files, shall use such information only in connection with the Offer and the Merger and, if
this Agreement shall be terminated, shall promptly deliver, and shall use their reasonable best efforts to cause their
Representatives to deliver, to the Company (or destroy) all copies and any extracts or summaries from such information then in their
possession or control, and, if requested by the Company, promptly certify to the Company in writing that all such material has been
returned or destroyed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</p>

<!-- Field: Split-Segment; Name: 2 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase">Article&nbsp;3</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MERGER TRANSACTION</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;3.1
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Merger of Purchaser into the Company</u>. Upon the terms and subject to the conditions set forth in
this Agreement and in accordance with the Section&nbsp;251(h)&nbsp;of the DGCL, at the Effective Time, the Company and Parent shall
consummate the Merger, whereby Purchaser shall be merged with and into the Company, the separate existence of Purchaser shall cease
and the Company will continue as the Surviving Corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;3.2	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Effect
of the Merger</u>. The Merger shall have the effects set forth in this Agreement and in the applicable provisions of the DGCL. Without
limiting the generality of the foregoing, and subject thereto, at the Effective Time, all of the property, rights, privileges, powers
and franchises of the Company and Purchaser shall vest in the Surviving Corporation, and all debts, liabilities and duties of the Company
and Purchaser shall become the debts, liabilities and duties of the Surviving Corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;3.3	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Closing;
Effective Time</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless
this Agreement shall have been terminated pursuant to <u>Article&nbsp;9</u>, and unless otherwise mutually agreed in writing between
the Company, Parent and Purchaser, the consummation of the Merger (the “<u>Closing</u>”) shall take place remotely by
electronic exchange of documents, as soon as practicable following (but in any event on the same date as) the Offer Acceptance Time
except if, subject to <u>Section&nbsp;2.1(b)</u>, the condition set forth in <u>Section&nbsp;8.1</u> shall not be satisfied or
waived by such date, in which case on no later than the first (1<sup>st</sup>) Business Day on which the condition set forth in <u>Section&nbsp;8.1</u>
is satisfied or waived. The date on which the Closing occurs is referred to in this Agreement as the “<u>Closing
Date</u><i>.</i>”</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to the provisions of this Agreement, as soon as practicable on the Closing Date, the Company and Purchaser shall file or cause to be filed
a certificate of merger with the Secretary of State of the State of Delaware with respect to the Merger, in such form as required by,
and executed and acknowledged in accordance with, the applicable provisions of the DGCL. The Merger shall become effective upon the date
and time of the filing of such certificate of merger with the Secretary of State of the State of Delaware or such later date and time
as is agreed upon in writing by the Parties and specified in the certificate of merger (such date and time, the “<u>Effective Time</u>”).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;3.4	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Certificate
of Incorporation and Bylaws; Directors and Officers</u>. At the Effective Time:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
certificate of incorporation of the Surviving Corporation shall be amended and restated as of the Effective Time to conform to <u>Exhibit&nbsp;A</u>;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
bylaws of the Surviving Corporation shall be amended and restated as of the Effective Time to conform to <u>Exhibit&nbsp;B</u>;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
directors of the Surviving Corporation shall be the respective individuals who served as the directors of Purchaser as of immediately
prior to the Effective Time, until their respective successors are duly elected and qualified, or their earlier death, resignation or
removal; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
officers of the Surviving Corporation shall be the respective individuals who served as the officers of Purchaser as of immediately prior
to the Effective Time, until their respective successors are duly appointed and qualified, or their earlier death, resignation or removal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;3.5	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Conversion
of Shares</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
the Effective Time, by virtue of the Merger and without any further action on the part of Parent, Purchaser, the Company or any other
stockholder of the Company:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Shares then held by the Company or any of its Subsidiaries (including Shares held in the Company’s treasury) shall automatically
be canceled and retired and shall cease to exist, and no consideration shall be delivered in exchange therefor;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Shares then held by Parent, Purchaser or any other direct or indirect wholly owned Subsidiary of Parent shall automatically be canceled
and retired and shall cease to exist, and no consideration shall be delivered in exchange therefor;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;except
for (A)&nbsp;the Excluded Shares and (B)&nbsp;Dissenting Shares, each Share then issued and outstanding shall be converted into the right
to receive the Offer Price in cash, without interest (the “<u>Merger Consideration</u>”), subject to any withholding of Taxes
required by applicable Laws in accordance with <u>Section&nbsp;3.6(e)</u>; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;each
share of the common stock, $0.01 par value per share, of Purchaser then outstanding shall be converted into one (1)&nbsp;share of common
stock of the Surviving Corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If,
between the Agreement Date and the Effective Time, the outstanding Shares are changed into a different number or class of shares by reason
of any stock split, division or subdivision of shares, stock dividend, reverse stock split, consolidation of shares, reclassification,
recapitalization or other similar transaction, then the Merger Consideration shall be appropriately adjusted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;3.6	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Surrender
of Certificates; Stock Transfer Books</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior
to the Offer Acceptance Time, Parent shall designate a bank or trust company reasonably acceptable to the Company to act as agent
(the “<u>Depository Agent</u>”), for the holders of Shares to receive the funds to which such holders shall become
entitled pursuant to <u>Section&nbsp;2.1(b)</u>&nbsp;and to act as agent (the “<u>Paying Agent</u>”) for the holders of
Shares to receive the funds to which such holders shall become entitled pursuant to <u>Section&nbsp;3.5(a)(iii)</u>. The Paying
Agent Agreement pursuant to which Parent shall appoint the Paying Agent shall be in form and substance reasonably acceptable to the
Company. Immediately prior to the Offer Acceptance Time, Parent shall deposit, or shall cause to be deposited, with the Depository
Agent cash sufficient to make payment of the cash consideration payable pursuant to <u>Section&nbsp;2.1(b)</u>&nbsp;and with the
Paying Agent cash sufficient to make payment of the cash consideration payable pursuant to <u>Section&nbsp;3.5</u> (such deposits
with the Depository Agent and with the Paying Agent, collectively, the “<u>Payment Fund</u>”). For the avoidance of
doubt, Parent shall not be required to deposit any funds related to any CVR with the Rights Agent unless and until such deposit is
required pursuant to the terms of the CVR Agreement. The Payment Fund shall not be used for any purpose other than to pay the
aggregate Offer Price in the Offer and the aggregate Merger Consideration in the Merger; <i>provided</i>, <i>however</i>, the
Payment Fund may be invested by the Paying Agent as directed by the Surviving Corporation; <i>provided</i>, <i>further</i>, that
such investments shall be (1)&nbsp;in obligations of or guaranteed by the United States of America in commercial paper obligations
rated A-1 or P-1 or better by Moody’s Investors Service,&nbsp;Inc. or Standard&nbsp;&amp; Poor’s Corporation,
respectively, (2)&nbsp;in certificates of deposit, bank repurchase agreements or banker’s acceptances of commercial banks with
capital exceeding $1&nbsp;billion, or (3)&nbsp;in money market funds having a rating in the highest investment category granted by a
recognized credit rating agency at the time of acquisition or a combination of the foregoing and, in any such case, (i)&nbsp;<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
such investment will relieve Parent, Purchaser, or the Paying Agent from making the payments required by this <u>Article&nbsp;3</u>
and (ii)&nbsp;no such investment will have maturities that could prevent or delay payments to be made pursuant to this
Agreement.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Promptly
after the Effective Time (but in no event later than three (3)&nbsp;Business Days thereafter), the Surviving Corporation shall cause
to be mailed to each Person who was, at the Effective Time, a holder of record of Shares entitled to receive the Merger
Consideration pursuant to <u>Section&nbsp;3.5(a)(iii)</u>, (1)&nbsp;in the case of holders of record of Certificated Shares, a form
of letter of transmittal in reasonable and customary form (which shall specify that delivery shall be effected, and risk of loss and
title to the certificates evidencing such Shares (the “<u>Certificates</u>”) shall pass, only upon proper delivery of
the Certificates (or effective affidavits of loss in lieu thereof) to the Paying Agent) and instructions for use in effecting the
surrender of the Certificates pursuant to such letter of transmittal and (2)&nbsp;in the case of Book-Entry Shares, reasonable and
customary provisions regarding delivery of an “agent’s message” with respect to such Book-Entry Shares. Upon
surrender to the Paying Agent of Certificates (or effective affidavits of loss in lieu thereof) or Book-Entry Shares, together with,
in the case of Certificated Shares, such letter of transmittal, duly completed and validly executed in accordance with the
instructions thereto, and such other documents as may be reasonably required pursuant to such instructions, the holder of such
Certificates or Book-Entry Shares shall be entitled to receive in exchange therefor the Merger Consideration for each Share formerly
evidenced by such Certificates or Book-Entry Shares, and such Certificates and Book-Entry Shares shall then be canceled and of no
further effect. No interest shall accrue or be paid on the Merger Consideration payable upon the surrender of any Certificates or
Book-Entry Shares for the benefit of the holder thereof. If the payment of any Merger Consideration is to be made to a Person other
than the Person in whose name the surrendered Certificates formerly evidencing the Shares is registered on the stock transfer books
of the Company, it shall be a condition of payment that the Certificate so surrendered shall be endorsed properly or otherwise be in
proper form for transfer and that the Person requesting such payment shall have paid all transfer and other similar Taxes required
by reason of the payment of the Merger Consideration to a Person other than the registered holder of the Certificate surrendered, or
shall have established to the reasonable satisfaction of the Surviving Corporation that such Taxes either have been paid or are not
applicable. Payment of the applicable Merger Consideration with respect to Book-Entry Shares shall only be made to the Person in
whose name such Book-Entry Shares are registered.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
any time following twelve (12) months after the Effective Time, the Surviving Corporation shall be entitled to require the Paying Agent
to deliver to it any funds which had been made available to the Paying Agent and not disbursed to the holders of Certificates or of Book-Entry
Shares (including, all interest and other income received by the Paying Agent in respect of all Payment Funds), and, thereafter, such
holders shall be entitled to look to the Surviving Corporation (subject to abandoned property, escheat and other similar Laws) only as
general creditors thereof with respect to the Merger Consideration that may be payable upon due surrender of the Certificates or Book-Entry
Shares held by them. Notwithstanding the foregoing, neither the Surviving Corporation nor the Paying Agent shall be liable to any holder
of Certificates or of Book-Entry Shares for the Merger Consideration delivered in respect of such Share to a public official pursuant
to any abandoned property, escheat or other similar Laws. Any amounts remaining unclaimed by such holders at such time at which such amounts
would otherwise escheat to or become property of any Governmental Body shall become, to the extent permitted by applicable Laws, the property
of the Surviving Corporation or its designee, free and clear of all Encumbrances of any Person previously entitled thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
the close of business on the day of the Effective Time, the stock transfer books of the Company with respect to the Shares shall be closed
and thereafter there shall be no further registration of transfers of Shares on the records of the Company. From and after the Effective
Time, the holders of the Shares outstanding immediately prior to the Effective Time shall cease to have any rights with respect to such
Shares except as otherwise provided herein or by applicable Laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
of the Paying Agent, Parent, Purchaser and the Surviving Corporation shall be entitled to deduct and withhold from any amounts
(including any CVRs in respect of Shares) payable pursuant to this Agreement or the CVR Agreement to any holder of Shares, Company
Options, Company RSU Awards or Company ESPP account balances such amounts as it is required to deduct and withhold therefrom under
applicable Tax Laws; <i>provided</i>, <i>however</i>, that except for payments to current or former employees of the Company with
respect to Company Options and Company RSU Awards, before making any such deduction or withholding, Purchaser shall provide to the
Company notice of any applicable payor’s intention to make such deduction or withholding, which notice shall include the
authority, basis and method of calculation for the proposed deduction or withholding and shall provide at least a commercially
reasonable period of time before such deduction or withholding is required in order for the applicable recipient to obtain reduction
of or relief from such deduction or withholding from the applicable Governmental Body or execute and deliver to or file with such
Governmental Body or Purchaser such affidavits, certificates and other documents to afford reduction of or relief from such
deduction or withholding. To the extent that such amounts are so deducted and withheld, each such payor shall take all action as may
be necessary to ensure that any such amounts so withheld are timely and properly remitted to the appropriate Governmental Body, and
such amounts so remitted shall be treated for all purposes under this Agreement as having been paid to the Person to whom such
amounts would otherwise have been paid.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
any Certificate shall have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the Person claiming such Certificate
to be lost, stolen or destroyed and, if required by the Surviving Corporation, the posting by such Person of a bond, in such reasonable
amount as Parent may direct, as indemnity against any claim that may be made against it with respect to such Certificate (which shall
not exceed the Merger Consideration payable with respect to such Certificate), the Paying Agent will pay (less any amounts entitled to
be deducted or withheld pursuant to <u>Section&nbsp;3.6(e)</u>), in exchange for such lost, stolen or destroyed Certificate, the applicable
Merger Consideration to be paid in respect of the Shares formerly represented by such Certificate, as contemplated by this <u>Article&nbsp;3</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
anything to the contrary in this Agreement, no holder of uncertificated Shares held through the Depository Trust Company (“<u>DTC</u>”)
will be required to provide a Certificate or an executed letter of transmittal to the Paying Agent in order to receive the payment that
such holder is entitled to receive pursuant to <u>Section&nbsp;3.5(a)(iii)</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior
to the Effective Time, each of Parent, Purchaser and the Company will cooperate to establish procedures with the Paying Agent and DTC
with the objective that the Paying Agent will transmit to DTC or its nominees on the first (1<sup>st</sup>) Business Day after the Closing
Date an amount in cash, by wire transfer of immediately available funds, equal to (i)&nbsp;the number of Shares (other than Excluded Shares
and Dissenting Shares) held of record by DTC or such nominee immediately prior to the Effective Time, <i>multiplied by</i> (ii)&nbsp;the
Merger Consideration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;3.7	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Dissenters’
Rights</u>. Notwithstanding anything to the contrary in this Agreement, Shares outstanding immediately prior to the Effective Time, and
held by holders who are entitled to demand appraisal rights under Section&nbsp;262 of the DGCL and have properly exercised and perfected
their respective demands for appraisal of such shares in the time and manner provided in Section&nbsp;262 of the DGCL and, as of the Effective
Time, have neither effectively withdrawn nor lost their rights to such appraisal and payment under the DGCL (the “<u>Dissenting
Shares</u>”), shall not be converted into the right to receive Merger Consideration, but shall, by virtue of the Merger, be entitled
to only such consideration as shall be determined pursuant to Section&nbsp;262 of the DGCL; <i>provided, that</i> if any such holder shall
have failed to perfect or shall have effectively withdrawn or lost such holder’s right to appraisal and payment under the DGCL,
such holder’s Shares shall be deemed to have been converted as of the Effective Time into the right to receive the Merger Consideration
(less any amounts entitled to be deducted or withheld pursuant to <u>Section&nbsp;3.6(e)</u>), and such shares shall not be deemed to
be Dissenting Shares. Within ten (10)&nbsp;days after the Effective Time, the Surviving Corporation shall provide each of the holders
of Dissenting Shares with the second (2<sup>nd</sup>) notice contemplated by Section&nbsp;262(d)(2)&nbsp;of the DGCL. The Company shall
give prompt notice to Parent of any demands received by the Company for appraisal of any Shares, withdrawals of such demands and any other
instruments served to it pursuant to Section&nbsp;262 of the DGCL, in each case prior to the Effective Time. Unless this Agreement is
terminated pursuant to <u>Article&nbsp;9</u>, Parent and Purchaser shall have the right to direct and participate in all negotiations
and proceedings with respect to such demands, and the Company shall not, without the prior written consent of Parent and Purchaser, settle
or offer to settle, or make any payment with respect to, any such demands, or agree or commit to do any of the foregoing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;3.8	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Treatment
of Company Options, Company RSU Awards and Company ESPP</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Company Option that is outstanding as of immediately prior to the Offer Acceptance Time shall automatically accelerate and become
fully vested and exercisable effective immediately prior to, and contingent upon, the Offer Acceptance Time. As of the Effective
Time, by virtue of the Merger and without any further action on the part of the holders thereof, Parent, Purchaser or the Company,
each Company Option that is then outstanding and unexercised as of immediately prior to the Effective Time shall be cancelled and
converted into the right to receive (A)&nbsp;cash in an amount equal to <i>the product of</i> (i)&nbsp;the total number of Shares
subject to such fully vested Company Option immediately prior to the Effective Time, <i>multiplied by</i> (ii)&nbsp;the excess, if
any, of (x)&nbsp;the Cash Amount <i>minus</i> (y)&nbsp;the exercise price payable per Share under such Company Option, which amount
shall be paid in accordance with <u>Section&nbsp;3.8(c)</u>&nbsp;and (B)&nbsp;two (2)&nbsp;CVRs for each Share subject to such
Company Option immediately prior to the Effective Time (clauses&nbsp;(A)&nbsp;and (B), collectively, the “<u>Option
Consideration</u>”). No holder of a Company Option that has an exercise price per Share that is equal to or greater than the
Cash Amount shall be entitled to any payment with respect to such Company Option before or after the Effective Time, whether in the
form of cash or CVR or otherwise, and such Company Option shall be canceled and retired and shall cease to exist, and no
consideration shall be delivered in exchange therefor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Company RSU Award, including any performance award, that is outstanding as of immediately prior to the Offer Acceptance Time shall automatically
accelerate and become fully vested effective immediately prior to, and contingent upon, the Offer Acceptance Time. As of the Effective
Time, by virtue of the Merger and without any further action on the part of the holders thereof, Parent, Purchaser or the Company, each
Company RSU Award that is then outstanding and unexercised as of immediately prior to the Effective Time shall be cancelled and converted
into the right to receive (A)&nbsp;cash in an amount equal to <i>the product of</i> (i)&nbsp;the total number of Shares subject to such
fully vested Company RSU Award immediately prior to the Effective Time, <i>multiplied by</i> (ii)&nbsp;the Cash Amount, which amount shall
be paid in accordance with <u>Section&nbsp;3.8(c)</u>&nbsp;and (B)&nbsp;two (2)&nbsp;CVRs for each Share subject to such Company RSU Award
immediately prior to the Effective Time (clauses&nbsp;(A)&nbsp;and (B), collectively, the “<u>RSU Consideration</u>”).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
soon as reasonably practicable after the Effective Time (but no later than the later of (i)&nbsp;five (5)&nbsp;Business Days after the
Effective Time or (ii)&nbsp;the first (1<sup>st</sup>) payroll date after the Effective Time), Parent shall, or shall cause the Surviving
Corporation to, pay through the Surviving Corporation’s payroll the aggregate cash portion of the Option Consideration and RSU Consideration
payable with respect to Company Options and Company RSU Awards, respectively, held by current or former employees of the Company or any
of its Subsidiaries (net of any withholding Taxes required to be deducted and withheld by applicable Laws in accordance with <u>Section&nbsp;3.6(e)</u>);
<i>provided, however, </i>that to the extent the holder of a Company Option or Company RSU Award did not receive such Company Option or
Company RSU Award in the holder’s capacity as an employee of the Company or any of its Subsidiaries for employment tax purposes,
the cash portion of the Option Consideration or RSU Consideration payable pursuant to <u>Section&nbsp;3.8</u> with respect to such Company
Option or Company RSU Award shall be deposited in the Payment Fund and paid by the Paying Agent in the manner described in <u>Section&nbsp;3.6</u>.
The terms of the CVRs to be issued to any holder of Company Options and Company RSU Awards, and the circumstances in which any payment
is made in respect thereof, shall be governed solely by the CVR Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior
to the Closing, the Company shall take all reasonable actions required to (i)&nbsp;terminate the Company ESPP, as of immediately prior
to the Closing Date, (ii)&nbsp;if the Closing shall occur prior to the end of any offering period in existence under the Company ESPP
as of the Closing Date, cause a new exercise date to be set under the Company ESPP, which date shall be within ten (10)&nbsp;Business
Days prior to the Closing Date, for the automatic exercise of such options on such date, and (iii)&nbsp;provide that the amount of the
accumulated contributions of each participant under the Company ESPP as of immediately prior to the Effective Time shall, to the extent
not used to purchase Shares in accordance with the terms and conditions of the Company ESPP (as amended pursuant to this <u>Section&nbsp;3.8(c)</u>,
be refunded to such participant as promptly as practicable following the Effective Time (but no later than the later of (i)&nbsp;five
(5)&nbsp;Business Days after the Effective Time or (ii)&nbsp;the first payroll date after the Effective Time).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
soon as reasonably practicable after the Effective Time (but no later than the later of (i)&nbsp;five (5)&nbsp;Business Days after the
Effective Time or (ii)&nbsp;the first (1<sup>st</sup>) payroll date after the Effective Time), Parent shall, or shall cause the Surviving
Corporation to, pay through the Surviving Corporation’s payroll each Company employee’s Company ESPP account balance measured
as of the time of plan termination to be distributed in cash to each such employee (net of any withholding Taxes required to be deducted
and withheld by applicable Laws in accordance with <u>Section&nbsp;3.6(e)</u>).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Parties hereby acknowledge and agree that the Offer, if consummated pursuant to the terms of this Agreement, constitutes a “Change
in Control” for the purposes of the Company Equity Plans containing a “Change in Control” or other similar provision
and that all outstanding restricted Shares issued pursuant thereto shall be deemed vested as of immediately prior to the Offer Acceptance
Time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;3.9	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Further
Action</u>. The Parties agree to take all necessary action (subject to the limitations on the obligations of the Parties pursuant to <u>Article&nbsp;7</u>)
to cause the Merger to become effective in accordance with <u>Article&nbsp;3</u> as soon as practicable following the consummation of
the Offer without a meeting of the Company’s stockholders, as provided in Section&nbsp;251(h)&nbsp;of the DGCL. If, at any time
after the Effective Time, any further action is reasonably determined by Parent to be necessary or desirable to carry out the purposes
of this Agreement or to vest the Surviving Corporation with full right, title and possession of and to all rights and property of Purchaser
and the Company, the officers and directors of the Surviving Corporation and Parent shall be fully authorized (in the name of Purchaser,
in the name of the Company and otherwise) to take such action.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase">Article&nbsp;4</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">REPRESENTATIONS AND WARRANTIES OF THE COMPANY</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With respect to any Section&nbsp;of
this <u>Article&nbsp;4</u>, except (a)&nbsp;as disclosed in the reports, statements and other documents filed by the Company with the
SEC or furnished by the Company to the SEC, in each case pursuant to the Exchange Act on or after January&nbsp;1, 2020 (other than any
disclosures contained or referenced therein under the captions “risk factors,” “forward-looking statements” and
any other disclosures contained or referenced therein of information, factors or risks to the extent that they are predictive, cautionary
or forward-looking in nature) and (b)&nbsp;as set forth in the Company Disclosure Schedule (but subject to <u>Section&nbsp;10.13</u>),
the Company hereby represents and warrants to Parent and Purchaser as follows :</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.1	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Due
Organization; Subsidiaries, Etc.</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware. The Company has
all necessary corporate power and authority (i)&nbsp;to conduct its business in the manner in which its business is currently being conducted
and (ii)&nbsp;to own and use its assets in the manner in which its assets are currently owned and used, except where any failure of such
power and authority would not reasonably be expected to have a Material Adverse Effect. The Company is qualified or licensed to do business
as a foreign Entity, and is in good standing, in each jurisdiction where the nature of its business requires such qualification or licensing,
except where the failure to be so qualified, licensed or in good standing does not have and would not reasonably be expected to have a
Material Adverse Effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Section&nbsp;4.1(b)</u>&nbsp;of
the Company Disclosure Schedule identifies each Subsidiary of the Company and indicates its jurisdiction of organization. Each Subsidiary
of the Company is an Entity duly organized or formed, validly existing and, to the extent applicable in good standing under the laws of
the jurisdiction of its organization, except where the failure to be in good standing does not have, and would not reasonably be expected
to have, a Material Adverse Effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company does not own any capital stock of, or any other equity interest of, or any equity interest of any nature in, any other Entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.2	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Certificate
of Incorporation and Bylaws</u>. The Company has delivered or made available to Parent or Parent’s Representatives (i)&nbsp;accurate
and complete copies of its certificate of incorporation and bylaws, including all amendments thereto, as in effect on the Agreement Date
and (ii)&nbsp;accurate and complete copies of the organizational documents of each of its Subsidiaries, including all amendments thereto,
as in effect on the Agreement Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.3	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Authority;
Binding Nature of Agreement</u>. The Company has the corporate power and authority to enter into and deliver and to perform its obligations
under this Agreement and to consummate the Transactions. The Company Board has (a)&nbsp;determined that this Agreement and the Transactions,
including the Offer and the Merger, are fair to, and in the best interest of, the Company and its stockholders, (b)&nbsp;approved the
execution, delivery and performance by the Company of this Agreement and the consummation of the Transactions, (c)&nbsp;resolved that
the Merger shall be effected under Section&nbsp;251(h)&nbsp;of the DGCL and (d)&nbsp;resolved to recommend that the stockholders of the
Company tender their shares to Purchaser pursuant to the Offer, which resolutions, as of the Agreement Date, have not been subsequently
withdrawn or modified in a manner adverse to Parent. This Agreement has been duly executed and delivered by the Company, and assuming
due authorization, execution and delivery by Parent and Purchaser, this Agreement constitutes the legal, valid and binding obligations
of the Company and is enforceable against the Company in accordance with its terms, subject to (i)&nbsp;Laws of general application relating
to bankruptcy, insolvency and the relief of debtors and (ii)&nbsp;rules&nbsp;of law governing specific performance, injunctive relief
and other equitable remedies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.4	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Capitalization,
Etc.</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
authorized capital stock of the Company consists of: (i)&nbsp;100,000,000 Shares, of which 45,690,547 Shares have been issued and are
outstanding as of the close of business on October&nbsp;7, 2021; and (ii)&nbsp;5,000,000 shares of the Company’s preferred stock,
$0.001 par value per share, of which no shares have been issued or are outstanding. All of the outstanding Shares have been duly authorized
and validly issued and are fully paid and nonassessable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;None
of the outstanding Shares are entitled or subject to any preemptive right, right of repurchase or forfeiture, right of
participation, right of maintenance or any similar right; (ii)&nbsp;none of the outstanding Shares is subject to any right of first
refusal in favor of the Company; (iii)&nbsp;there are no outstanding bonds, debentures, notes or other Indebtedness of the Company
having a right to vote on any matters on which the stockholders of the Company have a right to vote; and (iv)&nbsp;there is no
Company Contract relating to the voting or registration of, or restricting any Person from purchasing, selling, pledging or
otherwise disposing of (or from granting any option or similar right with respect to), any Shares. The Company is not under any
obligation, nor is it bound by any Contract pursuant to which it may become obligated, to repurchase, redeem or otherwise acquire
any outstanding Shares or other securities. The Company Common Stock constitutes the only outstanding class of securities of the
Company or any of its Subsidiaries registered under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the close of business on October&nbsp;7, 2021: (i)&nbsp;7,415,095 Shares are subject to issuance pursuant to Company Stock Awards granted
and outstanding under the Company Equity Plans and (ii)&nbsp;5,543,480 Shares are reserved for future issuance under the Company Equity
Plans and under the Company ESPP Plan. The Company has delivered or made available to Parent or Parent’s Representatives copies
of the Company Equity Plans covering the Company Stock Awards outstanding as of the Agreement Date and the forms of all agreements evidencing
such Company Stock Awards Other than as set forth in this <u>Section&nbsp;4.4(c)</u>, there is no issued, reserved for issuance, outstanding
or authorized stock option, restricted stock unit award, stock appreciation, phantom stock, profit participation or similar rights or
equity-based awards with respect to the Company. Each Company Stock Award was granted with an exercise price or initial per share price
equal to or greater than the fair market value of the underlying Shares on the date of grant and has a grant date identical to the date
on which the Company Board or compensation committee of the Company Board actually awarded the Company Stock Award. Each Company Stock
Award qualifies for the tax and accounting treatment afforded to such Company Stock Award in the Company’s tax returns and the Company’s
financial statements, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as set forth in this <u>Section&nbsp;4.4</u>, as of the close of business on the Business Day immediately preceding the Agreement Date,
there are no: (i)&nbsp;outstanding shares of capital stock, or other equity interest in, the Company or any of its Subsidiaries; (ii)&nbsp;outstanding
subscriptions, options, calls, warrants or rights (whether or not currently exercisable) to acquire any shares of capital stock, restricted
stock units, stock-based performance units or any other rights that are linked to, or the value of which is in any way based on or derived
from the value of any shares of capital stock or other securities of the Company or any of its Subsidiaries; (iii)&nbsp;outstanding securities,
instruments, bonds, debentures, notes or obligations that are or may become convertible into or exchangeable for any shares of the capital
stock or other securities of the Company or any of its Subsidiaries; or (iv)&nbsp;stockholder rights plans (or similar plan commonly referred
to as a “<u>poison pill</u>”) or Contracts under which the Company or any of its Subsidiaries is or may become obligated to
sell or otherwise issue any shares of its capital stock or any other securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
of the outstanding capital stock or other voting securities of, or ownership interests in, each Subsidiary of the Company is owned by
the Company, directly or indirectly, beneficially and of record, free and clear of all Encumbrances and transfer restrictions, except
for such Encumbrances and transfer restrictions of general applicability as may be provided under the Securities Act or other applicable
securities laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.5	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Non-Contravention;
Consents</u>. Assuming compliance with the applicable provisions of the DGCL, the HSR Act and the rules&nbsp;and regulations of Nasdaq,
the execution and delivery of this Agreement by the Company and the consummation by the Company of the Transactions will not: (a)&nbsp;cause
a violation of any of the provisions of the certificate of incorporation or bylaws of the Company or the organizational documents of any
of the Company’s Subsidiaries; (b)&nbsp;cause a material violation by the Company or any of its Subsidiaries of any Law applicable
to the Company or any of its Subsidiaries or to which the Company or any of its Subsidiaries is subject; or (c)&nbsp;conflict with, result
in breach of, or constitute a default under, any Material Contract, except in the case of this clause&nbsp;(c), for such conflicts, breaches
or defaults as would not reasonably be expected to have a Material Adverse Effect. Except as may be required by the Exchange Act, the
DGCL, the HSR Act, the rules&nbsp;and regulations of Nasdaq and immaterial notices or consents, to the Knowledge of the Company, neither
the Company nor any of its Subsidiaries is required to give notice to, make any filing with, or obtain any Consent from any Governmental
Body at any time prior to the Closing in connection with the execution and delivery of this Agreement, or the consummation by the Company
of the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.6	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>SEC
Filings; Financial Statements</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
January&nbsp;1, 2019, the Company has filed or furnished on a timely basis all reports, schedules, forms, statements and other
documents (including exhibits and all other information incorporated therein) required to be filed or furnished by the Company with
the SEC (the “<u>Company SEC Documents</u>”). As of their respective dates, the Company SEC Documents complied in all
material respects with the requirements of the Securities Act, the Exchange Act or the Sarbanes-Oxley Act, as the case may be, and
the rules&nbsp;and regulations of the SEC promulgated thereunder applicable to such Company SEC Documents and, except to the extent
that information contained in such Company SEC Document has been revised, amended, modified or superseded (prior to the Agreement
Date) by a later filed Company SEC Document, none of the Company SEC Documents when filed or furnished contained any untrue
statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they were made, not misleading.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
consolidated financial statements (including any related notes and schedules) contained or incorporated by reference in the Company SEC
Documents: (i)&nbsp;complied as to form in all material respects with the published rules&nbsp;and regulations of the SEC applicable thereto;
(ii)&nbsp;were prepared in accordance with United States generally accepted accounting principles (“<u>GAAP</u>”) applied
on a consistent basis throughout the periods covered (except as may be indicated in the notes to such financial statements or as permitted
by Regulation&nbsp;S-X, or, in the case of unaudited financial statements, as permitted by Form&nbsp;10-Q, Form&nbsp;8-K or
any successor form under the Exchange Act); and (iii)&nbsp;fairly present, in all material respects, the financial position of the Company
and its consolidated Subsidiaries as of the respective dates thereof and the results of operations and cash flows of the Company and its
consolidated Subsidiaries for the periods covered thereby (except subject, in the case of the unaudited financial statements, to the absence
of footnote disclosure and to normal and recurring year-end adjustments that are not, individually or in the aggregate, material). No
financial statements of any Person other than the consolidated Subsidiaries of the Company are required by GAAP to be included in the
consolidated financial statements of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has designed and maintains a system of internal control over financial reporting (as defined in Rules&nbsp;13a-15(f)&nbsp;and
15d-15(f)&nbsp;of the Exchange Act) sufficient to provide reasonable assurance regarding the reliability of financial reporting. The
Company (i)&nbsp;has designed and maintains disclosure controls and procedures (as defined in Rules&nbsp;13a-15(e)&nbsp;and 15d-15(e)&nbsp;of
the Exchange Act) to provide reasonable assurance that all information required to be disclosed by the Company in the reports that it
files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s
rules&nbsp;and forms and is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding
required disclosure and (ii)&nbsp;has disclosed, based on its most recent evaluation of its internal control over financial reporting
and disclosure controls and procedures prior to the date of this Agreement, to the Company’s auditors and the audit committee of
the Company Board (A)&nbsp;any significant deficiencies and material weaknesses in the design or operation of its internal control over
financial reporting that are reasonably likely to adversely affect in any material respect the Company’s ability to record, process,
summarize and report financial information and (B)&nbsp;any fraud, whether or not material, that involves management or other employees
who have a significant role in the Company’s internal control over financial reporting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Company nor any of its Subsidiaries is a party to or has any obligation or other commitment to become a party to any securitization
transaction, off-balance sheet partnership or any similar Contract (including any Contract relating to any transaction or relationship
between or among the Company, on the one hand, and any unconsolidated Affiliate, including any structured finance, special purpose or
limited purpose Entity, on the other hand, or any “off-balance sheet arrangements” (as defined in Item&nbsp;303(a)&nbsp;of
Regulation S-K under the Exchange Act)) where the result, purpose or intended effect of such Contract is to avoid disclosure of any material
transaction involving, or material liabilities of, the Company and its Subsidiaries in the Company’s published financial statements
or other Company SEC Documents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
of the principal executive officer and the principal financial officer of the Company (or each former principal executive officer and
each former principal financial officer of the Company, as applicable) has made all certifications required by Rule&nbsp;13a-14 or 15d-14
under the Exchange Act and Sections 302 and 906 of the Sarbanes-Oxley Act with respect to the Company SEC Documents, and the statements
contained in such certifications are true and accurate in all material respects. For purposes of this Agreement, “principal executive
officer” and “principal financial officer” shall have the meanings given to such terms in the Sarbanes-Oxley Act.
The Company is also in compliance in all material respects with all of the other applicable provisions of the Sarbanes-Oxley Act and the
applicable listing and corporate governance rules&nbsp;of Nasdaq.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
January&nbsp;1, 2020: (i)&nbsp;none of the Company or any of its Subsidiaries nor any director or officer of the Company or any of its
Subsidiaries has received any complaint, allegation, assertion, or claim regarding the financial accounting, internal accounting controls,
or auditing practices, procedures, methodologies, or methods of the Company or any of its Subsidiaries or any complaint, allegation, assertion,
or claim from employees of the Company or any of its Subsidiaries regarding questionable financial accounting or auditing matters with
respect to the Company or any of its Subsidiaries; and (ii)&nbsp;no attorney representing the Company or any of its Subsidiaries, whether
or not employed by the Company or any of its Subsidiaries, has reported any evidence of any material violation of securities Laws, breach
of fiduciary duty, or similar material violation by the Company, any of its Subsidiaries, or any of their respective officers, directors,
employees, or agents to the Company Board or any committee thereof, or to the chief executive officer, chief financial officer, or general
counsel of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
document required to be filed by the Company with the SEC in connection with the Offer (the “<u>Company Disclosure
Documents</u>”) (including the Schedule&nbsp;14D-9), and any amendments or supplements thereto, when filed, distributed or
disseminated, as applicable, will comply as to form in all material respects with the applicable requirements of the Exchange Act.
The Company Disclosure Documents, at the time of the filing of such Company Disclosure Documents or any supplement or amendment
thereto with the SEC and at the time such Company Disclosure Documents or any supplements or amendments thereto are first
distributed or disseminated to the Company’s stockholders, will not contain any untrue statement of a material fact or omit to
state any material fact necessary in order to make the statements made therein, in light of the circumstances under which they were
made, not misleading. The information with respect to the Company and its Subsidiaries that the Company furnishes to Parent or
Purchaser in writing specifically for inclusion or incorporation by reference in the Schedule&nbsp;TO and the Offer Documents, at
the time of the filing of the Schedule&nbsp;TO and at the time of any distribution or dissemination of the Offer Documents, will not
contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made
therein, in light of the circumstances under which they were made, not misleading. Notwithstanding the foregoing, the Company makes
no representation with respect to statements made or incorporated by reference therein based on information supplied by or on behalf
of Parent or Purchaser for inclusion or incorporation by reference in the Company Disclosure Documents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.7	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Absence
of Changes</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
the date of the Balance Sheet through the Agreement Date, there has not occurred any Effect that, individually or in the aggregate, has
had or would be reasonably expected to have a Material Adverse Effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
the date of the Balance Sheet, the Company and its Subsidiaries have operated in all material respects in the ordinary course of business
(except for matters relating to the Transactions, this Agreement or other potential strategic transactions).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.8	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Intellectual
Property</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Section&nbsp;4.8(a)</u>&nbsp;of
the Company Disclosure Schedule identifies (i)&nbsp;the name of the applicant/registrant, (ii)&nbsp;the jurisdiction of
application/registration, (iii)&nbsp;the application or registration number and (iv)&nbsp;any other co-owners, for each item of
material Registered IP owned in whole or in part by the Company or any of its Subsidiaries. To the Knowledge of the Company, each of
the patents and patent applications included in such material Registered IP properly identifies by name each and every inventor of
the claims thereof as determined in accordance with applicable Laws of the United States. As of the Agreement Date, no interference,
opposition, reissue, reexamination or other proceeding of any nature (other than initial examination proceedings) is pending in
which the scope, validity, enforceability, inventorship or ownership of any material Registered IP listed on <u>Section&nbsp;4.8(a)</u>&nbsp;of
the Company Disclosure Schedule is being or has been contested or challenged.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Either
the Company or one of its Subsidiaries owns and possesses or has a license to the right, title and interest in and to all Material Company
IP (except for the right, title and interest of any co-owner disclosed on <u>Section&nbsp;4.8(a)</u>&nbsp;of the Company Disclosure
Schedule), free and clear of all Encumbrances (other than Permitted Encumbrances and any Encumbrances caused or created by any action
or failure to act by any Person other than the Company or any of its Subsidiaries). No Company Associate or other Person (other than as
disclosed on <u>Section&nbsp;4.8(a)</u>&nbsp;of the Company Disclosure Schedule) owns or has any claim, right (whether or not currently
exercisable) or interest to or in any Material Company IP, other than any non-exclusive claim, right or interest, and each Company
Associate who is or was involved in the creation or development of any Company IP, pursuant to such Company Associate’s activities
on behalf of the Company or its Subsidiaries, has signed a written agreement containing an assignment to the Company or one of its Subsidiaries
of Intellectual Property Rights arising from such activities and confidentiality provisions protecting the Company IP.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Section&nbsp;4.8(c)</u>&nbsp;of
the Company Disclosure Schedule sets forth each license agreement pursuant to which the Company or any of its Subsidiaries (i)&nbsp;has
a license to any Material Company IP (other than any transfer agreements, services agreements, clinical trial agreements, non-disclosure
agreements, commercially available Software-as-a-Service offerings, off-the-shelf software licenses or generally available
patent license agreements entered into in the ordinary course of business) (each an “<u>Inbound License</u>”) or (ii)&nbsp;has
granted a license to any Material Company IP (other than any transfer agreements, services agreements, clinical trial agreements, non-disclosure
agreements, or non-exclusive outbound licenses entered into in the ordinary course of business) (each an “<u>Outbound License</u>”).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the Knowledge of the Company: (i)&nbsp;the operation of the business of the Company and its Subsidiaries as currently conducted does
not infringe any valid and enforceable Registered IP or misappropriate or otherwise violate any other Intellectual Property Right
owned by any other Person and (ii)&nbsp;no other Person is infringing, misappropriating or otherwise violating any Company IP. As of
the Agreement Date, no Legal Proceeding is pending and served (or, to the Knowledge of the Company, is being threatened in writing)
against the Company or any of its Subsidiaries or by the Company or any of its Subsidiaries relating to any actual, alleged or
suspected infringement, misappropriation or other violation of any Intellectual Property Rights of another Person or of the Company
IP. Since January&nbsp;1, 2020, the Company has not received any written notice or other written communication relating to any
actual, alleged or suspected infringement, misappropriation or other violation of any Intellectual Property Right of another Person
by the Company or any of its Subsidiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the Knowledge of the Company, the Company and its Subsidiaries have taken reasonable security and other measures to protect the Company
IP, including reasonable measures against unauthorized disclosure, to protect the secrecy, confidentiality, and value of its trade secrets
and other technical information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None
of the Material Company IP is subject to any pending or outstanding Order or other disposition of dispute that adversely and materially
restricts the use, transfer, registration or licensing of any such Material Company IP by the Company or any of its Subsidiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.9	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Privacy
and Security</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as would not reasonably be expected to be material to the business of the Company or the Subsidiaries, taken as a whole, (i)&nbsp;the
Company’s and the Subsidiaries’ receipt, access, acquisition, collection, compilation, use, storage, alteration, combination
processing, safeguarding, security, disposal, deletion, destruction, disclosure, sale, rental, transfer, transmission, dissemination,
or otherwise making available, in each case whether or not by automated means (collectively, “<u>Handling</u>”), of Personal
Data has been and is in compliance with all Privacy Obligations applicable to such Personal Data, (ii)&nbsp;the Company and the Subsidiaries
maintain policies and procedures (copies of which have been made available to Parent) regarding the protection of Personal Data and reasonable
and appropriate administrative, technical and physical safeguards, including implementing reasonable disaster recovery and security plans
and procedures so that the Company and its Subsidiaries are and remain in compliance with all Privacy Obligations applicable to them.
(iii)&nbsp;each such policy and procedure and all materials distributed or marketed by the Company or its Subsidiaries have at all times
made all disclosures to users or customers required by its Privacy Obligations, and (iv)&nbsp;none of such disclosures has been inaccurate,
misleading or deceptive or in violation of any Privacy Obligation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the Knowledge of the Company, there has been no unauthorized acquisition of, access to, loss of or misuse (by any means) of Personal
Data or any of the Company and its Subsidiaries’ Information Technology (and similar or related infrastructure including all
associated data contained therein, cloud (including public cloud), as-a-service product or service) (each a “<u>Security
Breach</u>”). The Company and its Subsidiaries have not been notified in writing by any Person of, or been required by any
Privacy Obligation to notify in writing any Person of, any Security Breach. The Company and its Subsidiaries have not received any
notice of any material Security Breach or any claims, investigations (including investigations by a Governmental Body) or alleged
material violations of Privacy Obligations with respect to Personal Data handled by any of them. No internal or independent third
party audit reports have identified material security vulnerabilities in the Company and its Subsidiaries’ Information
Technology (and similar or related infrastructure including all associated data contained therein, cloud (including public cloud),
as-a-service product or service) or material violations of any Privacy Obligation, or documented any material compliance gaps.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and its Subsidiaries have obtained all requisite consents of Governmental Bodies or other authorizations of Governmental Bodies
and all requisite consents from each Person that is the subject of the Personal Data (including, in each case, any required notices to
such Persons) to the extent required under all Privacy Obligations. The execution, delivery and performance of this Agreement, including
the transfer of data or databases or the change of data controller and data processor related thereto, complies with all Privacy Obligations.
None of the Company or its Subsidiaries are subject to any contractual requirements or other legal obligations that, following the Closing,
would prohibit Parent or the Surviving Corporation from receiving or using Personal Data in the manner in which the Company and its Subsidiaries
received and used such Personal Data prior to the Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the Knowledge of the Company, there have been no complaints, claims or warnings made or concerns raised by any Person in respect of any
Personal Data, and no enforcement notice has been served on the Company and its Subsidiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.10	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Contracts</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Section&nbsp;4.10(a)</u>&nbsp;of
the Company Disclosure Schedule identifies each Company Contract that constitutes a Material Contract as of the Agreement Date. Each of
the following Company Contracts shall be deemed to constitute a “<u>Material Contract</u>” for purposes of this Agreement:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Company Contract that requires by its terms or is reasonably likely to require the payment or delivery of cash or other consideration
by or to the Company or any of its Subsidiaries in an amount having an expected value in excess of $350,000 in the fiscal year ending
December&nbsp;31, 2021 or in any fiscal year thereafter and cannot be cancelled by the Company or any of its Subsidiaries without penalty
or further payment without more than ninety (90) days’ notice (other than payments for services rendered to the date), excluding
commercially available off-the-shelf software licenses and Software-as-a-Service offerings, generally available patent license
agreements entered into in the ordinary course of business and non-exclusive outbound licenses entered into in the ordinary course
of business;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Company Contract pursuant to which the Company or any of its Subsidiaries has contingent obligations that upon satisfaction of certain
conditions precedent will result in the payment by the Company or any of its Subsidiaries of more than $350,000 in the aggregate in the
fiscal year ending December&nbsp;31, 2021 or in any fiscal year thereafter, in either milestone payments or royalties, upon (A)&nbsp;the
achievement of regulatory or commercial milestones or (B)&nbsp;the receipt of revenue or income based on product sales;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Company Contract (A)&nbsp;limiting the freedom or right of the Company or any of its Subsidiaries, in any material respect, to engage
in any line of business, to make use of any material Company IP or to compete with any other Person in any location or line of business,
(B)&nbsp;containing any “most favored nations” terms and conditions (including with respect to pricing) granted by the Company
or any of its Subsidiaries or (C)&nbsp;containing exclusivity obligations or restrictions or otherwise materially limiting the freedom
or right of the Company or any of its Subsidiaries: (1)&nbsp;to sell, distribute or manufacture any products or services or any technology
or other assets to or for any other Person, or (2)&nbsp;to acquire or obtain any products or services from any other Person;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Company Contract constituting a joint venture, partnership or similar profit-sharing arrangement;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Company Contract constituting a Company Employee Agreement pursuant to which the Company or any of its Subsidiaries is or may become
obligated to (A)&nbsp;make any severance, termination, or similar payment to any Company Associate or any spouse or heir of any
Company Associate except for severance, termination or similar payments that do not exceed $200,000 in cash per beneficiary or that
is required by applicable Laws, (B)&nbsp;make any bonus, deferred compensation or similar payment (other than payments constituting
base salary, bonuses or commissions paid in the ordinary course of business or in accordance with past performance or a Company
Employee Agreement) in excess of $200,000 to any Company Associate, or (C)&nbsp;grant or accelerate the vesting of, or otherwise
modify, any Company Stock Award other than accelerated vesting provided in the Company Equity Plans or any other Company Employee
Agreement;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Company Contract with any Affiliate, director, executive officer (as such term is defined in the Exchange Act), holder of 5% or more of
Shares, or to the Knowledge of the Company, any of their Affiliates (other than the Company and its Subsidiaries) or immediate family
members (other than offer letters that can be terminated at will without severance obligations and Company Contracts pursuant to Company
Stock Awards);</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Company Contract, that is currently in effect and under which there remain material executory obligations, that relates to the acquisition
or disposition of any material business, a material amount of stock or assets of any Person or any real property (whether by merger, sale
of stock, sale of assets or otherwise) but excluding any transfer agreements, services agreements, clinical trial agreements and non-exclusive
licenses granted in the ordinary course of business;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Company Contract with any Governmental Body, other than any Company Contract, authorization, approval or program under which the Company
or any of its Subsidiaries, directly or indirectly, (A)&nbsp;receives refunds, rebates, repayments, reimbursements or similar payments
from or (B)&nbsp;makes any payments to, in each case, any Governmental Body in connection with Medicare and any similar federal, state
or local governmental programs;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Company Contract that is a settlement, conciliation or similar agreement with or approved by any Governmental Body: (A)&nbsp;pursuant
to which the Company or any of its Subsidiaries will be required after the Agreement Date to pay any monetary obligations or (B)&nbsp;that
contains material obligations or limitations on the Company’s or any of its Subsidiaries’ conduct;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Company Contract relating to Indebtedness in excess of $1,000,000 (whether incurred, assumed, guaranteed or secured by any asset) of the
Company or any of its Subsidiaries;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
hedging, swap, derivative or similar Company Contract; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
other Company Contract that is currently in effect and has been filed (or is required to be filed) by the Company as an exhibit pursuant
to Item&nbsp;601(b)(10)&nbsp;of Regulation S-K under the Securities Act or that would be required to be disclosed under Item&nbsp;404
of Regulation S-K under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the Agreement Date, the Company has either delivered or made available to Parent or Parent’s Representatives an accurate and
complete copy of each Material Contract or has publicly made available such Material Contract in the Electronic Data Gathering, Analysis
and Retrieval (EDGAR) database of the SEC. Neither the Company, any of its Subsidiaries nor, to the Knowledge of the Company, the other
party is in material breach of or material default under any Material Contract and, neither the Company, any of its Subsidiaries, nor,
to the Knowledge of the Company, the other party has taken or failed to take any action that with or without notice, lapse of time or
both would constitute a material breach of or material default under any Material Contract. Each Material Contract is, with respect to
the Company or any of its Subsidiaries and, to the Knowledge of the Company, the other party, a valid agreement, binding, and in full
force and effect. To the Knowledge of the Company, each Material Contract is enforceable by the Company or its Subsidiaries in accordance
with its terms, subject to (i)&nbsp;Laws of general application relating to bankruptcy, insolvency and the relief of debtors and (ii)&nbsp;rules&nbsp;of
law governing specific performance, injunctive relief and other equitable remedies. Since January&nbsp;1, 2020 through the Agreement Date,
neither the Company nor any of its Subsidiaries have received any written notice regarding any violation or breach or default under any
Material Contract that has not since been cured, except for violations or breaches that are immaterial. Neither the Company nor any of
its Subsidiaries have waived in writing any material rights under any Material Contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.11	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>No
Undisclosed Liabilities</u>. As of the Agreement Date, the Company and its Subsidiaries do not have any liabilities of the type required
to be disclosed in the liabilities column of a consolidated balance sheet prepared in accordance with GAAP, except for: (i)&nbsp;liabilities
disclosed on any balance sheet contained in the Company SEC Documents (including in the notes thereto); (ii)&nbsp;liabilities or obligations
incurred pursuant to the terms of this Agreement or in connection with the Transactions; (iii)&nbsp;liabilities arising in the ordinary
course of business in connection with performance obligations of the Company or any of its Subsidiaries under the Company Contracts (other
than those liabilities resulting from any breach by the Company thereof); (iv)&nbsp;liabilities incurred since the date of the Balance
Sheet in the ordinary course of business; and (v)&nbsp;immaterial liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.12	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Litigation</u>.
As of the Agreement Date, there is no material Legal Proceeding pending (or, to the Knowledge of the Company, threatened) against the
Company or any of its Subsidiaries, or against any present or former officer or director of the Company or any of its Subsidiaries in
such individual’s capacity as such. As of the Agreement Date, there is no material legally-binding settlement, Order, corporate
integrity agreement, monitoring agreement, consent decree, settlement order, or similar agreement to which the Company or any of its Subsidiaries
is subject, nor is the Company or any of its Subsidiaries in material breach or violation of any Order. As of the Agreement Date, no investigation
or review by any Governmental Body with respect to the Company or any of its Subsidiaries is pending or, to the Knowledge of the Company,
is being threatened, other than any investigations or reviews that would not, individually or in the aggregate, reasonably be expected
to be material.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.13	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Compliance
with Laws</u>. The Company and each of its Subsidiaries is, and since January&nbsp;1, 2018, the Company and each of its Subsidiaries has
been, in compliance with all applicable Laws, except where the failure to be in compliance has not had and would not reasonably be expected
to have a Material Adverse Effect and, since January&nbsp;1, 2018 through the Agreement Date, to the Company’s Knowledge, neither
the Company nor any of its Subsidiaries has been given written notice of, or been charged with, any unresolved violation of any Law, except,
in each case, for any such violation that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.14	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Regulatory
Matters; Product Liability and Recalls</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and its Subsidiaries have complied in all material respects with all obligations to make filings, declarations, listings, registrations,
reports or submissions (including but not limited to adverse event reports) with the FDA or any other Governmental Body performing functions
similar to those performed by the FDA. All such filings, declarations, listings, registrations, reports or submissions were in compliance
with applicable Laws in all material respects when filed (or were corrected or supplemented by a subsequent submission), and no deficiencies
have been asserted by any applicable Governmental Body with respect to any such filings, declarations, listing, registrations, reports
or submissions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
preclinical and clinical investigations sponsored by the Company or any of its Subsidiaries are being conducted in compliance with
applicable Laws in all material respects. As of the Agreement Date, neither the Company nor any of its Subsidiaries have received
any written notices or other written correspondence from the FDA or any other Governmental Body performing functions similar to
those performed by the FDA with respect to any ongoing clinical or pre-clinical studies or tests requiring the termination,
suspension or material modification of such studies or tests.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole, neither the Company nor any
of its Subsidiaries have (i)&nbsp;made an untrue statement of a material fact to the FDA or any other Governmental Body performing functions
similar to those performed by the FDA, (ii)&nbsp;failed to disclose a material fact required to be disclosed to the FDA or (iii)&nbsp;committed
any other act, made any statement or failed to make any statement, that (in any such case) establishes a reasonable basis for the FDA
to invoke its Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities Final Policy. As of the Agreement Date, the
Company is not the subject of any pending or, to the Company’s Knowledge, threatened investigation by the FDA pursuant to its Fraud,
Untrue Statements of Material Facts, Bribery, and Illegal Gratuities Final Policy. Neither the Company, any of its Subsidiaries nor, to
the Knowledge of the Company, any officers, employees, agents or clinical investigators of the Company or any of its Subsidiaries has
been suspended or debarred or convicted of any crime or engaged in any conduct that would reasonably be expected to result in (a)&nbsp;debarment
under 21&nbsp;U.S.C. Section&nbsp;335a or any similar Law or (b)&nbsp;exclusion under 42&nbsp;U.S.C. Section&nbsp;1320a-7 or any similar
Law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and its Subsidiaries are not, and since the date of the introduction of the Company Products to human populations have not been,
in violation of any applicable Law, including (i)&nbsp;the FDCA and applicable binding implementing regulations issued by the FDA and
(ii)&nbsp;the applicable Laws of any other jurisdiction, except, in the case of each of the foregoing clauses (i)&nbsp;and (ii), for violations
that would not, individually or in the aggregate, reasonably be expected to be material to the business of the Company and its Subsidiaries,
taken as a whole. None of the Company and its Subsidiaries has received any written notice, warning letter, or similar written communication
that (A)&nbsp;alleges a material violation of, or asserts a material failure to comply with, any applicable Law, or (B)&nbsp;imposes an
obligation to undertake, or to bear all or any portion of the cost of, any remedial action of any nature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as would not, individually or in the aggregate, reasonably be expected to be material to the Company or the Subsidiaries, taken as a
whole:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and its Subsidiaries own, possess or validly have the right to use all Permits required to research, develop, manufacture, market,
commercialize, distribute and sell the Company Products;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
Company Products (including any raw materials used in the manufacture thereof) are and have been researched, developed, manufactured and
marketed in accordance with applicable specifications, Permits and applicable Laws, including GMPs, GLPs, GCPs, GDPs and GVPs;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
January&nbsp;1, 2020, (A)&nbsp;no Company Product or manufacturing site has shut down, been subject to any import or export prohibition,
received any FDA Form&nbsp;483 or other Governmental Body notice of inspectional observations, “warning letters,” “untitled
letters” or requests or requirements to make changes to a Company Product or any manufacturing operations for a Company Product
and (B)&nbsp;no manufacturing site has received any written correspondence or written notice from the FDA or another Governmental Body
alleging or asserting noncompliance with any Law, Permits or any requests or requirements of a Governmental Body; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Either
the Company or one of its Subsidiaries is the sole and exclusive owner of each Product Registration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has made available to Parent or its Representatives true, complete and correct copies of all material Product Registrations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
January&nbsp;1, 2018, the Company and its Subsidiaries have performed audits of all manufacturing sites that supply regulatory starting
materials, drug substances, drug product intermediates, drug products or finished products to the Company or the Subsidiaries to the extent
permitted by any Contract relating to such manufacturing site or required by applicable Law. To the Knowledge of the Company, there are
no critical finds resulting from such audits or inspections since January&nbsp;1, 2018 that have not been remediated and such remediation
has been agreed to by the FDA. To the Knowledge of the Company, any such manufacturing site has materially performed all tasks required
by such remediation plans. The Company has made available to Parent complete and accurate copies of all reports from all audits or inspections
conducted since January&nbsp;1, 2018 by the Company and its Subsidiaries or, to the extent in the possession or control of the Company
and its Subsidiaries, by their Representatives or any Governmental Bodies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
January&nbsp;1, 2018, there have been no recalls, field notifications, field corrections, warnings, “dear doctor”
letters, investigator notices, safety alerts or other notices of action relating to an alleged lack of safety, efficacy, or
regulatory compliance of the Company Products (collectively, “<u>Safety Notices</u>”) and, to the Knowledge of the
Company, no facts or circumstances exist that would reasonably be expected to result in any Safety Notice with respect to Company
Products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
pre-clinical and clinical investigations in respect of a Company Product or Company Product candidate conducted or sponsored by the Company
or any of its Subsidiaries are being and, since the date of introduction of the Company Products to human populations, have been, conducted
in compliance with all applicable Laws, including (i)&nbsp;FDA regulations for the design, conduct, performance, monitoring, auditing,
recording, analysis and reporting of clinical trials contained in Title 21 parts 50, 54, 56, 312, 314 and 320 of the Code of Federal Regulations,
and (ii)&nbsp;any applicable federal, state and provincial applicable Laws restricting the collection, use and disclosure of individually
identifiable health information and personal information, except, in each case, for such noncompliance that, individually or in the aggregate,
would not reasonably be expected to be material to the business of the Company and its Subsidiaries, taken as a whole.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Company nor any of its Subsidiaries has received since January&nbsp;1, 2020 any written notice of observations, untitled letter, warning
letter, notice of enforcement action or other correspondence or communication from the FDA or any other analogous Governmental Body in
which the FDA or such other analogous Governmental Body asserted that the registration (including the Product Registrations), manufacturing,
packaging, promotion (including the Promotional Materials), distribution, marketing, use and sale of the Company Products was not in compliance
with applicable Law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and its Subsidiaries are, in all material respects, in compliance and, since January&nbsp;1, 2020, has been, in all material respects,
in compliance with all healthcare laws applicable to the operation of their business as currently conducted, including (i)&nbsp;any and
all applicable federal, state and local fraud and abuse laws, including the federal Anti-Kickback Statute (42&nbsp;U.S.C. Section&nbsp;1320a-7(b))
and the civil False Claims Act (31&nbsp;U.S.C. Section&nbsp;3729 <i>et seq.</i>); (ii)&nbsp;HIPAA, the Health Information and Technology
for Economic and Clinical Health Act; and (iii)&nbsp;Laws which are cause for exclusion from any federal health care program. As of the
Agreement Date, no material enforcement, regulatory or administrative proceeding is pending, or, to the Company’s Knowledge, no
such material enforcement, regulatory or administrative proceeding has been threatened in writing, against the Company or any of its Subsidiaries
under the Federal Food, Drug, and Cosmetic Act (21&nbsp;U.S.C. Section&nbsp;301 <i>et seq.</i>), the Anti-Kickback Statute or similar
Laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<!-- Field: Split-Segment; Name: 3 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
January&nbsp;1, 2020, all exports, re-exports, imports, sales or transfers of products or services have been effected in accordance with
all applicable Laws in all material respects. All Company Products shipped by the Company and its Subsidiaries have been accurately marked,
labeled and transported in accordance with applicable Laws in all material respects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.15	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Certain
Business Practices</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
January&nbsp;1, 2018, neither the Company, any of its Subsidiaries, nor, to the Knowledge of the Company, any of its employees or agents
(in each case, acting in the capacity of an employee or agent of the Company or any of its Subsidiaries) has (i)&nbsp;used any material
funds (whether of the Company and its Subsidiaries or otherwise) for unlawful contributions, gifts, entertainment or other unlawful expenses
relating to political activity, (ii)&nbsp;made any material unlawful payment to foreign or domestic government officials or employees
or to foreign or domestic political parties or campaigns or (iii)&nbsp;materially violated any provision of any Anti-Corruption Laws
or any rules&nbsp;or regulations promulgated thereunder, anti-money laundering laws or any rules&nbsp;or regulations promulgated thereunder
or any applicable Law of similar effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the Knowledge of the Company, (i)&nbsp;none of the executive officers of the Company or any of its Subsidiaries, have been disqualified
or debarred by any Governmental Body for any purpose, or have been charged with or convicted under any applicable Law for conduct relating
to the development or approval or otherwise relating to the regulation of any drug product under any applicable Law, and (ii)&nbsp;neither
the Company nor any of its Subsidiaries, is the subject of any pending investigation by the FDA pursuant to its “Fraud, Untrue Statements
of Material Facts, Bribery, and Illegal Gratuities” Final Policy set forth in 56 Fed. Reg. 46,191 (September&nbsp;10, 1991) and
any amendments thereto or comparable policies in any other applicable jurisdictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.16	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Governmental
Authorizations</u>. The Company and its Subsidiaries hold all Governmental Authorizations necessary to enable it to conduct their
business in the manner in which their business is currently being conducted, except where failure to hold such Governmental
Authorizations would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. The Company
and its Subsidiaries are in compliance with the terms and requirements of such Governmental Authorizations, except where failure to
be in compliance would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.17	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Tax
Matters</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, (i)&nbsp;each of the Tax Returns
required to be filed by the Company or any of its Subsidiaries with any Governmental Body has been filed on or before the applicable due
date (taking into account any extensions of such due date), and all such Tax Returns are accurate and complete, (ii)&nbsp;all Taxes shown
as due on such Tax Returns have been paid and (iii)&nbsp;<font style="background-color: white">the Company and its Subsidiaries have withheld
and paid over (or set aside for payment when due) to the appropriate taxing authority all Taxes required to have been withheld and paid
over in connection with amounts paid to any employee, independent contractor, stockholder, creditor or other third party</font>. The unpaid
Taxes of the Company and its Subsidiaries reflected on the Balance Sheet have been reserved for in accordance with GAAP and the Company
and its Subsidiaries have not incurred any material liability for Taxes since the date of the Balance Sheet other than in the ordinary
course of business or in connection with the Transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, or is being contested in good
faith by appropriate proceedings and for which reserves have been established in accordance with GAAP, no deficiency for any Tax has been
asserted or assessed by a taxing authority in writing against the Company or any of its Subsidiaries which deficiency has not been paid,
settled or withdrawn. <font style="background-color: white">No written claim has been made within the last five (5)&nbsp;years by a taxing
authority that the Company or any of its Subsidiaries is subject to Tax in a jurisdiction where it has not filed Tax Returns. No audits,
examinations, or other proceedings with respect to material Taxes or Tax Returns of the Company or any of its Subsidiaries are currently
in process, pending or threatened in writing.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Company nor any of its Subsidiaries is a party to or is bound by any material Tax sharing, allocation or indemnification agreement
or arrangement that would have a continuing effect after the Closing Date (other than such agreements or arrangements with third parties
made in the ordinary course of business, the principal purpose of which is not Tax). Neither the Company nor any of its Subsidiaries has
(i)&nbsp;been a member of an affiliated group (within the meaning of Section&nbsp;1504(a)&nbsp;of the Code) filing a consolidated federal
income Tax Return (other than a group the common parent of which was the Company) or (ii)&nbsp;had any material liability for the Taxes
of another Person (other than the Company) under Treasury Regulations Section&nbsp;1.1502-6 (or any similar provision of state, local
or foreign Law), as a transferee or successor, or otherwise by operation of Laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Within
the last two (2)&nbsp;years, neither the Company nor any of its Subsidiaries has been either a “distributing corporation”
or a “controlled corporation” in a distribution of stock intended to qualify for tax-free treatment under Section&nbsp;355
of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has not entered into any “listed transaction” within the meaning of Treasury Regulations Section&nbsp;1.6011-4(b)(2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
are no “<i>closing agreements</i>” (within the meaning of Section&nbsp;7121(a)&nbsp;of the Code), private letter rulings or
similar written agreements with any Governmental Body with regard to the determination of the Tax liability of the Company or any of its
Subsidiaries that would have continuing effect on periods (or portions thereof) ending after the Closing Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 43; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Company nor any of its Subsidiaries will be required to include any material amounts in income, or exclude any material items of deduction,
in a taxable period (or portion thereof) beginning after the Closing Date as a result of (i)&nbsp;a change in or incorrect method of accounting
occurring prior to the Closing, (ii)&nbsp;an installment sale or open transaction arising made prior to the Closing, (iii)&nbsp;a prepaid
amount received or deferred revenue accrued prior to the Closing (other than such prepaid amounts or deferred revenue received in the
ordinary course of business), (iv)&nbsp;a “<i>closing agreement</i>” as described in Section&nbsp;7121 of the Code (or any
corresponding or similar provision of state or local income Tax Law) executed prior to the Closing, (v)&nbsp;any intercompany transactions
or any excess loss account described in the U.S. Treasury Regulations under Section&nbsp;1502 of the Code (or any corresponding or similar
provision of state or local income Tax Law), or (vi)&nbsp;any election made under Section&nbsp;965 of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Company nor any of its Subsidiaries has deferred any payroll or employment Taxes or claimed any other similar Tax benefit or relief
pursuant to the CARES Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.18	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Employee
Matters; Benefit Plans</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as required by applicable Laws, the employment of each of the Company’s employees and the employees of the Company’s Subsidiaries
is terminable by the Company or its Subsidiaries at will.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the Agreement Date, neither the Company nor any of its Subsidiaries is a party to, has any duty to bargain for, or is not currently
negotiating in connection with entering into, any collective bargaining agreement or other Contract with a labor organization or work
council representing any of its employees and there are no labor organizations representing, purporting to represent or, to the Knowledge
of the Company, seeking to represent any employees of the Company or its Subsidiaries. Since January&nbsp;1, 2020, there has not been
any strike, slowdown, work stoppage, lockout, picketing or labor dispute, affecting the Company, any of its Subsidiaries or any of its
employees. As of the Agreement Date, there is not pending, and, to the Knowledge of the Company, no Person has threatened in writing to
commence, any such strike, slowdown, work stoppage, lockout, picketing or labor dispute.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the Agreement Date, there is no Legal Proceeding pending or, to the Knowledge of the Company, threatened in writing relating to employment,
including relating to any Company Employee Agreement, wages and hours, leave of absence, plant closing notification, employment statute
or regulation, privacy right, labor dispute, workers’ compensation policy or long-term disability policy, safety, retaliation, immigration
or discrimination matters involving any Company Associate, including charges of unfair labor practices or harassment complaints, other
than any Legal Proceedings that, individually or in the aggregate, have not had and would not reasonably be expected to have a Material
Adverse Effect. Since January&nbsp;1, 2020, the Company and its Subsidiaries have complied with all applicable Laws related to employment,
including applicable Laws relating to employment practices, wages, hours and other terms and conditions of employment, any reduction in
force (including notice, information and consultation requirements), except where the failure to be in compliance, individually or in
the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 44; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has either delivered or made available to Parent or Parent’s Representatives prior to the execution of this Agreement
with respect to each material Employee Plan accurate and complete copies of the following, as relevant: (i)&nbsp;all material plan
documents and all material amendments thereto, and all related trust or other funding documents; (ii)&nbsp;any currently effective
determination letter or opinion letter received from the IRS; (iii)&nbsp;the most recent annual actuarial valuation and the most
recent Form&nbsp;5500; and (iv)&nbsp;the most recent summary plan descriptions and any material modifications thereto. For purposes
of this <u>Section&nbsp;4.17(d)</u>&nbsp;and <u>Section&nbsp;4.17(d)</u>&nbsp;of the Company Disclosure Schedule, “<u>Employee
Plan</u>” shall exclude any employment, termination or severance agreement for employees of the Company with an annual base
salary less than $175,000 and equity grant notices, and related documentation, with respect to employees of the Company and
agreements with consultants entered into in the ordinary course of business). No Employee Plan is subject to the Laws of a
jurisdiction outside the United States.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Company or any of its Subsidiaries nor any other Person that would be or, at any relevant time, would have been considered a single
employer with the Company or any of its Subsidiaries within the meaning of Section&nbsp;414(b), (c), (m), or (o)&nbsp;of the Code has,
to the Knowledge of the Company, during the past six (6)&nbsp;years maintained, contributed to, or been required to contribute to a plan
subject to Title&nbsp;IV of ERISA or Code Section&nbsp;412, including any “single employer” defined benefit plan or any “multiemployer
plan” each as defined in Section&nbsp;4001 of ERISA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
of the Employee Plans that is intended to be qualified under Section&nbsp;401(a)&nbsp;of the Code has obtained a favorable determination
letter (or opinion letter, if applicable) as to its qualified status under the Code. To the Knowledge of the Company, each of the Employee
Plans is now and has been operated in compliance in all material respects with its terms and all applicable Laws, including but not limited
to ERISA and the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as would not have a Material Adverse Effect, no Employee Plan exists that could (i)&nbsp;result in any payment becoming due to any current
or former Company Associate, including any severance, unemployment compensation or any other cash payment, in each case, in excess of
$300,000, (ii)&nbsp;result in the acceleration of the time of payment or vesting, or the increase in the amount of, compensation or benefits
due to any such Company Associate, or (iii)&nbsp;directly or indirectly cause the Company or any of its Subsidiaries to transfer or set
aside any material assets to fund any benefits under any Employee Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the execution and delivery of this Agreement nor the consummation of the Transactions, either alone or in connection with any other event
(whether contingent or otherwise) is reasonably expected to result in any payment or benefit, individually or in combination with any
other payment or benefit, constituting an “excess parachute payment,” as defined in Section&nbsp;280G(b)(1)&nbsp;of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None
of the Employee Plans provides material health, medical or life insurance benefits to any retired Person, or any current employee of
any of the Company following such employee’s retirement or other termination of employment, except (i)&nbsp;as required by
applicable Law (including Section&nbsp;4980B of the Code) or (ii)&nbsp;for subsidized COBRA premiums during severance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 45; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.19	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Environmental
Matters</u>. Except for those matters that would not reasonably be expected to have a Material Adverse Effect: (a)&nbsp;the Company and
its Subsidiaries are, and since January&nbsp;1, 2018, have been, in compliance in all material respects with all applicable Environmental
Laws, which compliance includes obtaining, maintaining or complying with all Governmental Authorizations required under Environmental
Laws for the operation of their respective business; (b)&nbsp;as of the Agreement Date, neither the Company nor any of its Subsidiaries
has received any written notice, report or other information of or entered into any legally-binding settlement or Order involving uncompleted,
outstanding or unresolved violations, liabilities or requirements on the part of the Company or any of its Subsidiaries relating to or
arising under Environmental Laws; and (c)&nbsp;to the Knowledge of the Company, there are and have been no Hazardous Materials present
or Released on, at, under or from any property or facility, including the Leased Real Property, in a manner and concentration that would
reasonably be expected to result in any claim against or liability of the Company or any of its Subsidiaries under any Environmental Law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.20	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Real
Property</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Company nor any of its Subsidiaries own, and since January&nbsp;1, 2020, none of them has owned, any real property.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as would not reasonably be expected to have a Material Adverse Effect, either the Company or its Subsidiaries holds a valid and existing
leasehold interest in the material real property that is leased or subleased by the Company or its Subsidiaries from another Person (the
 “<u>Leased Real Property</u>”), free and clear of all Encumbrances other than Permitted Encumbrances and Encumbrances described
in the leases and subleases with respect to real property to which the Company or any of its Subsidiaries is a party, which Leased Real
Property is sufficient to permit the Company and its Subsidiaries to conduct their business as currently conducted. As of the Agreement
Date, neither the Company or any of its Subsidiaries has received any written notice regarding any violation or breach or default under
any Company Lease that has not since been cured, except for violations or breaches that are not, individually or in the aggregate, reasonably
likely to have a Material Adverse Effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.21	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Title
to Assets</u>. The Company and its Subsidiaries have good and valid title to all material assets owned by them as of the Agreement Date,
including all material assets (other than capitalized or operating leases) reflected on the Company’s unaudited balance sheet as
of June&nbsp;30, 2021 included in the last Quarterly Report on Form&nbsp;10-Q (the “<u>Balance Sheet</u>”) filed by the
Company with the SEC (but excluding Intellectual Property Rights which are covered by <u>Section&nbsp;4.8</u>) except for assets sold
or otherwise disposed of in the ordinary course of business since the date of such Balance Sheet and except where such failure would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.22	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Insurance</u>.
The Company has delivered or made available to Parent or Parent’s Representatives an accurate and complete copy of all material
insurance policies and all material self-insurance programs and arrangements relating to the business, assets and operations of the
Company and its Subsidiaries. All such material insurance policies are in full force and effect (except for any expiration thereof in
accordance with its terms), no written notice of cancellation or modification thereof has been received, and there is no existing default
or event which, with the giving of notice or lapse of time or both, would constitute a default by any insured thereunder. There are no
material claims related to the business of the Company or its Subsidiaries pending under any such material insurance policies as to which
coverage has been questioned, denied or disputed or in respect of which there is an outstanding reservation of rights.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 46; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.23	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Section&nbsp;203
of the DGCL</u>. Assuming the accuracy of the representations and warranties set forth in <u>Section&nbsp;5.8</u>, the Company Board has
taken all actions so that the restrictions applicable to business combinations contained in Section&nbsp;203 of the DGCL shall be inapplicable
to the execution, delivery and performance of this Agreement and to the consummation of the Transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.24	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Merger
Approval</u>. Following the Offer Acceptance Time, assuming satisfaction of the Minimum Condition, no vote of the holders of any class
or series of the Company’s or any of its Subsidiaries’ capital stock will be required in order to adopt this Agreement and
the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.25	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Opinion
of Financial Advisor</u>. The Company Board has received the opinion of the Company’s financial advisor, Lazard
Freres&nbsp;&amp; Co. LLC, to the effect that, as of the date of such opinion and based on and subject to the assumptions,
qualifications, limitations and other matters set forth therein, the Offer Price to be paid to (a)&nbsp;holders of Shares tendering
their Shares pursuant to the Offer and (b)&nbsp;holders of Shares (other than holders of Dissenting Shares and Excluded Shares) in
the Merger, in each case, is fair, from a financial point of view, to such holders, and such opinion has not been withdrawn, revoked
or modified. The Company will provide or make available to Parent, solely for informational purposes, a copy of the signed opinion
following receipt thereof by the Company, it being expressly understood and agreed that such opinion is for the benefit of the
Company Board and may not be relied upon by Parent or Purchaser.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;4.26	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Brokers
and Other Advisors</u>. Except for Lazard Freres&nbsp;&amp; Co. LLC, no broker, finder, investment banker, financial advisor or other
Person is entitled to any brokerage, finder’s or other similar fee or commission, or the reimbursement of expenses in connection
therewith, in connection with the Transactions based upon arrangements made by or on behalf of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase">Article&nbsp;5</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">REPRESENTATIONS AND WARRANTIES OF PARENT AND PURCHASER</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Parent and Purchaser jointly
and severally represent and warrant to the Company as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;5.1	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Due
Organization</u>. Each of Parent and Purchaser is a corporation duly organized, validly existing and in good standing under the laws of
its jurisdiction of organization and has all necessary power and authority (a)&nbsp;to conduct its business in the manner in which its
business is currently being conducted and (b)&nbsp;to own and use its assets in the manner in which its assets are currently owned and
used, except where any failure of such power and authority would not reasonably be expected to have a Parent Material Adverse Effect.
Parent has delivered or made available to the Company or the Company’s Representatives accurate and complete copies of the certificate
of incorporation, bylaws and other organizational documents of Parent and Purchaser, including all amendments thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 47; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;5.2	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Purchaser</u>.
Purchaser was formed solely for the purpose of engaging in the Transactions and activities incidental thereto and has not engaged in any
business activities or conducted any operations other than in connection with the Transactions and those incident to its formation. Either
Parent or a wholly owned Subsidiary of Parent owns beneficially and of record all of the outstanding capital stock of Purchaser.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;5.3	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Authority;
Binding Nature of Agreement</u>. Parent and Purchaser have the corporate power and authority to execute and deliver and perform their
obligations under this Agreement and the CVR Agreement; and the execution, delivery and performance by Parent and Purchaser of this Agreement
and the CVR Agreement and the consummation of the Transactions have been duly authorized by all necessary action on the part of Parent
and Purchaser and their respective boards of directors. This Agreement constitutes, and the CVR Agreement shall constitute, when executed
and delivered by Parent, the legal, valid and binding obligation of Parent and Purchaser, and assuming due authorization, execution and
delivery by the Company, is enforceable against them in accordance with its terms, subject to (a)&nbsp;Laws of general application relating
to bankruptcy, insolvency and the relief of debtors and (b)&nbsp;rules&nbsp;of law governing specific performance, injunctive relief and
other equitable remedies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;5.4	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Non-Contravention;
Consents</u>. Assuming compliance with the applicable provisions of the HSR Act, the execution and delivery of this Agreement and the
CVR Agreement by Parent and Purchaser, and the consummation of the Transactions, will not: (a)&nbsp;cause a violation of any of the provisions
of the certificate of incorporation or bylaws or other organizational documents of Parent or Purchaser; (b)&nbsp;cause a violation by
Parent or Purchaser of any Law or Order applicable to Parent or Purchaser, or to which they are subject; or (c)&nbsp;conflict with, result
in a breach of, or constitute a default on the part of Parent or Purchaser under any Contract, except, in the case of clause&nbsp;(c),
for such conflicts, violations, breaches or defaults as would not reasonably be expected to have a Parent Material Adverse Effect. Except
as may be required by the Exchange Act (including the filing with the SEC of the Offer Documents), state takeover laws, the DGCL or the
HSR Act, neither Parent nor Purchaser, nor any of Parent’s other Affiliates, is required to make any filing with or give any notice
to, or to obtain any Consent from, any Person at or prior to the Closing in connection with the execution and delivery of this Agreement
and the CVR Agreement by Parent or Purchaser or the consummation by Parent or Purchaser of the Transactions, other than such filings,
notifications, approvals, notices or Consents that, if not obtained, made or given, would not reasonably be expected to have a Parent
Material Adverse Effect. No vote of Parent’s stockholders is necessary to approve this Agreement or any of the Transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 48; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;5.5	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Disclosure</u>.
The Offer Documents, when filed, distributed or disseminated, as applicable, will comply as to form in all material respects with
the applicable requirements of the Exchange Act. The Offer Documents, at the time of the filing of such Offer Documents or any
supplement or amendment thereto with the SEC and at the time such Offer Documents or any supplements or amendments thereto are first
distributed or disseminated to the Company’s stockholders, will not contain any untrue statement of a material fact or omit to
state any material fact necessary in order to make the statements made therein, in light of the circumstances under which they were
made, not misleading. The information with respect to Parent or Purchaser that Parent or Purchaser furnishes to the Company in
writing specifically for inclusion or incorporation by reference in the Schedule&nbsp;14D-9 and the Company Disclosure
Documents, at the time of filing the Schedule&nbsp;14D-9 and at the time of any distribution or dissemination of the Company
Disclosure Documents, will not contain any untrue statement of a material fact or omit to state any material fact necessary in order
to make the statements made therein, in light of the circumstances under which they were made, not misleading. Notwithstanding the
foregoing, neither Parent nor Purchaser makes any representation with respect to statements made or incorporated by reference
therein based on information supplied by or on behalf of the Company for inclusion or incorporation by reference in the Offer
Documents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;5.6	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Litigation</u>.
As of the Agreement Date, there is no Legal Proceeding pending (or, to the Knowledge of Parent, threatened) against Parent or Purchaser,
except as would not and would not reasonably be expected to have a Parent Material Adverse Effect. As of the Agreement Date, neither Parent
nor Purchaser is subject to any legally-binding settlement or Order that is reasonably likely to have a Parent Material Adverse Effect.
As of the Agreement Date, no investigation or review by any Governmental Body with respect to Parent or Purchaser is pending or, to the
Knowledge of Parent or Purchaser, is being threatened, other than any investigations or reviews that would not reasonably be expected
to have a Parent Material Adverse Effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;5.7	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Solvency</u>.
Immediately after giving effect to the Transactions, Parent shall (a)&nbsp;be able to pay its debts as they become due and shall own property
having a fair saleable value greater than the amounts required to pay its debts (including a reasonable estimate of the amount of all
contingent liabilities) as they become due and (b)&nbsp;have adequate capital to carry on its businesses. No transfer of property is being
made and no obligation is being incurred in connection with the Transactions with the intent to hinder, delay or defraud either present
or future creditors of Parent or the Surviving Corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;5.8	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Ownership
of Company Common Stock; Absence of Certain Arrangements</u>. Neither Parent, nor Purchaser nor any of their respective Affiliates
directly or indirectly owns, and at all times for the past three (3)&nbsp;years, neither Parent nor any of Parent’s Affiliates
has owned, beneficially or otherwise, any shares of the Company’s capital stock or any securities, contracts or obligations
convertible into or exercisable or exchangeable for shares of the Company’s capital stock. Neither Parent nor Purchaser has
enacted or will enact a plan that complies with Rule&nbsp;10b5-1 under the Exchange Act covering the purchase of any of the
shares of the Company’s capital stock. As of the Agreement Date, neither Parent nor Purchaser is an “interested
stockholder” of the Company under Section&nbsp;203(c)&nbsp;of the DGCL. Neither Parent nor Purchaser nor any of their
respective Affiliates is a party to any Contract, or has authorized, made or entered into, or committed or agreed to enter into, any
formal or informal arrangements or other understandings (whether or not binding) with any stockholder, director, officer, employee
or other Affiliate of the Company or any of its Subsidiaries (a)&nbsp;relating to (i)&nbsp;this Agreement or the Transactions or
(ii)&nbsp;the Surviving Corporation or any of its businesses or operations (including as to continuing employment) from and after
the Effective Time or (b)&nbsp;pursuant to which (i)&nbsp;any holder of Shares would be entitled to receive consideration of a
different amount or nature than the Offer Price or Merger Consideration, as applicable, in respect of such holder’s Shares or
(ii)&nbsp;any holder of Shares has agreed to approve this Agreement or vote against any Superior Offer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 49; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;5.9	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Brokers
and Other Advisors</u>. No broker, investment banker, financial advisor or other Person is entitled to any broker’s, finder’s,
financial advisor’s or other similar fee or commission in connection with the Transactions based upon arrangements made by or on
behalf of Parent or any of its Subsidiaries except for Persons, if any, whose fees and expenses shall be paid by Parent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;5.10	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Sufficient
Funds</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Parent
and Purchaser have cash on hand as of the date hereof, and will have cash on hand at all times through the Effective Time, in each case,
necessary to consummate the Transactions, including payment in cash of the aggregate Offer Price at the Offer Acceptance Time and the
aggregate Merger Consideration at the Effective Time, to pay all related fees and expenses incurred in connection there with and to discharge
all of Parent’s and Purchaser’s other liabilities as they become due.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Parent
and Purchaser acknowledge that their obligations under this Agreement are not contingent or conditioned upon Parent’s, Purchaser’s,
their respective Affiliates’ or any other Person’s ability to obtain any financing for the consummation of the Transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;5.11	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Acknowledgement
by Parent and Purchaser</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
Parent nor Purchaser is relying and neither Parent nor Purchaser has relied on any representations or warranties whatsoever
regarding the subject matter of this Agreement, express or implied, except for the representations and warranties in <u>Article&nbsp;4</u>,
including the Company Disclosure Schedule. Such representations and warranties by the Company constitute the sole and exclusive
representations and warranties of the Company in connection with the Transactions, and each of Parent and Purchaser understands,
acknowledges and agrees that all other representations and warranties of any kind or nature whether express, implied or statutory
are specifically disclaimed by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
connection with the due diligence investigation of the Company by Parent and Purchaser and their respective Affiliates, stockholders or
Representatives, Parent and Purchaser and their respective Affiliates, stockholders or Representatives have received and may continue
to receive after the Agreement Date from the Company and its Affiliates, stockholders or Representatives certain estimates, projections,
forecasts and other forward-looking information, as well as certain business plan information, regarding the Company and its businesses
and operations. Parent and Purchaser hereby acknowledge that there are uncertainties inherent in attempting to make such estimates, projections,
forecasts and other forward-looking statements, as well as in such business plans, and that Parent and Purchaser will have no claim
against the Company, any of its Affiliates, stockholders or Representatives, or any other Person with respect thereto unless any such
information is expressly addressed or included in a representation or warranty contained in this Agreement. Accordingly, Parent and Purchaser
hereby acknowledge and agree that neither the Company nor any of its Affiliates, stockholders or Representatives, nor any other Person,
has made or is making any express or implied representation or warranty with respect to such estimates, projections, forecasts, forward-looking
statements or business plans unless any such information is expressly addressed or included in a representation or warranty contained
in this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 50; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase">Article&nbsp;6</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CERTAIN COVENANTS OF THE COMPANY</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;6.1	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Access
and Investigation</u>. During the period from the Agreement Date until the earlier of the Offer Acceptance Time and the termination
of this Agreement pursuant to <u>Section&nbsp;9.1</u> (the “<u>Pre-Closing Period</u>”), upon reasonable advance notice
to the Company, the Company and its directors, employees and officers shall, and the Company shall direct its other Representatives
of the Company, (a)&nbsp;to provide Parent and Parent’s Representatives with reasonable access during normal business hours of
the Company to the Company’s officers, employees, other personnel, and assets and to all existing books and records
(<i>provided, however,</i> that any such access shall be conducted at Parent’s sole expense, at a reasonable time, under the
supervision of appropriate personnel of the Company or its Subsidiaries and in such a manner as not to unreasonably interfere with
the normal operation of the business of the Company and its Subsidiaries) and (b)&nbsp;to furnish to Parent such financial and
operating data and other information as Parent may reasonably request, but in the case of clauses&nbsp;(a)&nbsp;and (b), solely to
the extent that such access or furnishing of data or other information is related to planning for integration or operation of the
Company and its Subsidiaries following the Closing or the satisfaction of any condition to Closing. The foregoing notwithstanding,
nothing herein shall require the Company or any of its Subsidiaries to permit any inspection or testing, or to disclose any
information, that the Company in the good faith determination of the Company (after consultation with its counsel): (i)&nbsp;would
reasonably be expected to (x)&nbsp;jeopardize any attorney-client privilege (so long as the Company has reasonably cooperated with
Parent to permit such inspection of or to disclose such information on a basis that does not waive such privilege with respect
thereto) or (y)&nbsp;contravene any applicable Law (including Antitrust Law), fiduciary duty or binding Contract (including any
confidentiality agreement to which the Company, its Subsidiaries or its Affiliates is a party); or (ii)&nbsp;is reasonably pertinent
to any adverse Legal Proceeding between the Company and its Affiliates, on the one hand, and Parent and its Affiliates, on the other
hand. Information disclosed pursuant to this <u>Section&nbsp;6.1</u> shall be disclosed subject to execution of a joint defense
agreement in customary form, and disclosure may be limited to external counsel for Parent, to the extent the Company determines
doing so may be reasonably required for the purpose of complying with applicable Antitrust Laws. With respect to the information
disclosed pursuant to this <u>Section&nbsp;6.1</u>, Parent shall comply with, and shall instruct Parent’s Representatives to
comply with, all of its obligations under the Non-Disclosure Agreement, dated as of August&nbsp;9, 2021, by and between the
Company and Parent (the “<u>Non-Disclosure Agreement</u>”). All requests for information made pursuant to this <u>Section&nbsp;6.1 </u>shall
be directed to an executive officer of the Company or other person designated by the Company in writing. Nothing in this <u>Section&nbsp;6.1 </u>will
be construed to require the Company, its Subsidiaries or any of its Representatives to prepare any reports, analyses, appraisals,
opinions or other information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 51; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;6.2	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Operation
of the Business</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the Pre-Closing Period: (i)&nbsp;except (A)&nbsp;as required or otherwise contemplated under this Agreement or as required by
applicable Laws, (B)&nbsp;any action taken, or omitted to be taken, pursuant to COVID-19 Measures, (C)&nbsp;with the written consent
of Parent (which consent shall not be unreasonably withheld, conditioned or delayed) or (D)&nbsp;as set forth in <u>Section&nbsp;6.2</u>
of the Company Disclosure Schedule, the Company shall use its, and shall cause its Subsidiaries to use their, commercially
reasonable efforts to (i)&nbsp;conduct in all material respects its business and operations in the ordinary course and
(ii)&nbsp;preserve intact the material components of the current business organization of the Company and its Subsidiaries,
including by maintaining their relations and goodwill with all material suppliers, material customers, Governmental Bodies and other
material business relations (it being understood that with respect to the matters specifically addressed by any provision of <u>Section&nbsp;6.2(b)</u>,
such specific provisions shall govern over the more general provision of this <u>Section&nbsp;6.2(a)</u>).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the Pre-Closing Period, except (i)&nbsp;as required or otherwise contemplated under this Agreement or as required by applicable Laws,
(ii)&nbsp;any action taken, or omitted to be taken, pursuant to COVID-19 Measures, (iii)&nbsp;with the written consent of Parent (which
consent shall not be unreasonably withheld, conditioned or delayed) or (iv)&nbsp;as set forth in <u>Section&nbsp;6.2</u> of the Company
Disclosure Schedule, the Company shall not, and shall cause its Subsidiaries to not:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;amend
or permit the adoption of any amendment to the Company’s certificate of incorporation and bylaws or the organizational documents
of its Subsidiaries;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)&nbsp;establish
a record date for, declare, accrue, set aside or pay any dividend or make any other distribution in respect of any shares of its capital
stock (including the Company Common Stock) or (B)&nbsp;repurchase, redeem or otherwise reacquire any of its shares of capital stock (including
any Company Common Stock), or any rights, warrants or options to acquire any shares of its capital stock, other than: (1)&nbsp;repurchases
or reacquisitions of Shares outstanding as of the Agreement Date pursuant to the Company’s right (under written commitments in effect
as of the Agreement Date) to purchase or reacquire Shares held by a Company Associate only upon termination of such associate’s
employment or engagement by the Company or any of its Subsidiaries; (2)&nbsp;repurchases of Company Stock Awards (or shares of capital
stock issued upon the exercise or vesting thereof) outstanding on the Agreement Date (in cancellation thereof) pursuant to the terms of
any such Company Stock Award (in effect as of the Agreement Date) between the Company or any of its Subsidiaries and a Company Associate
only upon termination of such Person’s employment or engagement by the Company or any of its Subsidiaries; or (3)&nbsp;in connection
with withholding to satisfy the exercise price or Tax obligations with respect to Company Stock Awards;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;split,
combine, subdivide or reclassify any Shares or other equity interests;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;issue,
sell, grant, deliver, pledge, transfer, encumber or authorize the issuance, sale, grant delivery, pledge, transfer or encumbrance (other
than pursuant to agreements in effect as of the Agreement Date) of (A)&nbsp;any capital stock, equity interest or other security of the
Company or any of its Subsidiaries, (B)&nbsp;any option, call, warrant, restricted securities or right to acquire any capital stock, equity
interest or other security of the Company or any of its Subsidiaries, or (C)&nbsp;any instrument convertible into or exchangeable for
any capital stock, equity interest or other security of the Company or any of its Subsidiaries (except that (1)&nbsp;the Company may issue
Shares as required to be issued upon the exercise of Company Options or the vesting of Company Stock Awards and (2)&nbsp;the Company may
issue Company Stock Awards to new employees who were offered Company Stock Awards as part of offer letters that were executed prior to
the Agreement Date), it being understood that no such Company Stock Awards may be accelerated other than in accordance with the terms
of this Agreement;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<!-- Field: Page; Sequence: 52; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;except
as contemplated by <u>Section&nbsp;3.8</u>, establish, adopt, terminate or amend any Employee Plan (or any plan, program, arrangement,
practice or agreement that would be an Employee Plan if it were in existence on the Agreement Date), or amend or waive any of its rights
under, or accelerate the vesting under, any provision of any of the Employee Plans (or any plan, program, arrangement, practice or agreement
that would be an Employee Plan if it were in existence on the Agreement Date) or grant any employee or director any increase in compensation,
bonuses or other benefits, except that the Company and its Subsidiaries may (A)&nbsp;change the title of its employees, provided such
changes in title do not involve increases in the applicable employee’s compensation except as otherwise provided for under this
<u>Section&nbsp;6.2(b)(v)</u>; (B)&nbsp;provide increases in salary, wages, bonuses or benefits to employees as required under a Company
Employee Agreement; (C)&nbsp;amend any Employee Plans to the extent required by applicable Laws; and (D)&nbsp;make bonus or commission
payments in the ordinary course of business in accordance with the bonus or commission plans existing on the Agreement Date;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)&nbsp;enter
into (1)&nbsp;any change-of-control agreement with any executive officer, employee, director or independent contractor or (2)&nbsp;any
retention, employment, severance or other material agreement with any executive officer or director, (B)&nbsp;enter into any employment
or severance agreement with any non-executive officer employee with an annual base salary greater than $175,000 or any consulting agreement
with an independent contractor with an annual base compensation greater than $175,000 or (C)&nbsp;hire any employee with an annual base
salary in excess of $175,000 or with officer-level responsibilities;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;form
any Subsidiary, acquire any equity interest in any other Entity or enter into any material joint venture, partnership, collaboration or
similar profit-sharing arrangement;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;make
or authorize any capital expenditure, except that the Company and its Subsidiaries may make any capital expenditure that is provided for
in the Company’s capital expense budget either delivered or made available to Parent prior to the Agreement Date, which expenditures
shall be in accordance with the categories set forth in such budget or (B)&nbsp;when added to all other capital expenditures made on behalf
of the Company and its Subsidiaries since the Agreement Date but not provided for in the Company’s capital expense budget either
delivered or made available to Parent prior to the Agreement Date, does not exceed $25,000 individually and $200,000 in the aggregate;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;acquire,
lease, license, sublicense, pledge, sell or otherwise dispose of, divest or spin-off, abandon, waive, relinquish or permit to lapse (other
than any patent expiring at the end of its statutory term), transfer, assign, guarantee, mortgage or otherwise subject to any material
Encumbrance (other than Permitted Encumbrances) any material right or other material asset or property, except, in the case of any of
the foregoing (A)&nbsp;in the ordinary course of business (including entering into non-exclusive license agreements in the ordinary course
of business), (B)&nbsp;pursuant to dispositions of obsolete, surplus or worn out assets that are no longer useful in the conduct of the
business of the Company and its Subsidiaries or (C)&nbsp;as provided for in the Company’s capital expense budget delivered or made
available to Parent prior to the Agreement Date;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<!-- Field: Page; Sequence: 53; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;lend
money or make capital contributions or advances to or make investments in, any Person, or incur or guarantee any Indebtedness, except
for advances to employees and consultants for travel and other business related expenses in the ordinary course of business consistent
with past practice;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;except
as required by applicable Law, (A)&nbsp;make or change any material Tax election, (B)&nbsp;adopt or change any material method of Tax
accounting, (C)&nbsp;consent to the extension or waiver of the statutory period of limitations applicable to any Tax claim or assessment
(other than pursuant to extensions of the due date for filing a Tax Return) or (D)&nbsp;settle or compromise any material Tax liability
or refund;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;settle,
release, waive or compromise any Legal Proceeding, other than (A)&nbsp;any Legal Proceeding relating to a breach of this Agreement
or any other agreements contemplated hereby or pursuant to a settlement that does not relate to any of the Transactions or
(B)&nbsp;any Legal Proceeding (1)&nbsp;that results solely in an obligation involving only the payment of monies by the Company that
is to be satisfied with the proceeds of the Company’ insurance policies and (2)&nbsp;does not involve the admission of
wrongdoing by the Company or any of its Subsidiaries;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;enter
into any collective bargaining agreement or other agreement with any labor organization (except to the extent required by applicable Laws);</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;adopt
or implement any stockholder rights plan or similar arrangement;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;adopt
a plan or agreement of complete or partial liquidation or dissolution, merger, consolidation, restructuring, recapitalization or other
reorganization; or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xvi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;authorize
any of, or agree or commit to take, any of the actions described in clauses (i)&nbsp;through (xv)&nbsp;of this <u>Section&nbsp;6.2(b)</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
the foregoing, nothing contained herein shall give to Parent or Purchaser, directly or indirectly, rights to control or direct the operations
of the Company or any of its Subsidiaries prior to the Effective Time, and nothing contained in this Agreement is intended to give the
Company and its Subsidiaries, directly or indirectly, the right to control or direct Parent’s or its Subsidiaries’ operations.
Prior to the Effective Time, each of Parent and the Company shall exercise, consistent with the terms and conditions hereof, complete
control and supervision of its and its Subsidiaries’ respective operations. Consent shall not be required pursuant to this <u>Section&nbsp;6.2</u>
if the Company has a reasonable good faith belief that obtaining such consent may violate Antitrust Law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 54; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;6.3	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>No
Solicitation</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as permitted by this <u>Section&nbsp;6.3</u>, during the Pre-Closing Period, the Company shall not, shall cause its Subsidiaries
to not, shall not authorize its Representatives to, and shall direct its Representatives not to, directly or indirectly,
(i)&nbsp;solicit, initiate or knowingly facilitate or encourage (including by way of furnishing non-public information) the
making of an Acquisition Proposal, (ii)&nbsp;engage in or otherwise participate in any discussions (except to notify a Person that
makes any inquiry or offer with respect to an Acquisition Proposal of the existence of the provisions of this <u>Section&nbsp;6.3</u>
or to clarify whether any such inquiry, offer or proposal constitutes an Acquisition Proposal) or negotiations regarding, or furnish
to any other Person any non-public information in connection with or for the purpose of knowingly encouraging or facilitating,
an Acquisition Proposal, (iii)&nbsp;enter into any letter of intent, acquisition agreement, agreement in principle or similar
agreement with respect to an Acquisition Proposal or (iv)&nbsp;waive or release any Person from, fail to use reasonable best efforts
to enforce any standstill agreement or any standstill provisions of any Contract entered into in respect of a potential Acquisition
Proposal; <i>provided</i>, <i>however</i>, the Company Board may take, or omit to take, any of the actions contemplated by
clause&nbsp;(iv)&nbsp;of this <u>Section&nbsp;6.3</u> in the event that the Company determines in good faith, after consultation
with the Company’s outside legal counsel, that the failure to do so would breach the fiduciary duties of the Company Board
under applicable Law. The Company and its directors, officers and employees shall, and the Company shall direct its other
Representatives to, (A)&nbsp;cease and cause to be terminated any solicitation and any and all existing discussions or negotiations
with any Person conducted heretofore with respect to any Acquisition Proposal and (B)&nbsp;terminate access by any Person (other
than Parent, Purchaser, the Company or any of their respective Affiliates or Representatives) to any physical or electronic data
room relating to any potential Acquisition Proposal. For the avoidance of doubt, any violation of the restrictions set forth in this <u>Section&nbsp;6.3(a)</u>&nbsp;by
a director or officer of the Company shall be deemed to be a breach of this <u>Section&nbsp;6.3(a)</u>&nbsp;by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Anything
to the contrary herein notwithstanding, if at any time on or after the Agreement Date and prior to the Offer Acceptance Time, the Company
or any of its Representatives receives an unsolicited <i>bona fide</i> written Acquisition Proposal from any Person or group of Persons,
which Acquisition Proposal was made or renewed on or after the Agreement Date and did not result from any material breach of this <u>Section&nbsp;6.3,</u>
and the Company Board determines in good faith, after consultation with financial advisors and outside legal counsel, that such Acquisition
Proposal constitutes or could reasonably be expected to lead to a Superior Offer, then the Company and its Representatives may (i)&nbsp;furnish,
pursuant to (but only pursuant to) an Acceptable Confidentiality Agreement, information (including non-public information) with respect
to the Company to the Person or group of Persons who has made such Acquisition Proposal; <i>provided</i>, that the Company shall promptly
provide to Parent any non-public information concerning the Company that is provided to any Person given such access which was not
previously provided to Parent or its Representatives and (ii)&nbsp;engage in or otherwise participate in discussions or negotiations with
the Person or group of Persons making such Acquisition Proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 55; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Following
the Agreement Date, the Company shall (i)&nbsp;promptly (and in any event within two (2)&nbsp;Business Days) notify Parent of any
inquiry, proposal or offer received by the Company or any of its Representatives that the Company believes is or may lead to an
Acquisition Proposal, (ii)&nbsp;provide to Parent a summary of the material terms and conditions of any Acquisition Proposal,
including the identity of the Person making such Acquisition Proposal, together with copies of all documents and written or
electronic communications received, directly or indirectly, from such Person relating to any such Acquisition Proposal,
(iii)&nbsp;keep Parent reasonably informed of any material developments, discussions or negotiations regarding any Acquisition
Proposal on a reasonably prompt basis and (iv)&nbsp;upon the written request of Parent, reasonably inform Parent of the status of
any Acquisition Proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nothing
in this Agreement, including this <u>Section&nbsp;6.3</u>, shall restrict the Company from (i)&nbsp;taking and disclosing to the stockholders
of the Company a position contemplated by Rule&nbsp;14e-2(a), Rule&nbsp;14d-9 or Item&nbsp;1012(a)&nbsp;of Regulation&nbsp;M-A
promulgated under the Exchange Act, (ii)&nbsp;making any “stop, look and listen” communication pursuant to Rule&nbsp;14d-9(f)&nbsp;promulgated
under the Exchange Act or (iii)&nbsp;making any legally required disclosure to the stockholders of the Company (<i>provided</i>, that
such disclosure includes an express reaffirmation of the Company Board Recommendation), and none of the foregoing actions shall be deemed
to constitute a Company Adverse Change Recommendation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase">Article&nbsp;7</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"></font>&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ADDITIONAL COVENANTS OF THE PARTIES</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.1	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Company
Board Recommendation</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to <u>Section&nbsp;7.1(b)</u>, the Company hereby consents to the inclusion of a description of the Company Board Recommendation in the
Offer Documents. During the Pre-Closing Period, neither the Company Board nor any committee thereof shall (i)(A)&nbsp;withdraw (or
modify in a manner adverse to Parent or Purchaser), or publicly propose to withdraw (or modify in a manner adverse to Parent or Purchaser),
the Company Board Recommendation or (B)&nbsp;approve, recommend or declare advisable, or publicly propose to approve, recommend or declare
advisable, any Acquisition Proposal (any action described in this clause (i)&nbsp;being referred to as a “<u>Company Adverse Change
Recommendation</u>”) or (ii)&nbsp;approve, recommend or declare advisable, or propose to approve, recommend or declare advisable,
or allow the Company to execute or enter into any Contract with respect to any Acquisition Proposal, requiring, or which would reasonably
expect to cause, the Company to abandon, terminate or fail to consummate the Transactions (other than an Acceptable Confidentiality Agreement).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 56; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
anything to the contrary contained in this Agreement, at any time prior to accepting for payment such number of Shares validly tendered
and not properly withdrawn pursuant to the Offer as satisfies the Minimum Condition (the “<u>Offer Acceptance Time</u>”),
if the Company has received a bona fide written Acquisition Proposal (which Acquisition Proposal did not arise out of a material breach
of <u>Section&nbsp;6.3(a)</u>) from any Person that has not been withdrawn and is a Superior Offer, (x)&nbsp;the Company Board may make
a Company Adverse Change Recommendation, or (y)&nbsp;the Company may terminate this Agreement to enter into a Specified Agreement with
respect to such Superior Offer, if and only if: (A)&nbsp;the Company Board determines in good faith, after consultation with the Company’s
outside legal counsel, that the failure to do so would breach the fiduciary duties of the Company Board under applicable Law; (B)&nbsp;the
Company shall have given Parent prior written notice of its intention to consider making a Company Adverse Change Recommendation or terminate
this Agreement pursuant to <u>Section&nbsp;9.1(d)(i)</u>&nbsp;at least five (5)&nbsp;Business Days prior to making any such Company Adverse
Change Recommendation or termination (a “<u>Determination Notice</u>”) (which notice shall not constitute a Company Adverse
Change Recommendation); and (C)(i)&nbsp;the Company shall have provided to Parent a summary of the material terms and conditions of the
Acquisition Proposal, including the identity of the Person making such Acquisition Proposal, in accordance with <u>Section&nbsp;6.3(c))</u>
and provide Parent with copies of all documents and written or electronic communications relating to such Acquisition Proposal, (ii)&nbsp;the
Company shall have given Parent five (5)&nbsp;Business Days after the Determination Notice to propose revisions to the terms of this Agreement
or make another proposal so that such Acquisition Proposal would cease to constitute a Superior Offer, and, to the extent requested by
Parent, shall have negotiated in good faith with Parent and its Representatives with respect to such proposed revisions or other proposal,
if any, and (iii)&nbsp;at the end of such five (5)&nbsp;Business Day period, the Company Board makes the determination under <u>Section&nbsp;7.1(b)(A)</u>&nbsp;(after
taking into account the amendments to this Agreement and the Transactions proposed by Parent, if any). With respect to <u>Section&nbsp;7.1(b)(C)</u>,
if there are any material amendments, revisions or changes to the terms of any such Superior Offer, the Company shall notify Parent of
each such material amendment, revision or change and the applicable five (5)&nbsp;Business Day period shall be extended until at least
three (3)&nbsp;Business Days after the time that Parent receives notification from the Company of each such revision.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.2	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Filings,
Consents and Approvals</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to the terms and conditions set forth in this Agreement, each of the Parties shall use their respective reasonable best efforts to
take, or cause to be taken, all actions, to file, or cause to be filed, all documents and to do, or cause to be done, and to assist
and cooperate with the other Parties in doing, all things necessary, proper or advisable under applicable Antitrust Laws to
consummate and make effective the Transactions as soon as reasonably practicable, including (i)&nbsp;the obtaining of all necessary
actions or nonactions, waivers, consents, clearances, decisions, declarations, approvals and, expirations or terminations of waiting
periods from Governmental Bodies and the making of all necessary registrations and filings and the taking of all steps as may be
reasonably necessary to obtain any such consent, decision, declaration, approval, clearance or waiver, or expiration or termination
of a waiting period by or from, or to avoid an action or proceeding by, any Governmental Body in connection with any Antitrust Law;
(ii)&nbsp;the obtaining of all necessary consents, authorizations, approvals or waivers from third parties; and (iii)&nbsp;the
execution and delivery of any additional instruments necessary to consummate the Transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to the terms and conditions of this Agreement, each of the Parties shall (and shall cause their respective Affiliates, if applicable,
to): (i)&nbsp;promptly, but in no event later than ten (10)&nbsp;Business Days after the Agreement Date unless otherwise agreed to in
writing by Parent and the Company, make an appropriate filing of all Notification and Report forms as required by the HSR Act with respect
to the Transactions and (ii)&nbsp;cooperate with each other in determining whether, and promptly preparing and making, any other filings
or notifications or other consents required to be made with, or obtained from, any other Governmental Bodies in connection with the Transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 57; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Without
limiting the generality of anything contained in this <u>Section&nbsp;7.2</u>, during the Pre-Closing Period, each of Company
and Parent (on its and Purchaser’s behalf) shall use its reasonable best efforts to (i)&nbsp;cooperate in all respects and
consult with each other in connection with any filing or submission in connection with any investigation or other inquiry, including
allowing the other Party to have a reasonable opportunity to review in advance and comment on drafts of filings and
submissions,(ii)&nbsp;give the other Party prompt notice of the making or commencement of any request, inquiry, investigation,
action or Legal Proceeding brought by a Governmental Body or brought by a third party before any Governmental Body, in each case,
with respect to the Transactions, (iii)&nbsp;keep the other Party promptly informed as to the status of any such request, inquiry,
investigation, action or Legal Proceeding, (iv)&nbsp;promptly inform the other Party of any communication to or from the FTC, DOJ or
any other Governmental Body in connection with any such request, inquiry, investigation, action or Legal
Proceeding,(v)&nbsp;promptly furnish the other Party, subject to an appropriate confidentiality agreement to limit disclosure to
outside counsel and consultants retained by such counsel, with copies of documents provided to or received from any Governmental
Body in connection with any such request, inquiry, investigation, action or Legal Proceeding, (vi)&nbsp;subject to an appropriate
confidentiality agreement to limit disclosure to counsel and outside consultants retained by such counsel, consult in advance and
cooperate with the other Party and consider in good faith the views of the other Party in connection with any substantive
communication, analysis, appearance, presentation, memorandum, brief, argument, opinion or proposal to be made or submitted in
connection with any such request, inquiry, investigation, action or Legal Proceeding, and (vii)&nbsp;except as may be prohibited by
any Governmental Body or by any Law, in connection with any such request, inquiry, investigation, action or Legal Proceeding in
respect of the Transactions, each Party shall provide advance notice of and permit authorized Representatives of the other Party to
be present at each meeting or conference, including any virtual or telephonic meetings and discussions, relating to such request,
inquiry, investigation, action or Legal Proceeding and to have access to and be consulted in advance in connection with any
argument, opinion or proposal to be made or submitted to any Governmental Body in connection with such request, inquiry,
investigation, action or Legal Proceeding; <i>provided, however</i>, that materials required to provided pursuant to this <u>Section&nbsp;7.2(d)</u>&nbsp;may
be redacted (A)&nbsp;to remove references concerning the valuation of Parent, Purchaser, Company, or any of their respective
Subsidiaries or assets, (B)&nbsp;as necessary to comply with contractual arrangements, and (C)&nbsp;as necessary to address
reasonable privilege concerns. Each Party shall supply as promptly as practicable such information, documentation, other material or
testimony that may be reasonably requested by any Governmental Body, including by complying at the earliest reasonably practicable
date with any reasonable request for additional information, documents or other materials received by any Party or any of their
respective Subsidiaries from any Governmental Body in connection with such applications or filings for the transactions contemplated
by this Agreement. Notwithstanding anything in this Agreement to the contrary, none of Parent, Purchaser, or any of their respective
Affiliates shall be required to defend, contest, or resist any Legal Proceeding or to take any action to have vacated, lifted,
reversed, or overturned any Order in connection with any Antitrust Laws applicable to the Transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchaser
shall pay all filing fees under the HSR Act and for any filings required under foreign Antitrust Laws, but the Company shall bear its
own costs for the preparation of any such filings. Neither Party shall commit to or agree with any Governmental Body to (i)&nbsp;stay,
toll or extend any applicable waiting period under the HSR Act, (ii)&nbsp;pull and refile under the HSR Act, (iii)&nbsp;not consummate
the Transactions for any period of time or (iv)&nbsp;enter into any timing agreement, without the prior written consent of the other Party.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<!-- Field: Page; Sequence: 58; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
anything to the contrary set forth in this Agreement, none of Parent, Purchaser, the Company or any of their respective Subsidiaries
shall be required to, and the Company may not, without the prior written consent of Parent, become subject to, consent to, or offer
or agree to, or otherwise take any action with respect to, any requirement, condition, limitation, understanding, agreement, or
order to: (i)&nbsp;sell, license, assign, transfer, divest, hold separate, or otherwise dispose of any assets, business, or portion
of business of the Company, the Surviving Corporation, Parent, Purchaser, or any of their respective Subsidiaries;
(ii)&nbsp;conduct, restrict, operate, invest, or otherwise change the assets, business, or portion of business of the Company, the
Surviving Corporation, Parent, Purchaser, or any of their respective Subsidiaries in any manner; or (iii)&nbsp;impose any
restriction, requirement, or limitation on the operation of the business or portion of the business of the Company, the Surviving
Corporation, Parent, Purchaser, or any of their respective Subsidiaries; <i>provided</i>, that if requested by Parent, the Company
will become subject to, consent to, or offer or agree to, or otherwise take any action with respect to, any such requirement,
condition, limitation, understanding, agreement, or Order so long as such requirement, condition, limitation, understanding,
agreement, or Order is only binding on the Company in the event the Closing occurs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchaser
and Parent shall not, before the Closing, permit any of their Affiliates to, directly or indirectly, acquire or agree to acquire any assets,
business or any Person, whether by merger, consolidation, purchasing a substantial portion of the assets of or equity in any Person or
by any other manner or engage in any other transaction or take any other action, if the entering into of an agreement relating to or the
consummation of such acquisition, merger, consolidation or purchase or other transaction or action would reasonably be expected to (i)&nbsp;impose
any delay in the expiration or termination of any applicable waiting period or impose any delay in the obtaining of, or increase the risk
of not obtaining, any Consent or Order of a Governmental Body necessary to consummate the Offer, the Merger and the other Transactions,
including any approvals and expiration of waiting periods pursuant to the HSR Act or any other applicable Law, (ii)&nbsp;increase the
risk of any Governmental Body entering, or increase the risk of not being able to remove or successfully challenge, any permanent, preliminary
or temporary Order that would delay, restrain, prevent, enjoin or otherwise prohibit consummation of the Offer, the Merger and the other
Transactions or (iii)&nbsp;otherwise delay or impede the consummation of the Offer, the Merger and the other Transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<!-- Field: Page; Sequence: 59; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.3	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Continuing
Employee Benefits</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Parent
agrees that from and after the Effective Time, Parent shall assume and honor all severance and employment agreements for all
Continuing Employees and Non-Continuing Employees, in each case, in accordance with their terms as in effect immediately prior
to the Effective Time. Following the Effective Time, Parent shall provide, or cause to be provided, to each Continuing Employee
(i)&nbsp;base salary (or base wages, as the case may be) that is substantially comparable to the base salary provided by the Company
and its Subsidiaries to such Continuing Employee immediately before the Effective Time, (ii)&nbsp;short-term cash incentive
compensation opportunities at least as favorable as those provided to similarly-situated employees of Parent and its Subsidiaries,
and (iii)&nbsp;benefits (including severance benefits but excluding equity and long-term incentive compensation) that are, in the
aggregate and at a minimum, at least as favorable as the benefits (including severance benefits but excluding equity and long-term
incentive compensation) provided to similarly-situated employees of Parent and its Subsidiaries. For any employee of the Company
that is not a Continuing Employee (each a “<u>Non-Continuing Employee</u>”), Parent shall provide such
Non-Continuing Employee with the severance payments and termination payments or benefits under the Company’s applicable
severance plan (as made available to Parent), any agreement between such Non-Continuing Employee and the Company or any of its
Subsidiaries, or any agreement governing the relationship between such Non-Continuing Employee and the Company or any of its
Subsidiaries (such payments and benefits, the “<u>Non-Continuing Employee Severance Benefits</u>”). In the event
that a Transition Employee is terminated without Cause on or before the expiration of the term of employment (or other services
arrangement) set forth in such Transition Employee’s offer letter, Parent shall provide such Transition Employee with
(i)&nbsp;the severance payments and termination payments or benefits set forth in the applicable offer letter (and under any
arrangement between such Transition Employee and Parent or its applicable Subsidiary (including the Surviving Corporation, if any),
the terms of which shall be in accordance with this <u>Section&nbsp;7.3(a)</u>) and (ii)&nbsp;an additional amount in cash severance
equal to the base salary (or base wages, as the case may be) that such Transition Employee would have been entitled to receive for
the remainder of the term of employment (or other services arrangement) assuming such Transition Employee had not been terminated
before the end of the term set forth in such Transition Employee’s offer letter (together, such payments and benefits, the
 “<u>Transition Employee Severance Benefits</u>”), <i>provided</i>, that, for the avoidance of doubt, a Transition
Employee shall not be entitled to Transition Employee Severance Benefits to the extent such Transition Employee voluntarily resigns
prior to the expiration of the term of employment (or other services arrangement) set forth in such Transition Employee’s
offer letter, other than in accordance with such offer letter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as otherwise required by applicable Law, Parent will pay or deliver the Non-Continuing Employee Severance Benefits to any such Non-Continuing
Employee and the Transition Employee Severance Benefits to such Transition Employee as soon as reasonably practicable following the termination
of such Non-Continuing Employee’s or such Transition Employee’s employment or other service arrangement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
purposes of this <u>Section&nbsp;7.3(a)</u>, “<u>Cause</u>” means a Transition Employee’s (i)&nbsp;commission of
any felony or any crime involving fraud, dishonesty or moral turpitude under the laws of the United States or any state thereof;
(ii)&nbsp;attempted commission of, or participation in, a fraud or act of dishonesty against the Surviving Corporation or any of its
Subsidiaries; (iii)&nbsp;intentional, material violation of any agreement between the Transition Employee and the Surviving
Corporation or any of its Subsidiaries or of any statutory duty owed to the Surviving Corporation or any of its Subsidiaries;
(iv)&nbsp;unauthorized use or disclosure of the Surviving Corporation’s or any of its Subsidiaries’ confidential
information or trade secrets; (v)&nbsp;an act by the Transition Employee that constitutes gross negligence, willful misconduct or
insubordination in the course of employment such employee’s employment or service with the Surviving Corporation or any of its
Subsidiaries; or (vi)&nbsp;the continued failure of the Transition Employee to perform the essential duties and responsibilities of
such employee’s position, after having received notice of the deficiencies and having had thirty (30) days to cure such
defects in performance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 60; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Without
limiting the foregoing:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Continuing Employee shall be given service credit for all purposes, including for eligibility to participate, benefit levels (including,
for the avoidance of doubt, levels of benefits under Parent’s or the Surviving Corporation’s vacation policy) and eligibility
for vesting under Parent or the Surviving Corporation’s employee benefit plans and arrangements with respect to his or her length
of service with the Company (and its predecessors) prior to the Closing Date, provided, that the foregoing shall not result in the duplication
of benefits or to benefit accrual under any pension plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With
respect to any accrued but unused personal, sick or vacation time to which any Continuing Employee is entitled pursuant to the personal,
sick or vacation policies applicable to such Continuing Employee immediately prior to the Effective Time, Parent shall, or shall cause
the Surviving Corporation to and instruct its Affiliates to, as applicable (and without duplication of benefits), use commercially reasonable
efforts to assume the liability for such accrued personal, sick or vacation time and allow such Continuing Employee to use such accrued
personal, sick or vacation time in accordance with the practice and policies of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the extent that service is relevant for eligibility, vesting or allowances (including paid time off) under any health or welfare
benefit plan of Parent or the Surviving Corporation, then Parent shall use commercially reasonable efforts to (i)&nbsp;waive all
limitations as to pre-existing conditions, exclusions and waiting periods with respect to participation and coverage
requirements applicable to the Continuing Employees, to the extent that such conditions, exclusions and waiting periods would not
apply under a similar employee benefit plan in which such employees participated prior to the Effective Time and (ii)&nbsp;ensure
that such health or welfare benefit plan shall, for purposes of eligibility, vesting, deductibles, co-payments and out-of-pocket
maximums and allowances (including paid time off), credit Continuing Employees for service and amounts paid prior to the Effective
Time with the Company to the same extent that such service and amounts paid was recognized prior to the Effective Time under the
corresponding health or welfare benefit plan of the Company. For the avoidance of doubt, Parent shall use commercially reasonable
efforts to cause any eligible expenses incurred by a Continuing Employee and his or her covered dependents during the portion of the
plan year immediately before the Effective Time to be taken into account for purposes of satisfying all deductible, coinsurance and
maximum out-of-pocket requirements applicable to such Continuing Employee and his or her covered dependents for the applicable plan
year as if such amounts had been paid in accordance with the applicable health or welfare benefit plan of Parent or the Surviving
Corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
provisions of this <u>Section&nbsp;7.3</u> are solely for the benefit of the Parties to this Agreement, and no provision of this <u>Section&nbsp;7.3</u>
is intended to, or shall, be construed as providing any right to continued employment or service for any Person, or constitute the establishment
or adoption of or an amendment to any employee benefit plan for purposes of ERISA or otherwise, and no current or former employee or any
other individual associated therewith shall be regarded for any purpose as a third party beneficiary of this Agreement or have the right
to enforce the provisions hereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.4	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Indemnification
of Officers and Directors</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
bylaws of the Surviving Corporation shall provide for rights to indemnification, advancement of expenses and exculpation in favor of those
Persons who are directors, officers and employees of the Company or any of its Subsidiaries as of the Agreement Date or have been directors,
officers and employees of the Company or any of its Subsidiaries in the past (the “<u>Indemnified Persons</u>”) for their
acts and omissions occurring prior to the Effective Time (such provisions of the bylaws of the Surviving Corporation, the “<u>Indemnification
Provisions</u>”). The Indemnification Provisions shall not be amended, repealed or otherwise modified in any manner that would adversely
affect the rights thereunder of such Indemnified Persons, and shall be observed by Parent, the Surviving Corporation and their successors
and assigns to the fullest extent available under Delaware Law for a period of six (6)&nbsp;years from the Effective Time, and any claim
made pursuant to such rights within such six (6)-year period shall continue to be subject to this <u>Section&nbsp;7.4(a)</u>&nbsp;and
the rights provided under this <u>Section&nbsp;7.4(a)</u>&nbsp;until disposition of such claim.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<!-- Field: Page; Sequence: 61; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Split-Segment; Name: 4 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From
and after the Effective Time until the sixth (6<sup>th</sup>) anniversary of the date on which the Effective Time occurs, Parent and
the Surviving Corporation (together with their successors and assigns, the “<u>Indemnifying Parties</u>”) shall, to the
fullest extent permitted under applicable Laws, indemnify and hold harmless each Indemnified Person in his or her capacity as an
officer or director of the Company or any of its Subsidiaries against all losses, claims, damages, liabilities, fees, expenses,
judgments or fines incurred by such Indemnified Person as an officer or director of the Company or any of its Subsidiaries in
connection with any pending or threatened Legal Proceeding based on or arising out of, in whole or in part, the fact that such
Indemnified Person is or was a director or officer of the Company or any of its Subsidiaries at or prior to the Effective Time and
pertaining to any and all matters pending, existing or occurring at or prior to the Effective Time, whether asserted or claimed
prior to, at or after the Effective Time, including any such matter arising under any claim with respect to the Transactions.
Without limiting the foregoing, from the Effective Time until the sixth (6<sup>th</sup>) anniversary of the date on which the
Effective Time occurs, the Indemnifying Parties shall also, to the fullest extent permitted under applicable Laws, advance
reasonable and documented out-of-pocket costs and expenses (including reasonable and documented attorneys’ fees)
incurred by the Indemnified Persons in connection with matters for which such Indemnified Persons are eligible to be indemnified
pursuant to this <u>Section&nbsp;7.4(b)</u>, subject to the execution by such Indemnified Persons of appropriate undertakings in
favor of the Indemnifying Parties to repay such advanced costs and expenses if it is ultimately determined in a final and
non-appealable judgment of a court of competent jurisdiction that such Indemnified Person is not entitled to be indemnified
under this <u>Section&nbsp;7.4(b)</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From
the Effective Time until the sixth (6<sup>th</sup>) anniversary of the Effective Time, the Surviving Corporation shall maintain, and Parent
shall cause the Surviving Corporation to maintain, in effect, the current policy of directors’ and officers’ liability insurance
maintained by the Company and its Subsidiaries as of the Agreement Date for the benefit of the Indemnified Persons who are currently covered
by such existing policy with respect to their acts and omissions occurring prior to the Effective Time in their capacities as directors
and officers of the Company or any of its Subsidiaries, on terms with respect to coverage, deductibles and amounts no less favorable than
the existing policy (or at or prior to the Effective Time, Parent or the Company may (through a nationally recognized insurance broker
approved by Parent (such approval not to be unreasonably withheld, conditioned or delayed)) purchase a six (6)-year “tail”
policy for the existing policy effective as of the Effective Time) and if such “tail policy” has been obtained, it shall be
deemed to satisfy all obligations to obtain or maintain insurance pursuant to this <u>Section&nbsp;7.4(c)</u>; <i>provided, however,</i>
that in no event shall the Surviving Corporation be required to expend in any one (1)&nbsp;year an amount in excess of 300% of the annual
premium currently payable by the Company and its Subsidiaries with respect to such current policy, it being understood that if the annual
premiums payable for such insurance coverage exceeds such amount, Parent shall be obligated to cause the Surviving Corporation to obtain
a policy with the greatest coverage available for a cost equal to such amount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 62; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event Parent or the Surviving Corporation or any of their respective successors or assigns (i)&nbsp;consolidates with or merges
into any other Person and shall not be the continuing or surviving Entity of such consolidation or merger or (ii)&nbsp;transfers all
or substantially all of its properties and assets to any Person, then, and in each such case, Parent shall ensure that the
successors and assigns of Parent or the Surviving Corporation, as the case may be, or at Parent’s option, Parent, shall assume
the obligations set forth in this <u>Section&nbsp;7.4</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
provisions of this <u>Section&nbsp;7.4</u> shall survive the acceptance of Shares for payment pursuant to the Offer and the consummation
of the Merger and are (i)&nbsp;intended to be for the benefit of, and shall be enforceable by, each of the Indemnified Persons and their
successors, assigns and heirs and (ii)&nbsp;in addition to, and not in substitution for, any other rights to indemnification or contribution
that any such Person may have by contract or otherwise. This <u>Section&nbsp;7.4</u> may not be amended, altered or repealed after the
Offer Acceptance Time in such a manner as to adversely affect the rights of any Indemnified Person or any of their successors, assigns
or heirs without the prior written consent of the affected Indemnified Person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Securityholder
Litigation</u>. The Company shall promptly notify Parent of any Legal Proceeding commenced against the Company or its directors relating
to the Transactions. The Company shall give Parent the right to review and comment on all material filings or responses to be made by
the Company in connection with such litigation or existing litigation, and the right to consult on the settlement with respect to such
litigation, and the Company shall in good faith take such comments into account. No such settlement of such litigation including existing
litigation shall be agreed to without Parent’s prior written consent (such consent not to be unreasonably withheld, conditioned
or delayed), except to the extent the settlement is fully covered by the Company’s insurance policies (other than any applicable
deductible), but only if such settlement would not result in the imposition of any restriction on the business or operations of the Company
and its Subsidiaries after the Closing Date. The Company will keep Parent reasonably informed with respect to the status of any such
Legal Proceeding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Further
Assurances</u>. Without limitation or contravention of the provisions of <u>Section&nbsp;7.2</u>, and subject to the terms and conditions
of this Agreement, Parent and the Company shall use commercially reasonable efforts to take, or cause to be taken, all actions necessary
to consummate the Offer and the Merger and make effective the other Transactions. Without limiting the generality of the foregoing, subject
to the terms and conditions of this Agreement, each Party will use commercially reasonable efforts to (a)&nbsp;make all filings (if any)
and give all notices (if any) required to be made and given by such Party pursuant to any Material Contract in connection with the Offer
and the Merger and the other Transactions, (b)&nbsp;seek each Consent (if any) required to be obtained pursuant to any Material Contract
by such Party in connection with the Transactions to the extent requested in writing by Parent and (c)&nbsp;seek to lift any restraint,
injunction or other legal bar to the Offer, the Merger or the other Transactions brought by any third party against such Party.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<!-- Field: Page; Sequence: 63; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Public
Announcements; Disclosure</u>. The initial press release relating to this Agreement shall be a joint press release issued by the Company
and Parent, and thereafter, Parent and the Company shall consult with each other before issuing any further press release(s)&nbsp;or otherwise
making any public statement (to the extent not previously issued or made in accordance with this Agreement) with respect to the Offer,
the Merger, this Agreement or any of the other Transactions and shall not issue any such press release or public statement without the
other Party’s written consent (which shall not be unreasonably withheld, conditioned or delayed). Notwithstanding the foregoing:
(a)&nbsp;each Party may, without such consultation or consent, make any public statement in response to questions from the press, analysts,
investors or those attending industry conferences, so long as such statements are consistent with previous press releases, public disclosures
or public statements made jointly by the Parties (or individually, if approved by the other Party); (b)&nbsp;subject to any other applicable
terms of this Agreement, the Company may make any disclosures, without Parent’s prior written consent (but with prior notice), in
the Company SEC Documents as may be required by applicable federal securities Laws; (c)&nbsp;a Party may, without the prior consent of
the other Party but subject to giving advance notice to the other Party, issue any such press release or make any such public announcement
or statement as may be required by any applicable Law; and (d)&nbsp;the Company need not consult with Parent in connection with such portion
of any press release, public statement or filing to be issued or made pursuant to <u>Section&nbsp;6.3(d)</u>&nbsp;or with respect to any
Acquisition Proposal or Company Adverse Change Recommendation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Takeover
Laws</u>. If any Takeover Law may become, or may purport to be, applicable to the Offer, the Merger or any of the other Transactions,
each of Parent and the Company and their respective boards of directors shall use their respective reasonable best efforts to grant such
approvals and take such actions as are necessary so that the Offer, the Merger and the other Transactions may be consummated as promptly
as practicable on the terms and conditions contemplated hereby and otherwise act to lawfully eliminate the effect of any Takeover Law
on any of the Offer, the Merger or the other Transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Section&nbsp;16
Matters</u>. The Company, and the Company Board, shall, to the extent necessary, take appropriate action, prior to or as of the Offer
Acceptance Time, to approve, for purposes of Section&nbsp;16(b)&nbsp;of the Exchange Act, the disposition and cancellation or deemed
disposition and cancellation of the Shares and Company Stock Awards in the Transactions by applicable Section&nbsp;16 individuals and
to cause such dispositions or cancellations to be exempt under Rule&nbsp;16b-3 promulgated under the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Rule&nbsp;14d-10
Matters</u>. Prior to the Offer Acceptance Time and to the extent permitted by applicable Laws, the compensation committee of the Company
Board shall approve, as an “employment compensation, severance or other employee benefit arrangement” within the meaning of
Rule&nbsp;14d-10(d)(2)&nbsp;under the Exchange Act, each agreement, arrangement or understanding between the Company or any of its
Affiliates and any of the officers, directors or employees of the Company that are effective as of the Agreement Date or are entered into
after the Agreement Date and prior to the Offer Acceptance Time pursuant to which compensation is paid to such officer, director or employee
and shall take all other action reasonably necessary to satisfy the requirements of the non-exclusive safe harbor set forth in Rule&nbsp;14d-10(d)(2)&nbsp;under
the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 64; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Purchaser
Stockholder Consent</u>. Immediately following the execution of this Agreement, Parent shall execute and deliver, in accordance with Section&nbsp;228
of the DGCL and in its capacity as the sole stockholder of Purchaser, a written consent adopting this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Stock
Exchange Delisting; Deregistration</u>. Prior to the Closing Date, the Company shall cooperate with Parent and use its reasonable best
efforts to take, or cause to be taken, all actions, and do or cause to be done all things, reasonably necessary, proper or advisable on
its part under applicable Laws and rules&nbsp;and policies of Nasdaq to enable the delisting by the Surviving Corporation of the Shares
from Nasdaq and the deregistration of the Shares under the Exchange Act as promptly as practicable after the Effective Time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;7.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Other
Agreements and Understandings</u>. Without the prior written consent of the Company Board, neither Parent nor Purchaser (or any other
Affiliate of Parent) shall enter into any Contract or other agreement, arrangement or understanding (whether oral or written) or commitment
to enter into an agreement, arrangement or understanding (whether oral or written) (a)&nbsp;between Parent, Purchaser or any of their
Affiliates, on the one hand, and any member of the Company’s management or the Company Board, on the other hand, as of the Agreement
Date that relate in any way to the Company and its Subsidiaries or the Transactions or (b)&nbsp;pursuant to which any stockholder of the
Company would be entitled to receive consideration of a different amount or nature from the Offer Price or Merger Consideration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase">Article&nbsp;8</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CONDITIONS PRECEDENT TO THE MERGER</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The obligations of the Parties
to effect the Merger are subject to the satisfaction, at or prior to the Closing, of each of the following conditions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;8.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>No
Restraints</u>. There shall not have been issued by any court of competent jurisdiction and remain in effect any temporary, preliminary
or permanent Order preventing the consummation of the Merger, nor shall any Law (other than any Antitrust Law) or Order have been promulgated,
entered, enforced, enacted, issued or deemed applicable to the Merger by any Governmental Body of competent jurisdiction and remain in
effect that directly or indirectly prohibits, or makes illegal, the consummation of the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;8.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Consummation
of Offer</u>. Purchaser (or Parent on Purchaser’s behalf) shall have accepted for payment and paid for all of the Shares validly
tendered pursuant to the Offer and not withdrawn.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase">Article&nbsp;9</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">TERMINATION</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;9.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Termination</u>.
This Agreement may be terminated, and the Offer and the Merger may be abandoned:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by
mutual written consent of Parent and the Company at any time prior to the Offer Acceptance Time;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 65; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by
either Parent or the Company:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
the Offer Acceptance Time shall not have occurred on or before midnight, Eastern Time, on February&nbsp;10, 2022 (the “<u>End
Date</u>”); <i>provided</i>, that neither Parent nor the Company, as applicable, shall be permitted to terminate this
Agreement pursuant to this <u>Section&nbsp;9.1(b)(i)</u>&nbsp;in the event that such Party’s material breach of any provision
of this Agreement has caused or resulted in the Offer Acceptance Time not occurring on or prior to the End Date;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
a court of competent jurisdiction or other Governmental Body shall have issued an Order, having the effect of permanently restraining,
enjoining or otherwise prohibiting the acceptance for payment of Shares pursuant to the Offer or the Merger or making consummation of
the Offer or the Merger illegal, which Order shall be final and nonappealable; <i>provided, however,</i> that neither Parent nor the Company
shall be permitted to terminate this Agreement pursuant to this <u>Section&nbsp;9.1(b)(ii)</u>&nbsp;in the event that such Party’s
material breach of any provision of this Agreement shall have been the cause of, or resulted in, the issuance of such final and nonappealable
Order; or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
the Offer (as extended in accordance with the terms of this Agreement) has been withdrawn or terminated in accordance with the terms of
this Agreement without the acceptance for payment of Shares pursuant to the Offer; <i>provided</i>, <i>however</i>, that neither Parent
nor the Company, as applicable, shall be permitted to terminate this Agreement pursuant to this <u>Section&nbsp;9.1(b)(iii)</u>&nbsp;in
the event that such Party’s material breach of any provision of this Agreement has caused or resulted in the events specified in
this <u>Section&nbsp;9.1(b)(iii)</u>&nbsp;occurring;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by
Parent, at any time prior to the Offer Acceptance Time:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
(i)&nbsp;the Company Board shall have failed to include the Company Board Recommendation in the Schedule&nbsp;14D-9 when mailed, or
shall have effected a Company Adverse Change Recommendation; (ii)&nbsp;the Company Board shall have failed to publicly reaffirm the Company
Board Recommendation within ten (10)&nbsp;Business Days after Parent so requests in writing, or, if earlier, within two (2)&nbsp;Business
Days before the Expiration Date (it being agreed that Parent shall only have the right to request the Company to do so on two (2)&nbsp;occasions);
or (iii)&nbsp;in the case of a tender offer or exchange offer subject to Regulation&nbsp;14D under the Exchange Act (other than the Offer),
the Company Board fails to recommend, in a Solicitation/Recommendation Statement on Schedule&nbsp;14D-9, rejection of such tender
offer or exchange offer within ten (10)&nbsp;Business Days of the commencement of such tender offer or exchange offer (each of clauses
(i)&nbsp;through (iii), a “<u>Trigger Event</u>”); <i>provided</i>, that Parent shall be permitted to terminate this Agreement
pursuant to this <u>Section&nbsp;9.1(c)(i)</u>&nbsp;only if Parent delivers written notice of termination within five (5)&nbsp;Business
Days of the Trigger Event giving rise to Parent’s right to terminate pursuant to this <u>Section&nbsp;9.1(c)(i)</u>; or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 66; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
breach of any representation or warranty contained in <u>Article&nbsp;4</u> of this Agreement or failure to perform any covenant or obligation
in this Agreement on the part of the Company shall have occurred such that the conditions set forth in clause (b)&nbsp;(<i>Representations
and Warranties of the Company</i>) or clause&nbsp;(c)&nbsp;(<i>Covenants of the Company</i>) of <u>Annex I</u> would not be satisfied
and cannot be cured by the Company by the End Date, or if capable of being cured, shall not have commenced to have been cured within thirty
(30) days of the date on which Parent gives the Company written notice of such breach or failure to perform; <i>provided, however,</i>
that, Parent shall not have the right to terminate this Agreement pursuant to this <u>Section&nbsp;9.1(c)(ii)</u>&nbsp;if either Parent
or Purchaser is then in material breach of any representation, warranty, covenant or obligation hereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by
the Company, at any time prior to the Offer Acceptance Time:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in
order to accept a Superior Offer and enter into a binding written definitive acquisition agreement providing for the consummation of a
transaction constituting a Superior Offer (a “<u>Specified Agreement</u>”) if the Company has complied in all material respects
with the notice, negotiation and other requirements of <u>Section&nbsp;7.1(b)</u>&nbsp;and the Company, substantially concurrently with
such termination, pays to Parent the Termination Fee;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
a breach of any representation or warranty contained in <u>Article&nbsp;5</u> of this Agreement or failure to perform any covenant or
obligation in this Agreement on the part of Parent or Purchaser shall have occurred, in each case if such breach or failure would reasonably
be expected to prevent Parent or Purchaser from consummating the Transactions and such breach or failure cannot be cured by Parent or
Purchaser, as applicable, by the End Date, or if capable of being cured, shall not have commenced to have been cured within thirty (30)
days of the date the Company gives Parent written notice of such breach or failure to perform; <i>provided, however,</i> that, the Company
shall not have the right to terminate this Agreement pursuant to this <u>Section&nbsp;9.1(d)(ii)</u>&nbsp;if the Company is then in material
breach of any representation, warranty, covenant or obligation hereunder; or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in
the event that (i)&nbsp;Purchaser shall have failed to commence (within the meaning of Rule&nbsp;14d-2 under the Exchange Act) the
Offer within the period specified in <u>Section&nbsp;2.1(a)</u>&nbsp;or (ii)&nbsp;Purchaser shall have failed to purchase all Shares validly
tendered (and not validly withdrawn) when required to do so in accordance with the terms of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;9.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Effect
of Termination</u>. In the event of the termination of this Agreement as provided in <u>Section&nbsp;9.1</u>, written notice thereof shall
be given to the other Party or Parties, specifying the provision hereof pursuant to which such termination is made, and this Agreement
shall be of no further force or effect and there shall be no liability on the part of Parent, Purchaser or the Company or their respective
directors, officers and Affiliates following any such termination except to the extent provided in <u>Section&nbsp;9.3</u>; <i>provided,
however,</i> that (a)&nbsp;<u>Section&nbsp;2.1(d)</u>, <u>Section&nbsp;2.2(b)</u>, Parent’s reimbursement obligations under <u>Section&nbsp;7.13</u>,
this <u>Section&nbsp;9.2</u>, <u>Section&nbsp;9.3</u> and <u>Article&nbsp;10</u> shall survive the termination of this Agreement and shall
remain in full force and effect, (b)&nbsp;the Non-Disclosure Agreement shall survive the termination of this Agreement and shall remain
in full force and effect in accordance with its terms; and (c)&nbsp;the termination of this Agreement shall not relieve any Party from
any claim, liability or damages to the other in respect of any Willful Breach of this Agreement prior to such termination. Nothing shall
limit or prevent any Party from exercising any rights or remedies it may have under <u>Section&nbsp;10.5(b)</u>&nbsp;in lieu of terminating
this Agreement pursuant to <u>Section&nbsp;9.1</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 67; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;9.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Expenses;
Termination Fee</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as set forth in this <u>Section&nbsp;9.3</u>, all fees and expenses incurred in connection with this Agreement and the Transactions shall
be paid by the Party incurring such expenses, whether or not the Offer and Merger are consummated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event that:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this
Agreement is terminated by the Company in accordance with <u>Section&nbsp;9.1(d)(i)</u>;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this
Agreement is terminated by Parent in accordance with <u>Section&nbsp;9.1(c)(i)</u>; or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x)&nbsp;this
Agreement is terminated pursuant to <u>Section&nbsp;9.1(b)(i)</u>&nbsp;(but in the case of a termination by the Company, only if at
such time Parent has complied with its obligations under this Agreement in all material respects such that Parent would not be
prohibited from terminating this Agreement pursuant to the second proviso of <u>Section&nbsp;9.1(b)(i)</u>) as a result of the
failure to satisfy the Minimum Condition, (y)&nbsp;after the Agreement Date and prior to such termination, any Person shall have
publicly disclosed a <i>bona fide</i> Acquisition Proposal and such Acquisition Proposal shall not have been publicly withdrawn
prior to the time of the termination of this Agreement and (z)&nbsp;within twelve (12) months of such termination, the Company shall
have consummated an Acquisition Proposal (<i>provided</i>, that for purposes of this clause&nbsp;(z)&nbsp;the references to “a
material portion” and “10% or more” in the definition of “<u>Acquisition Proposal</u>” shall be deemed
to be references to “51% or more”);</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">then, in any such event under this <u>Section&nbsp;9.3(b)</u>,
the Company shall pay, or shall cause to be paid, to Parent the Termination Fee by wire transfer of same day funds to an account designed
in writing by Parent (A)&nbsp;in the case of <u>Section&nbsp;9.3(b)(i)</u>, substantially concurrently with the termination of this Agreement
(it being agreed that if such termination occurs on a day that is not a Business Day, “substantially concurrently” shall mean
no later than on the next Business Day), (B)&nbsp;in the case of <u>Section&nbsp;9.3(b)(ii)</u>, within two (2)&nbsp;Business Days after
such termination or (C)&nbsp;in the case of <u>Section&nbsp;9.3(b)(iii)</u>, within two (2)&nbsp;Business Days after the consummation
of the Acquisition Proposal referred to in clause&nbsp;(z)&nbsp;above. Notwithstanding anything to the contrary in this Agreement, the
Parties agree that in no event shall the Company be required to pay the Termination Fee on more than one occasion. As used herein, “<u>Termination
Fee</u>” means a cash amount equal to $16,000,000. In the event that Parent or its designee shall receive full payment pursuant
to this <u>Section&nbsp;9.3(b)</u>, the receipt of the Termination Fee shall be deemed to be liquidated damages for any and all losses
or damages suffered or incurred by Parent, Purchaser, any of their respective Affiliates and Representatives or any other Person in connection
with this Agreement (and the termination hereof), the Transactions (and the abandonment thereof) or any matter forming the basis for such
termination, and none of Parent, Purchaser, any of their respective Affiliates and Representatives (collectively, “<u>Parent Related
Parties</u>”) or any other Person shall be entitled to bring or maintain any claim, action or proceeding against the Company, any
of its Affiliates or any of its Representatives arising out of, relating to, or in connection with, this Agreement, any of the Transactions
or any matters forming the basis for such termination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 68; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Parent’s
right to receive payment from the Company of the Termination Fee pursuant to <u>Section&nbsp;9.3(b)</u>&nbsp;shall be the sole and
exclusive remedy of the Parent Related Parties against the Company and any of their respective former, current or future officers,
directors, partners, stockholders, optionholders, managers, members, Affiliates or Representatives (collectively, “<u>Company
Related Parties</u>”) in any circumstance in which the Termination Fee becomes due and payable, and upon payment of such
amount, none of the Company Related Parties shall have any further liability or obligation relating to, arising out of, or in
connection with, this Agreement or the Transactions. For the avoidance of doubt, Parent or Purchaser may seek specific performance
to cause the Company to consummate the Transactions in accordance with <u>Section&nbsp;10.5(b)</u>&nbsp;or the payment of the
Termination Fee pursuant to <u>Section&nbsp;9.3(b)</u>, but in no event shall Parent or Purchaser be entitled to both
(i)&nbsp;equitable relief ordering the Company to consummate the Transactions in accordance with <u>Section&nbsp;10.5(b)</u>&nbsp;and
(ii)&nbsp;the payment of the Termination Fee pursuant to <u>Section&nbsp;9.3(b)</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Party acknowledges that the agreements contained in this <u>Section&nbsp;9.3</u> are an integral part of the Transactions and that, without
these agreements, the Parties would not enter into this Agreement. Each Party further acknowledges that the Termination Fee is not a penalty,
but rather is liquidated damages in a reasonable amount that will compensate Parent and Purchaser in the circumstances in which the Termination
Fee is payable for the efforts and resources expended and opportunities foregone while negotiating this Agreement and in reliance on this
Agreement and on the expectation of the consummation of the Transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase">Article&nbsp;10</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MISCELLANEOUS PROVISIONS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;10.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Amendments</u>.
Prior to the Offer Acceptance Time, subject to <u>Section&nbsp;7.4(e)</u>, this Agreement may be amended only with the approval of the
Company Board and the board of directors of Parent. This Agreement may not be amended except by an instrument in writing signed on behalf
of each of the Parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;10.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Waiver</u>.
No failure on the part of any Party to exercise any power, right, privilege or remedy under this Agreement, and no delay on the part of
any Party in exercising any power, right, privilege or remedy under this Agreement, shall operate as a waiver of such power, right, privilege
or remedy; and no single or partial exercise of any such power, right, privilege or remedy shall preclude any other or further exercise
thereof or of any other power, right, privilege or remedy. No Party shall be deemed to have waived any claim arising out of this Agreement,
or any power, right, privilege or remedy under this Agreement, unless the waiver of such claim, power, right, privilege or remedy is expressly
set forth in a written instrument duly executed and delivered on behalf of such Party; and any such waiver shall not be applicable or
have any effect except in the specific instance in which it is given.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 69; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;10.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>No
Survival</u>. None of the representations, warranties, covenants and agreements in this Agreement or in any certificate, instrument
or document delivered pursuant to this Agreement, including any rights arising out of any breach of such representations,
warranties, covenants and agreements, will survive the Effective Time, except for (a)&nbsp;those covenants and agreements contained
herein that by their terms expressly apply or are to be performed in whole or in part after the Effective Time and (b)&nbsp;this <u>Article&nbsp;10</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;10.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Entire
Agreement; Counterparts</u>. This Agreement (including the Company Disclosure Schedules and the exhibits, annexes, schedules and instruments
referred to herein) and the CVR Agreement constitute the entire agreement and supersede all contemporaneous and prior agreements and understandings,
both written and oral, among or between any of the Parties, with respect to the subject matter hereof and thereof; <i>provided, however,</i>
that the Non-Disclosure Agreement shall not be superseded and shall remain in full force and effect; <i>provided, further, </i>that,
if the Effective Time occurs, the Non-Disclosure Agreement shall automatically terminate and be of no further force and effect. This
Agreement may be executed in several counterparts, each of which shall be deemed an original and all of which shall constitute one and
the same instrument. The exchange of a fully executed Agreement (in counterparts or otherwise) in pdf, DocuSign or similar format and
transmitted by facsimile or email shall be sufficient to bind the Parties to the terms and conditions of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;10.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Applicable
Laws; Jurisdiction; Specific Performance; Remedies</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement shall be governed by, and construed in accordance with, the Laws of the State of Delaware, regardless of the Laws that
might otherwise govern under applicable principles of conflicts of Laws thereof. In any action or proceeding arising out of or
relating to this Agreement or any of the Transactions: (i)&nbsp;each of the Parties irrevocably and unconditionally consents and
submits to the exclusive jurisdiction and venue of the Court of Chancery of the State of Delaware and any state appellate court
therefrom or, if such court lacks subject matter jurisdiction, the United States District Court sitting in New Castle County in the
State of Delaware (it being agreed that the consents to jurisdiction and venue set forth in this <u>Section&nbsp;10.5(a)</u>&nbsp;shall
not constitute general consents to service of process in the State of Delaware and shall have no effect for any purpose except as
provided in this paragraph and shall not be deemed to confer rights on any Person other than the Parties); and (ii)&nbsp;each of the
Parties irrevocably consents to service of process by first class certified mail, return receipt requested, postage prepaid, to the
address at which such Party is to receive notice in accordance with <u>Section&nbsp;10.8</u>. Each of the Parties hereby irrevocably
and unconditionally waives any objection to the laying of venue of any action, suit or proceeding arising out of this Agreement or
the Transactions in the Court of Chancery of the State of Delaware and any state appellate court therefrom or, if such court lacks
subject matter jurisdiction, the United States District Court sitting in New Castle County in the State of Delaware, and hereby
further irrevocably and unconditionally waives and agrees not to plead or claim in any such court that any such action, suit or
proceeding brought in any such court has been brought in an inconvenient forum (including, any claim based on the doctrine of <i>forum
non conveniens</i> or any similar doctrine). The Parties agree that a final judgment in any such action or proceeding shall be
conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable Laws; <i>provided,
however, </i>that nothing in the foregoing shall restrict any Party’s rights to seek any post-judgment relief regarding, or
any appeal from, such final trial court judgment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 70; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Parties agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy, would occur in the
event that the Parties do not perform their obligations under the provisions of this Agreement in accordance with its specified terms
or otherwise breach such provisions. Subject to the terms and conditions of this <u>Section&nbsp;10.5(b)</u>, the Parties acknowledge
and agree that (i)&nbsp;the Parties shall be entitled to an injunction or injunctions, specific performance, or other equitable relief,
to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in the courts described in <u>Section&nbsp;10.5(a)</u>&nbsp;without
proof of damages or otherwise, this being in addition to any other remedy to which they are entitled under this Agreement, (ii)&nbsp;the
provisions set forth in <u>Section&nbsp;9.3</u>: (x)&nbsp;except with respect to monetary damages, are not intended to and do not adequately
compensate for the harm that would result from a breach of this Agreement and (y)&nbsp;shall not be construed to diminish or otherwise
impair in any respect any Party’s right to specific enforcement and (iii)&nbsp;the right of specific performance is an integral
part of the Transactions and without that right, neither the Company nor Parent nor Purchaser would have entered into this Agreement.
Each of the Parties agrees that it will not oppose the granting of an injunction, specific performance and other equitable relief on the
basis that the other Parties have an adequate remedy at law or an award of specific performance is not an appropriate remedy for any reason
at law or equity. The Parties acknowledge and agree that any Party seeking an injunction or injunctions to prevent breaches of this Agreement
and to enforce specifically the terms and provisions of this Agreement in accordance with this <u>Section&nbsp;10.5(b)</u>&nbsp;shall
not be required to provide any bond or other security in connection with the seeking of any such injunction or specific performance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;EACH
PARTY HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY&nbsp;ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED
AND DIFFICULT ISSUES, AND THEREFORE SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY&nbsp;HAVE TO A TRIAL
BY JURY IN ANY LITIGATION ARISING OUT OF, RELATING TO OR IN CONNECTION WITH THIS AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES
THAT (I)&nbsp;NO REPRESENTATIVE, AGENT, OR ATTORNEY OF ANY PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH PARTY WOULD
NOT,&nbsp;IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (II)&nbsp;EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE
IMPLICATION OF THIS WAIVER, (III)&nbsp;EACH PARTY MAKES THIS WAIVER VOLUNTARILY AND (IV)&nbsp;EACH OTHER PARTY HAS BEEN INDUCED TO
ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;10.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Assignment</u>.
This Agreement shall be binding upon, and shall be enforceable by and inure solely to the benefit of, the Parties and their respective
successors and permitted assigns; <i>provided, however,</i> that neither this Agreement nor any of the rights hereunder may be assigned
without the prior written consent of the other Parties, and any attempted assignment of this Agreement or any of such rights without such
consent shall be void <i>ab initio</i> and of no effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 71; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;10.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>No
Third Party Beneficiaries</u>. Nothing in this Agreement, express or implied, is intended to or shall confer upon any Person (other than
the Parties) any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement; except for: (i)&nbsp;if the Offer
Acceptance Time occurs (A)&nbsp;the right of the Company’s stockholders to receive the Offer Price or Merger Consideration, as applicable
and (B)&nbsp;the right of the holders of Company Stock Awards to receive the Merger Consideration pursuant to <u>Section&nbsp;3.8</u>;
(ii)&nbsp;each Indemnified Person set forth in <u>Section&nbsp;7.4</u>; and (iii)&nbsp;the limitations on liability of the Company Related
Parties set forth in <u>Section&nbsp;9.3(c)</u>. Notwithstanding the foregoing, the Company shall have the right to recover, through a
Legal Proceeding brought by the Company, damages from Parent in the event of a breach of this Agreement by Parent or Purchaser, in which
event the damages recoverable by the Company for itself and on behalf of the holders of Shares shall be determined by reference to the
total amount, including the loss of the economic benefit of the Transactions, that would have been recoverable under the circumstances
of such breach by such holders of Shares if all such holders brought an action against Parent and were recognized as third party beneficiaries
hereunder. The representations and warranties in this Agreement are the product of negotiations among the Parties and are for the sole
benefit of the Parties and that, in some instances, the representations and warranties in this Agreement may represent an allocation among
the Parties of risks associated with particular matters regardless of the knowledge of any of the Parties. Consequently, Persons other
than the Parties may not rely on the representations and warranties in this Agreement as characterizations of actual facts or circumstances
as of the date of this Agreement or as of any other date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;10.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Notices</u>.
Any notice or other communication required or permitted to be delivered to any Party under this Agreement shall be in writing and
shall be deemed properly delivered, given and received (a)&nbsp;upon receipt when delivered by hand, (b)&nbsp;two (2)&nbsp;Business
Days after being sent by registered mail or by courier or express delivery service, (c)&nbsp;if sent by email transmission prior to
5:00 p.m.&nbsp;recipient’s local time, upon transmission thereof (provided that no bounceback or similar
 “undeliverable” message is received by such sender) or (d)&nbsp;if sent by email transmission after 5:00
p.m.&nbsp;recipient’s local time, the Business Day following the date of transmission thereof (provided that no bounceback or
similar “undeliverable” message is received by such sender); <i>provided </i>that in each case the notice or other
communication is sent to the physical address or email address, as applicable, set forth beneath the name of such Party below (or to
such other physical address or email address as such Party shall have specified in a written notice given to the other Parties):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">if to Parent or Purchaser
(or following the Effective Time, the Company):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 6%; text-align: left"></td><td style="text-align: justify; width: 94%">Supernus Pharmaceuticals,&nbsp;Inc.</td>
</tr></tbody></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 6%; text-align: left"></td><td style="text-align: justify; width: 94%">9715 Key West Ave</td>
</tr></tbody></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 6%; text-align: left"></td><td style="text-align: justify; width: 94%">Rockville MD, 20850</td>
</tr></tbody></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 6%"></td><td style="width: 12%; text-align: left">Attention:</td><td style="text-align: justify; width: 82%">Jack A. Khattar</td>
</tr></tbody></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 6%"></td><td style="width: 12%; text-align: left">Email:</td><td style="text-align: justify; width: 82%">jkhattar@supernus.com</td>
</tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<!-- Field: Page; Sequence: 72; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">with a copy to (which shall
not constitute notice):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Saul Ewing Arnstein&nbsp;&amp; Lehr LLP<br>
1919 Pennsylvania Avenue, N.W., Suite&nbsp;550<br>
Washington, DC 20006-3434</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.65in; text-align: left">Attention:</td><td style="text-align: justify">Mark I. Gruhin</td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td></td><td style="text-align: left">Facsimile:&nbsp;</td><td style="text-align: justify">(202) 295-6719</td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td></td><td style="text-align: left">Email:</td><td style="text-align: justify">mark.gruhin@saul.com</td>
</tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">if to the Company (prior to
the Effective Time):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Adamas Pharmaceuticals,&nbsp;Inc.<br>
1900 Powell Street, Suite&nbsp;1000<br>
Emeryville, CA 94608</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.65in; text-align: left">Attention:</td><td style="text-align: justify">Christopher B. Prentiss</td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td></td><td style="text-align: left">Email:</td><td style="text-align: justify">cprentiss@adamaspharma.com</td>
</tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">with a copy to (which shall
not constitute notice):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Cooley LLP<br>
101 California Street, 5<sup>th</sup> Floor<br>
San Francisco, CA 94111</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.65in; text-align: left">Attention:</td><td style="text-align: justify">Jamie Leigh</td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td></td><td style="text-align: left"></td><td style="text-align: justify">Ian Nussbaum</td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td></td><td style="text-align: left"></td><td style="text-align: justify">Polina A. Demina</td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td></td><td style="text-align: left">Facsimile:&nbsp;</td><td style="text-align: justify">(415) 693-2222</td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td></td><td style="text-align: left"></td><td style="text-align: justify">(212) 479 6275</td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td></td><td style="text-align: left">E-mail:</td><td style="text-align: justify">jleigh@cooley.com</td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td></td><td style="text-align: left">&nbsp;</td><td style="text-align: justify">inussbaum@cooley.com</td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td></td><td style="text-align: left">&nbsp;</td><td style="text-align: justify">pdemina@cooley.com</td>
</tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;10.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Severability</u>.
Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity
or enforceability of the remaining terms and provisions of this Agreement or the validity or enforceability of the offending term or provision
in any other situation or in any other jurisdiction. If a final judgment of a court of competent jurisdiction declares that any term or
other provision of this Agreement is invalid, illegal, or incapable of being enforced by any rule&nbsp;of law or public policy, the remaining
provisions of this Agreement will be enforced so as to conform to the original intent of the Parties as closely as possible such that
the Transactions are fulfilled to the fullest extent possible.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;10.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Obligation
of Parent</u>. Parent shall ensure that each of its Subsidiaries (including Purchaser), and shall use reasonable best efforts to
ensure that each of its Representatives, duly performs, satisfies and discharges on a timely basis each of the covenants,
obligations and liabilities applicable to its Subsidiaries or its Representatives under this Agreement, and Parent shall be jointly
and severally liable with its Subsidiaries and Representatives, as applicable, for the due and timely performance and satisfaction
of each of said covenants, obligations and liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 73; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;10.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Transfer
Taxes</u>. Except as expressly provided in <u>Section&nbsp;3.6(b)</u>, all transfer, documentary, sales, use, stamp, registration, value-added
and other similar Taxes and fees incurred in connection with this Agreement and the Transaction shall be paid by Parent and Purchaser
when due and payable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;10.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Interpretations</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
purposes of this Agreement, the Parties agree that:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;whenever
the context requires, the singular number shall include the plural, and vice versa;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
word “extent” in the phrase “to the extent” means the degree to which a subject or other thing extends, and does
not simply mean “if”;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
words “include” and “including,” and variations thereof, shall not be deemed to be terms of limitation, but rather
shall be deemed to be followed by the words “without limitation;”</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
meaning assigned to each capitalized term defined and used in this Agreement is equally applicable to both the singular and the plural
forms of such term, and words denoting any gender include all genders;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;where
a word or phrase is defined in this Agreement, each of its other grammatical forms has a corresponding meaning unless the context otherwise
requires;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
reference to any specific Law or to any provision of any Law includes any amendment to, and any modification, re-enactment or
successor thereof, any legislative provision substituted therefor and all rules, regulations and statutory instruments issued or
promulgated thereunder or pursuant thereto, except that, for purposes of any representations and warranties in this Agreement that
are made as a specific date, references to any specific Law will be deemed to refer to such legislation or provision (and all rules,
regulations and statutory instruments issued or promulgated thereunder or pursuant thereto) as of such date;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;references
to any agreement or Contract are to that agreement or Contract as amended, modified or supplemented as of the date of this Agreement or,
thereafter from time to time;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
information contained in this Agreement and in the Company Disclosure Schedule is disclosed solely for purposes of this Agreement, and
no information contained herein or therein will be deemed to be an admission by any Party to any third Person of any matter whatsoever,
including (i)&nbsp;any violation of Law or breach of Contract; or (ii)&nbsp;that such information is material or that such information
is required to be referred to or disclosed under this Agreement or such information constitutes a representation or warranty of the Company;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="background-color: white">the
word “or” shall not be exclusive (i.e., “or” shall be </font>deemed <font style="background-color: white">to mean
</font>“and<font style="background-color: white">/</font>or”<font style="background-color: white">)</font>;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
references to “dollars” or “$” are to U.S. Dollars, unless expressly stated otherwise; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 74; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
measure of a period of one (1)&nbsp;month or year for purposes of this Agreement will be the date of the following month or year corresponding
to the starting date. If no corresponding date exists, then the end date of such period being measured will be the next actual date of
the following month or year (for example, one month following August&nbsp;18 is September&nbsp;18 and one month following August&nbsp;31
is October&nbsp;1).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as otherwise indicated, all references in this Agreement to “Sections,” “Exhibits,” “Annexes”
and “Schedules” are intended to refer to Sections of this Agreement and Exhibits, Annexes or Schedules to this
Agreement. The bold-faced headings contained in this Agreement are for convenience of reference only, shall not be deemed to be a
part of this Agreement and shall not be referred to in connection with the construction or interpretation of this Agreement.
Notwithstanding anything to the contrary in this Agreement, nothing in this Agreement shall require the Company to take any action
in violation of applicable Law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement will be construed without regard to any presumption or rule&nbsp;requiring construction or interpretation against the Party
drafting or causing any instrument to be drafted. Time is of the essence with respect to the performance of the obligations set forth
in this Agreement and the provisions hereof will be interpreted as such.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;10.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Company
Disclosure Schedule References</u>. The Parties agree that the disclosure set forth in any particular section or subsection of the Company
Disclosure Schedule will be deemed to be an exception to (or, as applicable, a disclosure for purposes of) the representations and warranties
(or covenants, as applicable) of the Company and its Subsidiaries that are set forth in the corresponding Section&nbsp;or subsection of
this Agreement and any other Section&nbsp;or subsection of this Agreement where the relevance of that disclosure as an exception to (or
a disclosure for purposes of) such other representations and warranties (or covenants, as applicable) is reasonably apparent on the face
of such disclosure.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<i>Signature pages&nbsp;follow</i>]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 75; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence -->-&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="text-transform: uppercase">In
Witness Whereof</font>, the Parties have caused this Agreement to be executed as of the date first above written.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 50%; text-align: left"></td><td style="text-align: justify; width: 50%"><font style="font-variant: small-caps"><b>Adamas </b><font style="font-variant: small-caps"><b>Pharmaceuticals,&nbsp;Inc.</b></font></font></td>
</tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 50%; text-align: left">&nbsp;</td><td style="text-align: justify; width: 3%">By:</td>
                                                    <td style="border-bottom: Black 1pt solid; text-align: justify; width: 47%">/s/ Neil F. McFarlane</td>
</tr></tbody></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 50.5%"></td><td style="width: 3.5%; text-align: left">Name:</td><td style="border-bottom: Black 1pt solid; text-align: justify; width: 46%">&nbsp;&nbsp;Neil F. McFarlane</td>
</tr></tbody></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 50%"></td><td style="width: 4%; text-align: left">Title:</td><td style="border-bottom: Black 1pt solid; text-align: justify; width: 46%">&nbsp;&nbsp;&nbsp;&nbsp;Chief Executive
                                            Officer</td>
</tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</p>

<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[<i>Signature Page to Agreement
and Plan of Merger</i>]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 76 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="text-transform: uppercase">In
Witness Whereof</font>, the Parties have caused this Agreement to be executed as of the date first above written.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 50%; text-align: left"></td><td style="text-align: justify; width: 50%"><font style="font-variant: small-caps"><b>Supernus </b><font style="font-variant: small-caps"><b>Pharmaceuticals,&nbsp;Inc.</b></font></font></td>
</tr><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left">&nbsp;</td><td style="text-align: justify">&nbsp;</td></tr>
     </tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 50%; text-align: left">&nbsp;</td><td style="text-align: justify; width: 3%">By:</td>
                                                    <td style="border-bottom: Black 1pt solid; text-align: justify; width: 47%">/s/ Jack A. Khattar</td>
</tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 50.5%"></td><td style="width: 3.5%; text-align: left">Name:</td><td style="border-bottom: Black 1pt solid; text-align: justify; width: 46%">&nbsp;&nbsp;Jack A. Khattar</td>
</tr></tbody></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 50%"></td><td style="width: 4%; text-align: left">Title:</td><td style="border-bottom: Black 1pt solid; text-align: justify; width: 46%">&nbsp;&nbsp;&nbsp;&nbsp;Chief Executive
                                            Officer</td>
</tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 50%; text-align: left"></td><td style="text-align: justify; width: 50%"><font style="font-variant: small-caps"><b>Supernus</b></font> <font style="font-variant: small-caps"><b>Reef,&nbsp;Inc.</b></font></td>
</tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 50%; text-align: left">&nbsp;</td><td style="text-align: justify; width: 3%">By:</td>
                                                    <td style="border-bottom: Black 1pt solid; text-align: justify; width: 47%">/s/ Jack A. Khattar</td>
</tr></tbody></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 50.5%"></td><td style="width: 3.5%; text-align: left">Name:</td><td style="border-bottom: Black 1pt solid; text-align: justify; width: 46%">&nbsp;&nbsp;Jack A. Khattar</td>
</tr></tbody></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 50%"></td><td style="width: 4%; text-align: left">Title:</td><td style="border-bottom: Black 1pt solid; text-align: justify; width: 46%">&nbsp;&nbsp;&nbsp;&nbsp;Chief Executive
                                            Officer</td>
</tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</p>

<p style="text-align: center; font-size: 10pt"><font style="font-size: 10pt">[<i>Signature Page to Agreement and Plan of Merger</i>]</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 77 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<!-- Field: Split-Segment; Name: 5 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b><u>EXHIBIT&nbsp;A</u></b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Second Amended and Restated<br>
Certificate of Incorporation<br>
of<br>
Surviving Corporation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[See attached]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 78 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b>SECOND
AMENDED AND RESTATED<br>
CERTIFICATE OF INCORPORATION<br>
OF<br>
ADAMAS PHARMACEUTICALS,&nbsp;INC.</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><u>FIRST</u></b>:	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
name of the corporation is Adamas Pharmaceuticals,&nbsp;Inc. (the “<i>Corporation</i>”).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><u>SECOND</u></b>:	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
address of its registered office in the State of Delaware is 1209 Orange Street, Corporation Trust Center, Wilmington, New Castle County,
Delaware 19801. The name of its registered agent at such address is The Corporation Trust Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><u>THIRD</u></b>:	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
nature of the business or purposes to be conducted or promoted by the Corporation are to engage in any lawful act or activity which corporations
may be organized under the General Corporation Law of Delaware.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><u>FOURTH</u></b>:	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
total number of shares of capital stock which the Corporation shall have authority to issue is One Thousand (1,000) shares of common stock
with a par value of one cent ($0.01) per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><u>FIFTH</u></b>:	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Corporation is to have perpetual existence.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><u>SIXTH</u></b>:	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
furtherance and not in limitation of the powers conferred by the laws of the State of Delaware, the Board of Directors is expressly authorized
to make, alter or repeal the Bylaws of the Corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><u>SEVENTH</u></b>:	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the fullest extent that the DGCL or any other law of the State of Delaware (as they exist on the date hereof or as they may
hereafter be amended) permits the limitation or elimination of the liability of directors, no director of the Corporation shall be
liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director.&nbsp; No amendment
to, or modification or repeal of, this Article&nbsp;Seventh shall adversely affect any right or protection of a director of the
Corporation existing hereunder with respect to any act or omission occurring prior to such amendment, modification or repeal<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>.</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><u>EIGHTH</u></b>:	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Corporation shall indemnify and advance expenses to, and hold harmless, to the fullest extent permitted by applicable law as it presently
exists or may hereafter be amended, any person (an “<i>Indemnitee</i>”) who was or is made, or is threatened to be made, a
party or is otherwise involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative (a “<i>Proceeding</i>”),
by reason of the fact that he or she, or a person for whom he or she is the legal representative, is or was a director or an officer of
the Corporation or, while a director or an officer of the Corporation, is or was serving at the request of the Corporation as a director,
officer, employee, member, trustee or agent of another corporation or of a partnership, joint venture, trust, nonprofit entity or other
enterprise (including, but not limited to, service with respect to employee benefit plans), against all liability and loss suffered (including,
but not limited to, expenses (including, but not limited to, attorneys’ fees and expenses), judgments, fines and amounts paid in
settlement and reasonably incurred by such Indemnitee). Notwithstanding the preceding sentence, the Corporation shall be required to indemnify,
or advance expenses to, an Indemnitee in connection with a Proceeding (or part thereof) commenced by such Indemnitee only if the commencement
of such Proceeding (or part thereof) by the Indemnitee was authorized by the Board of Directors of the Corporation or the Proceeding (or
part thereof) relates to the enforcement of the Corporation’s obligations under this Article&nbsp;Eighth.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><u>NINTH</u></b>:	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
indemnification provided by this Article&nbsp;Ninth is not exclusive of other indemnification rights arising under any bylaw, agreement,
vote of directors or stockholders or otherwise, and shall inure to the benefit of the heirs and legal representatives of such Indemnitee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><u>TENTH</u></b>:	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
business and affairs of the Corporation shall be managed by or under the direction of the board of directors, and the election of directors
need not be by written ballot unless the Bylaws of the Corporation so provide.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><u>ELEVENTH</u></b>:	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Corporation reserves the right to amend or repeal any provision contained in this Certificate of Incorporation in the manner prescribed
by the laws of the State of Delaware. All rights herein conferred are granted subject to this reservation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<i>Remainder of Page&nbsp;Intentionally Left Blank</i>]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 79; Options: NewSection; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><u>EXHIBIT B</u></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Second Amended and Restated Bylaws<br>
of<br>
Surviving Corporation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[See attached]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 80 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECOND AMENDED &amp; RESTATED<br>
BYLAWS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OF </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ADAMAS PHARMACEUTICALS, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(the “<i>Corporation</i>”)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 128.6pt 0pt 118.85pt; text-align: center"><font style="color: #010000"><b>SECTION
1 -</b></font><b> STOCKHOLDERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15.7pt 0pt 6pt; text-align: justify; text-indent: 0.5in"><font style="color: #010000">Section
1.1 </font> <u>Annual Meeting</u>. An annual meeting of the stockholders for the election of directors to succeed those whose term expire
and for the transaction of such other business as may properly come before the meeting shall be held at the place, if any, within or without
the State of Delaware, on the date and at the time that the Board of Directors shall each year fix. Unless stated otherwise in the notice
of the annual meeting of the stockholders of the Corporation, such annual meeting shall be at the principal office of the Corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 1.2	</font><u>Advance
Notice of Nominations and Proposals of Business</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.9pt 0pt 5.95pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(a)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font></font>Nominations of persons for election to the Board of Directors and proposals for business to be transacted by the stockholders
at an annual meeting of stockholders may be made (i) pursuant to the Corporation’s notice with respect to such meeting, (ii) by
or at the direction of the Board of Directors or (iii) by any stockholder of record of the Corporation who (A) was a stockholder of record
at the time of the giving of the notice contemplated in Section 1.2(b), (B) is entitled to vote at such meeting and (C) has complied with
the notice procedures set forth in this Section 1.2. Except as otherwise required by law, clause (iii) of this Section 1.2 shall be the
exclusive means for a stockholder to make nominations or propose other business (other than nominations and proposals properly brought
pursuant to applicable provisions of federal law, including the Securities Exchange Act of 1934 (as amended from time to time, the “<i>Act</i>”)
and the rules and regulations of the Securities and Exchange Commission thereunder) before an annual meeting of stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.95pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(b)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font></font>Except as otherwise required by law, for nominations or proposals to be properly brought before an annual meeting by a stockholder
pursuant to clause (iii) of Section 1.2(a), (i) the stockholder must have given timely notice thereof in writing to the Secretary of the
Corporation with the information contemplated by Section 1.2(c), and (ii) the business must be a proper matter for stockholder action
under the Delaware General Corporation Law (the “<i>DGCL</i>”).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.85pt 0pt 5.95pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(c)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>To
be timely for purposes of Section 1.2(b), a stockholder’s notice must be delivered to the Secretary of the Corporation at the
principal executive offices of the Corporation a date (i) not less than 90 nor more than 120 days prior to the anniversary date of
the prior year’s annual meeting or (ii) if there was no annual meeting in the prior year or if the date of the current
year’s annual meeting is more than 30 days before or after the anniversary date of the prior year’s annual meeting, on
or before 15 days after the day on which the date of the current year’s annual meeting is first disclosed in a public
announcement. In no event shall any adjournment or postponement of an annual meeting or the announcement thereof commence a new time
period for the delivery of such notice. Such notice from a stockholder must state (i) as to each nominee that the stockholder
proposes for election or reelection as a director, (A) all information relating to such nominee that would be required to be
disclosed in solicitations of proxies for the election of such nominee as a director pursuant to Regulation 14A under the Act and
such nominee’s written consent to serve as a director if elected, and (B) a description of all direct and indirect
compensation and other material monetary arrangements, agreements or understandings during the past three years, and any other
material relationship, if any, between or concerning such stockholder and its respective affiliates or associates, on the one hand,
and the proposed nominee, and his or her respective affiliates or associates, on the other hand; (ii) as to each proposal that the
stockholder seeks to bring before the meeting, a brief description of such proposal, the reasons for making the proposal at the
meeting, and any material interest that the stockholder has in the proposal; (iii) (A) the name and address of the stockholder, (B)
the class (and, if applicable, series) and number of shares of stock of the Corporation that are, directly or indirectly, owned
beneficially or of record by the stockholder or any Stockholder Associated Person (as defined below), (C) any option, warrant,
convertible security, stock appreciation right or similar right with an exercise or conversion privilege or a settlement payment or
mechanism at a price related to any class (or, if applicable, series) of shares of stock of the Corporation or with a value derived
in whole or in part from the value of any class (or, if applicable, series) of shares of stock of the Corporation, whether or not
such instrument or right shall be subject to settlement in the underlying class or series of capital stock of the Corporation or
otherwise (each, a “<i>Derivative Instrument</i>”) directly or indirectly owned beneficially or of record by such
stockholder or any Stockholder Associated Person and any other direct or indirect opportunity to profit or share in any profit
derived from any increase or decrease in the value of shares of stock of the Corporation of the stockholder or any Stockholder
Associated Person, (D) any proxy, contract, arrangement, understanding or relationship pursuant to which such stockholder or any
Stockholder Associated Person has a right to vote any securities of the Corporation, (E) any proportionate interest in shares of the
Corporation or Derivative Instruments held, directly or indirectly, by a general or limited partnership in which such stockholder or
any Stockholder Associated Person is a general partner or beneficially owns an interest in a general partner, (F) any
performance-related fees (other than an asset-based fee) that such stockholder or any Stockholder Associated Person is entitled to
based on any increase or decrease in the value of the shares of stock of the Corporation or Derivative Instruments and (G) whether
either the stockholder intends to deliver a proxy statement and form of proxy to holders of, in the case of a proposal, at least the
percentage of the Corporation’s voting shares required under applicable law to carry the proposal or, in the case of a
nomination or nominations, a sufficient number of holders of the Corporation’s voting shares reasonably believed by such
stockholder to be sufficient to elect such nominee or nominees. For purposes of these by-laws, a “STOCKHOLDER ASSOCIATED
PERSON” of any stockholder means any “affiliate” or “associate” (as those terms are defined in Rule
12b-2 under the Act) of the stockholder that owns beneficially or of record any capital stock or other securities of the
Corporation. In addition, any nominee proposed by a stockholder shall complete a questionnaire, in a form provided by the
Corporation, within 10 days of receipt of the form of questionnaire from the Corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 6pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(d)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font></font>Subject to the certificate of incorporation of the Corporation and applicable law, only persons nominated in accordance
with procedures stated in this Section 1.2 shall be eligible for election as and to serve as members of the Board of Directors and the
only business that shall be conducted at an annual meeting of stockholders is the business that has been brought before the meeting in
accordance with the procedures set forth in this Section 1.2.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 78pt; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 6pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(e)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>The
chairman of the meeting shall have the power and the duty to determine whether a nomination or any proposal has been made according
to the procedures stated in this Section 1.2 and, if any nomination or proposal does not comply with this Section 1.2, unless
otherwise required by law, the nomination or proposal shall be disregarded.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.35pt 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.35pt 0pt 0.5in; text-align: left; text-indent: 0in"></p>

<!-- Field: Page; Sequence: 81; Options: NewSection; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.35pt 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 6pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(f)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font></font>For purposes of this Section 1.2, “public announcement” means disclosure in a press release reported by the
Dow Jones News Service, Associated Press or a comparable news service or in a document publicly filed by the Corporation with the Securities
and Exchange Commission pursuant to Section 13, 14 or 15(d) of the Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.35pt 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 6pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(g)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font></font>Notwithstanding the foregoing provisions of this Section 1.2, a stockholder shall also comply with applicable requirements
of the Act and the rules and regulations thereunder with respect to matters set forth in this Section 1.2. Nothing in this Section 1.2
shall affect any rights, if any, of stockholders to request inclusion of nominations or proposals in the Corporation’s proxy statement
pursuant to applicable provisions of federal law, including the Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 1.3	</font><u>Special
Meetings; Notice</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.25pt 0pt 6pt; text-align: justify; text-indent: 0.5in">Special meetings
of the stockholders of the Corporation may be called only in the manner set forth in the certification of incorporation of the Corporation.
Notice of every special meeting of the stockholders of the Corporation shall state the purpose of such meeting. Except as otherwise required
by law, the business conducted at a special meeting of stockholders of the Corporation shall be limited exclusively to the business set
forth in the Corporation’s notice of meeting, and the individual or group calling such meeting shall have exclusive authority to
determine the business included in such notice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 1.4	</font><u>Notice
of Meetings</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 6pt; text-align: justify; text-indent: 0.5in">Notice of the
place, if any, date and time of all meetings of stockholders of the Corporation, and the means of remote communications, if any, by which
stockholders and proxy holders may be deemed present and vote at such meeting, and, in the case of all special meetings of stockholders,
the purpose of the meeting, shall be given, not less than 10 nor more than 60 days before the date on which such meeting is to be held,
to each stockholder entitled to notice of the meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.2pt 0pt 6pt; text-align: justify; text-indent: 0.5in">The Corporation
may postpone or cancel any previously called annual or special meeting of stockholders of the Corporation by making a public announcement
(as defined in Section 1.2(e)) of such postponement or cancellation prior to the meeting. When a previously called annual or special meeting
is postponed to another time or place, if any, notice of the place (if any), date and time of the postponed meeting and the means of remote
communications, if any, by which stockholders and proxy holders may be deemed present and vote at such postponed meeting, shall be given
in conformity with this Section 1.4 unless such meeting is postponed not more than 60 days after initial notice of the meeting was provided
in conformity with this Section 1.4.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.2pt 0pt 6pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.2pt 0pt 6pt; text-align: justify; text-indent: 0.5in">When a
meeting is adjourned to another time or place, notice need not be given of the adjourned meeting if the time and place, if any,
thereof and the means of remote communication, if any, by which stockholders and proxy holders may be deemed to be present and vote
at such adjourned meeting are announced at the meeting at which the adjournment is taken; <u>however,</u> if the date of any
adjourned meeting is more than 30 days after the date for which the meeting was originally noticed, or if a new record date is fixed
for voting at the adjourned meeting, notice of the place, if any, date and time of the adjourned meeting and the means of remote
communication, if any, by which stockholders and proxy holders may be deemed present and vote at such adjourned meeting, shall be
given in conformity herewith. At any adjourned meeting, any business may be transacted that may have been transacted at the original
meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 1.5	</font><u>Quorum</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10.25pt 0pt 5.95pt; text-align: justify; text-indent: 0.5in">At any meeting
of the stockholders, the holders of shares of stock of the Corporation entitled to cast a majority of the total votes entitled to be cast
by the holders of all outstanding capital stock of the Corporation, present in person or by proxy, shall constitute a quorum for all purposes,
unless or except to the extent that the presence of a larger number is required by applicable law or the certificate of incorporation
of the Corporation. If a separate vote by one or more classes or series is required, the holders of shares entitled to cast a majority
of the total votes entitled to be cast by the holders of the shares of the class or classes or series, present in person or represented
by proxy, shall constitute a quorum entitled to take action with respect to that vote on that matter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10.25pt 0pt 6pt; text-align: justify; text-indent: 0.5in">If a quorum
shall fail to attend any meeting, the chairman of the meeting may adjourn the meeting to another place, if any, date and time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 1.6	</font><u>Organization</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10.35pt 0pt 5.95pt; text-align: justify; text-indent: 0.5in">The Chairman
of the Board or, in his or her absence, the person whom the Board of Directors designates or, in the absence of that person or the failure
of the Board of Directors to designate a person, the President of the Corporation or, in his or her absence, the person chosen by the
holders of a majority of the shares entitled to vote who are present, in person or by proxy, shall call to order any meeting of the stockholders
of the Corporation and act as chairman of the meeting. In the absence of the Secretary or any Assistant Secretary of the Corporation,
the secretary of the meeting shall be the person the chairman appoints.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 1.7	</font><u>Conduct
of Business</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10.25pt 0pt 6pt; text-align: justify; text-indent: 0.5in">The chairman
of any meeting of stockholders of the Corporation shall determine the order of business and the rules of procedure for the conduct of
such meeting, including the manner of voting and the conduct of discussion as he or she determines to be in order. The chairman shall
have the power to adjourn the meeting to another place, if any, date and time. The date and time of the opening and closing of the polls
for each matter upon which the stockholders will vote at the meeting shall be announced at the meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10.25pt 0pt 6pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 1.8	</font><u>Proxies;
Inspectors</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.95pt 0pt 6pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(a)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font></font>At any meeting of the stockholders, every stockholder entitled to vote may vote in person or by proxy authorized by an instrument
in writing or by a transmission permitted by applicable law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 5.95pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(b)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>Prior
to a meeting of the stockholders of the Corporation, the Corporation shall appoint one or more inspectors to act at a meeting of
stockholders of the Corporation and make a written report thereof. The Corporation may designate one or more persons as alternate
inspectors to replace any inspector who fails to act. If no inspector or alternate is able to act at a meeting of stockholders, the
person presiding at the meeting may, and to the extent required by applicable law, shall, appoint one or more inspectors to act at
the meeting. Each inspector, before beginning the discharge of his or her duties, shall take and sign an oath faithfully to execute
the duties of inspector with strict impartiality and according to the best of his or her ability. The inspectors may appoint or
retain other persons or entities to assist the inspectors in the performance of the duties of inspectors. The inspectors shall have
the duties prescribed by applicable law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 1.9	</font><u>Voting</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.9pt 0pt 5.95pt; text-align: justify; text-indent: 0.5in">Except as otherwise
required by applicable law or by the certificate of incorporation of the Corporation, all matters other than the election of directors
shall be determined by a majority of the votes cast on the matter affirmatively or negatively. All elections of directors shall be determined
by a plurality of the votes cast.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 1.10	</font><u>Stock
List</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.95pt 0pt 5.95pt; text-align: justify; text-indent: 0.5in">A complete
list of stockholders of the Corporation entitled to vote at any meeting of stockholders of the Corporation, arranged in alphabetical order
for each class of stock and showing the address of each such stockholder and the number of shares registered in the name of such stockholder,
shall be open to the examination of any such stockholder, for any purpose germane to a meeting of the stockholders of the Corporation,
for a period of at least 10 days before the meeting (i) on a reasonably accessible electronic network, provided that the information required
to gain access to such list is provided with the notice of the meeting or (ii) during ordinary business hours at the principal place of
business of the Corporation; provided, however, if the record date for determining the stockholders entitled to vote is less than 10 days
before the meeting date, the list shall reflect the stockholders entitled to vote as of the 10th day before such meeting date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.9pt 0pt 6pt; text-align: justify; text-indent: 0.5in">The stock list
shall also be open to the examination of any such stockholder during the entire meeting. The Corporation may look to this list as the
sole evidence of the identity of the stockholders entitled to vote at a meeting and the number of shares held by each stockholder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.9pt 0pt 6pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.9pt 0pt 6pt; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.9pt 0pt 6pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 121.7pt 0pt 1.65in; text-align: center"><font style="color: #010000">SECTION
2 -</font> BOARD OF DIRECTORS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 2.1	</font><u>Qualifications
of Directors</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.5pt 0pt 6pt; text-indent: 0.5in">Directors need not be stockholders
to be qualified for election or service as a director of the Corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 2.2	</font><u>Removal;
Resignation</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.6pt 0pt 6pt; text-align: justify; text-indent: 0.5in">Any director or
the entire Board of Directors may be removed, but only with cause, by the holders of a majority of the shares then entitled to vote at
an election of directors. Any director may resign at any time upon notice given in writing, including by electronic transmission, to the
Corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 2.3	</font><u>Regular
Meetings</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.65pt 0pt 5.95pt; text-align: justify; text-indent: 0.5in">Regular meetings
of the Board of Directors shall be held at the place (if any), on the date and at the time as shall have been established by the Board
of Directors and publicized among all directors. A notice of a regular meeting, the date of which has been so publicized, shall not be
required.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 2.4	</font><u>Special
Meetings</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.55pt 0pt 5.95pt; text-align: justify">Special meetings of the Board
of Directors may be called by the President or by two or more directors then in office and shall be held at the place, if any, on the
date and at the time as he, she or they shall fix. Notice of the place, if any, date and time of each special meeting shall be given to
each director either (a) by mailing written notice thereof not less than five days before the meeting, or (b) by telephone, facsimile
or electronic transmission providing notice thereof not less than twenty-four hours before the meeting. Unless otherwise stated in the
notice thereof, any and all business may be transacted at a special meeting of the Board of Directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 2.5	</font><u>Quorum</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.55pt 0pt 6pt; text-align: justify; text-indent: 0.5in">At any meeting
of the Board of Directors, a majority of the total number of directors then in office shall constitute a quorum for all purposes. If a
quorum shall fail to attend any meeting, a majority of those present may adjourn the meeting to another place, if any, date or time, without
further notice or waiver thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 2.6	</font><u>Participation
in Meetings By Conference Telephone or Other Communications Equipment</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.55pt 0pt 6pt; text-align: justify; text-indent: 0.5in">Members of the
Board of Directors, or of any committee thereof, may participate in a meeting of the Board of Directors or committee thereof by means
of conference telephone or other communications equipment by means of which all directors participating in the meeting can hear each other
director, and such participation shall constitute presence in person at the meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 2.7	</font><u>Conduct
of Business</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.9pt 0pt 5.95pt; text-align: justify; text-indent: 0.5in">At any meeting
of the Board of Directors, business shall be transacted in the order and manner that the Board of Directors may from time to time determine,
and all matters shall be determined by the vote of a majority of the directors present, except as otherwise provided in the certificate
of incorporation of the Corporation or these bylaws or required by applicable law. The Board of Directors or any committee thereof may
take action without a meeting if all members thereof consent thereto in writing or by electronic transmission, and the writing or writings,
or electronic transmission or electronic transmissions, are filed with the minutes of proceedings of the Board of Directors or any committee
thereof. Such filing shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes
are maintained in electronic form.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 2.8	</font><u>Compensation
of Directors</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.95pt 0pt 5.95pt; text-align: justify; text-indent: 0.5in">The Board
of Directors shall be authorized to fix the compensation of directors. The directors of the Corporation shall be paid their expenses,
if any, of attendance at each meeting of the Board of Directors and may be reimbursed a fixed sum for attendance at each meeting of the
Board of Directors, paid an annual retainer or paid other compensation, including equity compensation, as directors of the Corporation
determine. No such payment shall preclude any director from serving the Corporation in any other capacity and receiving compensation therefor.
Members of committees have their expenses, if any, of attendance of each meeting of such committee reimbursed and may be paid compensation
for attending committee meetings or being a member of a committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 121.7pt 0pt 1.65in; text-align: center"><font style="color: #010000">SECTION
3 -</font> COMMITTEES</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 3.1	</font><u>Committees
of the Board of Directors</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 19.3pt 0pt 6pt; text-align: justify; text-indent: 0.5in">The Board of
Directors may designate committees of the Board of Directors, with such lawfully delegable powers and duties as it thereby confers, to
serve at the pleasure of the Board of Directors and shall, for those committees, appoint a director or directors to serve as the member
or members, designating, if it desires, other directors as alternate members who may replace any absent or disqualified member at any
meeting of such committee. In the absence or disqualification of any member of any committee and any alternate member in his or her place,
the member or members of the committee present at the meeting and not disqualified from voting, whether or not he or she or they constitute
a quorum, may by unanimous vote appoint another member of the Board of Directors to act at the meeting in the place of the absent or disqualified
member.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 121.7pt 0pt 1.65in; text-align: center"><font style="color: #010000">SECTION
4 -</font> OFFICERS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 4.1	</font><u>Generally</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10.65pt 0pt 6pt; text-indent: 0.5in">The officers of the Corporation
shall consist of a President, one or more Vice Presidents, a Secretary, one or more Assistant Secretaries, a Treasurer, one or more
Assistant Treasurers, a Chief Financial Officer and other officers as may from time to time be appointed by the Board of Directors.
Each officer shall hold office until his or her successor is elected and qualified or until his or her earlier resignation or
removal. Any number of offices may be held by the same person. The compensation of officers appointed by the Board of Directors
shall be determined from time to time by the Board of Directors or a committee thereof or by the officers as may be designated by
resolution of the Board of Directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 4.2	</font><u>President</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.65pt 0pt 6pt; text-align: justify; text-indent: 0.5in">Unless otherwise
determined by the Board of Directors, the President shall be the Chief Executive Officer of the Corporation. Subject to the provisions
of these bylaws and to the direction of the Board of Directors, he or she shall have the responsibility for the general management and
control of the business and affairs of the Corporation and shall perform all duties and have all powers that are commonly incident to
the office of chief executive or which are delegated to him or her by the Board of Directors. He or she shall have the power to sign all
stock certificates, contracts and other instruments of the Corporation that are authorized and shall have general supervision and direction
of all of the other officers, employees and agents of the Corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 4.3	</font><u>Vice
President</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.7pt 0pt 5.95pt; text-align: justify; text-indent: 0.5in">Each Vice President
shall have the powers and duties delegated to him or her by the Board of Directors or the President. One Vice President may be designated
by the Board of Directors to perform the duties and exercise the powers of the President in the event of the President’s absence
or disability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 4.4	</font><u>Secretary
and Assistant Secretaries</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.7pt 0pt 5.95pt; text-align: justify; text-indent: 0.5in">The Secretary
shall issue all authorized notices for, and shall keep minutes of, all meetings of the stockholders and the Board of Directors. He or
she shall have charge of the corporate books and shall perform other duties as the Board of Directors may from time to time prescribe.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.7pt 0pt 5.95pt; text-align: justify; text-indent: 0.5in">Any Assistant
Secretary shall perform such duties and possess such powers as the Board of Directors, the Chief Executive Officer or the Secretary may
from time to time prescribe. In the event of the absence, inability or refusal to act of the Secretary, the Assistant Secretary, (or if
there shall be more than one, the Assistant Secretaries in the order determined by the Board of Directors) shall perform the duties and
exercise the powers of the Secretary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 4.5	</font><u>Chief
Financial Officer</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.7pt 0pt 5.95pt; text-align: justify; text-indent: 0.5in">The Chief
Financial Officer shall keep or cause to be kept the books of account of the Corporation in a thorough and proper manner and shall
render statements of the financial affairs of the Corporation in such form and as often as required by the Board of Directors or the
President. The Chief Financial Officer, subject to the order of the Board of Directors, shall have the custody of all funds and
securities of the Corporation. The Chief Financial Officer shall perform other duties commonly incident to his office and shall also
perform such other duties and have such other powers as the Board of Directors or the President shall designate from time to time.
The President may direct the Treasurer or any Assistant Treasurer to assume and perform the duties of the Chief Financial Officer in
the absence or disability of the Chief Financial Officer, and each Treasurer and Assistant Treasurer shall perform other duties
commonly incident to his office and shall also perform such other duties and have such other powers as the Board of Directors or the
President shall designate from time to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 4.6	</font><u>Delegation
of Authority</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 41.15pt 0pt 5.95pt; text-align: justify; text-indent: 0.5in">The Board
of Directors may from time to time delegate the powers or duties of any officer to any other officer or agent, notwithstanding any provision
hereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 4.7	</font><u>Removal</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 22.15pt 0pt 5.95pt; text-indent: 0.5in">The Board of Directors may remove
any officer of the Corporation at any time, with or without cause.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 4.8	</font><u>Action
with Respect to Securities of Other Companies</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 13.65pt 0pt 5.95pt; text-align: justify; text-indent: 0.5in">Unless otherwise
directed by the Board of Directors, the President, or any officer of the Corporation authorized by the President, shall have power to
vote and otherwise act on behalf of the Corporation, in person or by proxy, at any meeting of stockholders or equityholders of, or with
respect to any action of, stockholders or equityholders of any other entity in which the Corporation may hold securities and otherwise
to exercise any and all rights and powers which the Corporation may possess by reason of its ownership of securities in such other entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 121.7pt 0pt 1.65in; text-align: center"><font style="color: #010000">SECTION
5 -</font> STOCK</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 5.1	</font><u>Certificates
of Stock</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 11.3pt 0pt 6pt; text-align: justify; text-indent: 0.5in">Shares of the
capital stock of the Corporation may be certificated or uncertificated, as provided in the DGCL. Stock certificates shall be signed by,
or in the name of the Corporation by, (i) the Chairman of the Board (if any), the President or a Vice President, and (ii) the Secretary
or an Assistant Secretary, or the Treasurer or an Assistant Treasurer, or the Chief Financial Officer, certifying the number of shares
owned by such stockholder. Any signatures on a certificate may be by facsimile.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 5.2	</font><u>Transfers
of Stock</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 11.3pt 0pt 6pt; text-align: justify; text-indent: 0.5in">Transfers of
stock shall be made only upon the transfer books of the Corporation kept at an office of the Corporation (within or without the State
of Delaware) or by transfer agents designated to transfer shares of the stock of the Corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.75pt"><font style="color: #010000">Section 5.3	</font><u>Lost,
Stolen or Destroyed Certificates</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.05pt 0pt 6pt; text-align: justify; text-indent: 0.5in">In the event
of the loss, theft or destruction of any certificate of stock, another may be issued in its place pursuant to regulations as the Board
of Directors may establish concerning proof of the loss, theft or destruction and concerning the giving of a satisfactory bond or indemnity,
if deemed appropriate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.05pt 0pt 6pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.4in 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><font style="color: #010000">Section
5.4	</font><u>Regulations</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt">The issue, transfer, conversion and registration of certificates
of stock of the Corporation</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt">shall be governed by other regulations as the Board of Directors
may establish.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.4in 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><font style="color: #010000">Section
5.5	</font><u>Record Date</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.95pt 0pt 5.95pt; text-align: justify; text-indent: 0.5in">In order for
the Corporation to determine the stockholders of the Corporation entitled to notice of any meeting of stockholders of the Corporation,
the Board of Directors may, except as otherwise required by applicable law, fix a record date, which record date shall not precede the
date on which the resolution fixing the record date is adopted and which record date shall not be more than 60 nor less than 10 days before
the date of any meeting of stockholders. If the Board of Directors so fixes a date, such date shall also be the record date for determining
the stockholders entitled to vote at such meeting unless the Board of Directors determines that a later date on or before the date of
the meeting shall be the date for making such determination. If no record date is fixed by the Board of Directors, the record date for
determining stockholders entitled to notice of and to vote at a meeting of stockholders of the Corporation shall be at the close of business
on the day next preceding the day on which notice is given or, if notice is waived, at the close of business on the day next preceding
the day on which the meeting is held.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9pt 0pt 5.95pt; text-align: justify; text-indent: 0.5in">A determination
of stockholders of record entitled to notice of or to vote at a meeting of stockholders of the Corporation shall apply to any postponement
or adjournment of the meeting, provided, that the Board of Directors may fix a new record date for determination of the stockholders entitled
to vote at a postponed or adjourned meeting, and in such case shall also fix the record date of the stockholders entitled to notice of
such postponed or adjourned meeting at the same or on an earlier date as that fixed for determination of the stockholders entitled to
vote at the postponed or adjourned meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 121.7pt 0pt 1.65in; text-align: center"><font style="color: #010000">SECTION
6 -</font> NOTICES</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.4in 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><font style="color: #010000">Section
6.1	</font><u>Notices</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9pt 0pt 5.95pt; text-align: justify; text-indent: 0.5in">If mailed, notice
to a stockholder of the Corporation shall be deemed given when deposited in the mail, postage prepaid, directed to a stockholder at such
stockholder’s address as it appears on the records of the Corporation. Without limiting the manner by which notice otherwise may
be given effectively to stockholders, any notice to stockholders of the Corporation may be given by electronic transmission in the manner
provided in Section 232 of the DGCL.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.4in 0pt 5.75pt; text-align: justify; text-indent: 0.5in"><font style="color: #010000">Section
6.2	</font><u>Waivers</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.95pt 0pt 5.95pt; text-align: justify; text-indent: 0.5in">A written
waiver of any notice, signed by a stockholder or director, or a waiver by electronic transmission by such person or entity, whether given
before or after the time of the event for which notice is to be given, shall be deemed equivalent to the notice required to be given to
such person or entity. Neither the business nor the purpose of any meeting need be specified in the waiver. Attendance at any meeting
shall constitute waiver of notice except attendance for the sole purpose of objecting, at the beginning of the meeting, to the transaction
of any business because the meeting is not lawfully called or convened.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 86; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 121.7pt 0pt 1.65in; text-align: center"><font style="color: #010000">SECTION
7 -</font> MISCELLANEOUS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt"><font style="color: #010000">Section 7.1	</font><u>Corporate
Seal</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9pt 0pt 6pt; text-align: justify; text-indent: 0.5in">The Board of Directors
may provide a suitable seal, containing the name of the Corporation, which seal shall be in the charge of the Secretary. If and when so
directed by the Board of Directors, duplicates of the seal may be kept and used by the Treasurer or by an Assistant Secretary, Assistant
Treasurer or the Chief Financial Officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt"><font style="color: #010000">Section 7.2	</font><u>Reliance
upon Books, Reports, and Records</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.95pt 0pt 6pt; text-align: justify; text-indent: 0.5in">Each director
and each member of any committee designated by the Board of Directors of the Corporation shall, in the performance of his or her duties,
be fully protected in relying in good faith upon the books and records of the Corporation and upon such information, opinions, reports
or statements presented to the Corporation by any of its officers, agents or employees, or committees of the Board of Directors so designated,
or by any other person or entity as to matters which such director or committee member reasonably believes are within such other person’s
or entity’s professional or expert competence and that has been selected with reasonable care by or on behalf of the Corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.95pt"><font style="color: #010000">Section 7.3</font>	<u>Fiscal
Year</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.95pt">The fiscal year of the Corporation shall be as fixed by
the Board of Directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.95pt">Section 7.4. 	 <u>Time Periods</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.95pt 0pt 5.95pt; text-align: justify; text-indent: 0.5in">In applying
any provision of these bylaws that requires that an act be done or not be done a specified number of days before an event or that an act
be done during a specified number of days before an event, calendar days shall be used, the day of the doing of the act shall be excluded,
and the day of the event shall be included.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 121.7pt 0pt 1.65in; text-align: center; color: #010000">SECTION 8
 – INDEMNIFICATION</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 6pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(a)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font></font><font style="background-color: white"><u>Indemnity in Third-Party Proceedings</u>. The Corporation shall be liable to indemnify
the current and former (for a period of six (6) years following the resignation or removal of such former officer or director) officers
and directors of the Corporation (the “<i>Indemnitees</i>”) in accordance with the provisions of this Section 8 if Indemnitee
is, or is threatened to be made, a party to or a participant (as a witness or otherwise) in any Proceeding, other than a Proceeding by
or in the right of the Corporation to procure a judgment in its favor. Pursuant to this Section 8, Indemnitee shall be indemnified against
all Expenses, judgments, fines and amounts paid in settlement actually and reasonably incurred by Indemnitee or on Indemnitee’s
behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner Indemnitee
reasonably believed to be in or not opposed to the best interests of the Corporation and, in the case of a criminal Proceeding, had no
reasonable cause to believe that Indemnitee’s conduct was unlawful</font>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 6pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(b)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font></font> <font style="background-color: white"><u>Indemnity in Proceedings by or in the Right of the Corporation</u>. The Corporation
shall be liable to indemnify Indemnitee in accordance with the provisions of this Section 8 if Indemnitee is, or is threatened to be made,
a party to or a participant (as a witness or otherwise) in any Proceeding by or in the right of the Corporation to procure a judgment
in its favor. Pursuant to this Section 8, Indemnitee shall be indemnified against all Expenses actually and reasonably incurred by Indemnitee
or on Indemnitee’s behalf in connection with such Proceeding (or any claim, issue or matter therein) if Indemnitee acted in good
faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Corporation; <u>provided</u>,
<u>however</u>, that no indemnification for Expenses shall be made under this Section 8 in respect of any claim, issue or matter as to
which Indemnitee shall have been finally adjudged by a court of competent jurisdiction to be liable to the Corporation, unless and only
to the extent that any court in which the Proceeding was brought shall determine upon application that, despite the adjudication of liability
but in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnification.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 78pt; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 6pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(c)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font></font><font style="background-color: white"><u>Indemnification for Expenses of a Party Who is Wholly or Partly Successful</u>.
Notwithstanding any other provisions of these Bylaws, to the extent that Indemnitee is a party to (or a participant in) and is successful,
on the merits or otherwise, in any Proceeding, the Corporation shall be liable to indemnify Indemnitee against all Expenses actually and
reasonably incurred by him in connection therewith. If Indemnitee is not wholly successful in such Proceeding but is successful, on the
merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the Corporation shall be liable
to indemnify Indemnitee against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection
with each successfully resolved claim, issue or matter. For purposes of this Section and without limitation, the termination of any claim,
issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim,
issue or matter.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 78pt; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 6pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(d)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font></font><font style="background-color: white"><u>Indemnification For Expenses of a Witness</u>. Notwithstanding any other provision
of these Bylaws, to the extent that Indemnitee is, by reason of Indemnitee’s Corporate Status, a witness in any Proceeding to which
Indemnitee is not a party, the Corporation shall be liable to indemnify Indemnitee against all Expenses actually and reasonably incurred
by Indemnitee or on Indemnitee’s behalf in connection therewith.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 78pt; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 6pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(e)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font></font><font style="background-color: white"><u>Additional Indemnification</u>. Notwithstanding any limitation in this Section&nbsp;8,
the Corporation shall be liable to indemnify Indemnitee to the fullest extent permitted by law if Indemnitee is a party to, or threatened
to be made a party to, any Proceeding (including a Proceeding by or in the right of the Corporation to procure a judgment in its favor)
against all Expenses, judgments, fines and amounts paid in settlement actually and reasonably incurred by Indemnitee in connection with
the Proceeding; <u>provided</u>, <u>however</u>, that no indemnity shall be made under this Section 8(e) on account of Indemnitee’s
conduct which has been adjudicated to constitute a breach of Indemnitee’s duty of loyalty to the Corporation or its shareholders
or to constitute an act or omission not in good faith or involving intentional misconduct or a knowing violation of the law.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.5pt 0pt 5.75pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(f)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font></font><font style="background-color: white">For purposes of Section&nbsp;8(e), the meaning of the phrase “to the fullest
extent permitted by law” shall include, but not be limited to</font>:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">i.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">to the fullest extent permitted by the provision
of the DGCL that authorizes or contemplates additional indemnification by agreement, or the corresponding provision of any amendment to
or replacement of the DGCL; and</font></td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">ii.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">to the fullest extent authorized or permitted
by any amendments to or replacements of the DGCL adopted after the date of these Bylaws that increase the extent to which a corporation
may indemnify its officers and directors</font>.</td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 6pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(g)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font></font><font style="background-color: white"><u>Exclusions</u>. Notwithstanding any provision in this Section 8, the Corporation
shall not be obligated to make any indemnity payment, or to advance any expenses, in connection with any claim made against Indemnitee:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">i.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">for which payment has actually been received
by or on behalf of Indemnitee under any insurance policy or other indemnity provision, except with respect to any excess beyond the amount
actually received under any insurance policy or other indemnity provision;</font></td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: left; text-indent: 0in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">ii.</td><td style="text-align: justify; padding-right: 6.3pt">for an accounting of profits made from the purchase and sale (or sale and purchase)
by Indemnitee of securities of the Corporation within the meaning of Section 16(b) of the Exchange Act or similar provisions of state
statutory law or common law; <u>provided</u>, <u>however</u>, that notwithstanding any limitation on the Corporation’s obligation
to provide indemnification set forth in this Section 8(g) or elsewhere, Indemnitee shall be entitled to receive advancement of Expenses
hereunder with respect to any such claim unless and until a court having jurisdiction over the claim shall have made a final judicial
determination (as to which all rights of appeal therefrom have been exhausted or lapsed) that Indemnitee has violated said statute; or</td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: left; text-indent: 0in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">iii.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">in connection with any Proceeding (or any
part of any Proceeding) initiated by Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee against
the Corporation or its directors, officers, employees or other indemnitees, unless (i) such indemnification is expressly required to be
made by applicable law, (ii) the Proceeding was authorized by the Board, (iii) such indemnification is provided by the Corporation, in
its sole discretion, pursuant to the powers vested in the Corporation under the DGCL, or (iv) such indemnification is required to be made
pursuant to Section&nbsp;8(n) of these Bylaws.</font></td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: left; text-indent: 0in"></p>

<!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 6pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(h)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="background-color: white"><u>Advancement
of Expenses; Defense of Claim</u>. Except as otherwise provided herein, the Corporation shall be obligated to advance any and all
Expenses incurred by Indemnitee in connection with any Proceeding within thirty (30) days after the receipt by the Corporation of a
statement or statements requesting such advances from time to time, whether prior to or after final disposition of any
Proceeding.&nbsp; Such statement or statements shall reasonably evidence the </font>Expenses incurred by Indemnitee and shall
include or be preceded or accompanied by a written undertaking by or on behalf of Indemnitee to repay any Expenses advanced to the
extent and only to the extent that it is ultimately determined that Indemnitee is not entitled to be indemnified by the Corporation.
Any advances (i) shall be unsecured and interest free; (ii) shall be made without regard to Indemnitee’s ability to repay the
advances and without regard to Indemnitee’s ultimate entitlement to indemnification under the other provisions of these
Bylaws; and (iii) shall include any and all reasonable Expenses incurred pursuing an action to enforce this right of advancement,
including Expenses incurred preparing and forwarding statements to the Corporation to support the advances claimed. The Corporation
will be entitled to participate reasonably in the Proceeding at its own expense.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 78pt; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 6pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(i)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font></font><font style="background-color: white"><u>Procedure for Notification and Requests for Advancement and Indemnification</u></font>.
<font style="background-color: white">To obtain advancement of Expenses and/or indemnification under these Bylaws, Indemnitee shall, not
later than sixty (60) days after receipt by Indemnitee of notice of the commencement of any Proceeding, except for Proceedings pending
as of the date of these Bylaws, submit to the Corporation written notification of the Proceeding; with regard to Proceedings pending as
of the date of these Bylaws, Indemnitee shall submit to the Corporation written notification not later than thirty (30) days after the
date of these Bylaws. The omission to notify the Corporation will relieve the Corporation of its advancement or indemnification obligations
under these Bylaws only to the extent the Corporation can establish that such omission to notify resulted in actual prejudice to it, and
the omission to notify the Corporation will, in any event, not relieve the Corporation from any liability which it may have to indemnify
Indemnitee otherwise than under these Bylaws. The Secretary of the Corporation shall, promptly upon receipt of notification from Indemnitee
pursuant to this Section 8(i), advise the Board in writing that Indemnitee has provided such notification.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 78pt; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 6pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(j)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font></font><font style="background-color: white"><u>Expense Request</u>. Subject to Section 8(h), to obtain advancement of Expenses
under these Bylaws, Indemnitee shall submit to the Corporation a written request therefor, together with such invoices or other supporting
information as may be reasonably requested by the Corporation and reasonably available to Indemnitee, and, only to the extent required
by applicable law which cannot be waived, an unsecured written undertaking to repay amounts advanced. The Corporation shall make advance
payment of Expenses to Indemnitee no later than thirty (30) days after receipt of the written request for advancement (and each subsequent
request for advancement) by Indemnitee. If, at the time of receipt of any such written request for advancement of Expenses, the Corporation
has director and officer insurance policies in effect, the Corporation will promptly notify the relevant insurers in accordance with the
procedures and requirements of such policies. The Corporation shall thereafter keep such director and officer insurers informed of the
status of the Proceeding or other claim, as appropriate to secure insurance coverage of Indemnitee for such claim.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 78pt; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 6pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(k)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style="background-color: white"><u>Indemnification
Request</u>. In order to obtain indemnification under these Bylaws, Indemnitee shall, anytime at Indemnitee’s discretion
following notification by Indemnitee of the commencement of any Proceeding pursuant to Section 8(l)(i) of these Bylaws, submit to
the Corporation a written request for indemnification pursuant to this Section 8(k), including therein or therewith such
documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what
extent Indemnitee is entitled to indemnification. No determination of Indemnitee’s entitlement to indemnification shall be
made until such written request for a determination is submitted by Indemnitee to the Corporation </font>pursuant to this Section
8(k). The failure to submit a written request to the Corporation will relieve the Corporation of its indemnification obligations
under these Bylaws only to the extent the Corporation can establish that such failure to make a written request resulted in actual
prejudice to it, and the failure to make a written request will not relieve the Corporation from any liability which it may have to
indemnify Indemnitee otherwise than under these Bylaws.&nbsp; The Secretary of the Corporation shall, promptly upon receipt of such
a request for indemnification, advise the Board in writing that Indemnitee has requested indemnification.&nbsp; Upon submission of a
written request for indemnification by Indemnitee pursuant to this Section 8(k), Indemnitee’s entitlement to indemnification
shall be determined according to Section 8(l) of these Bylaws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 78pt; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 78pt; text-align: left; text-indent: 0in"></p>

<!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 78pt; text-align: left"></p>

<!-- Field: Split-Segment; Name: 6 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 78pt; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.5pt 0pt 5.75pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(l)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font></font><font style="background-color: white"><u>Procedure Upon Application for Indemnification.</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">i.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">Upon receipt of Indemnitee’s written
request for indemnification pursuant to Section 8(k), a determination with respect thereto shall be made in the specific case by one of
the following four methods, which shall be at the election of the Board:&nbsp; (i) by a majority vote of the Disinterested Directors,
even though less than a quorum, (ii) by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors,
even though less than a quorum, (iii)&nbsp;if there are no Disinterested Directors or if the Disinterested Directors so direct, by Independent
Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee or (iv) by the stockholders of the Corporation.
Notwithstanding the above, if a determination with respect to Indemnitee’s right to indemnification is to be made following a Change
of Control, such determination shall be made in the specific case by Independent Counsel in a written opinion to the Board, a copy of
which shall be delivered to Indemnitee.&nbsp; If it is so determined that Indemnitee is entitled to indemnification, payment to Indemnitee
shall be made within ten (10) days after such determination. Indemnitee shall reasonably cooperate with the person, persons or entity
making such determination with respect to Indemnitee’s entitlement to indemnification, including providing to such person, persons
or entity upon reasonable advance request any documentation or information which is not privileged or otherwise protected from disclosure
and which is reasonably available to Indemnitee and reasonably necessary to such determination.&nbsp; Any costs or expenses (including
attorneys’ fees and disbursements) incurred by Indemnitee in so cooperating with the Disinterested Directors or Independent Counsel,
as the case may be, making such determination shall be advanced and borne by the Corporation (irrespective of the determination as to
Indemnitee’s entitlement to indemnification) and the Corporation is liable to indemnify and hold Indemnitee harmless therefrom.</font></td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: left; text-indent: 0in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">ii.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">In the event the determination of entitlement
to indemnification is to be made by Independent Counsel pursuant to Section 8(<i>l</i>) hereof, the Independent Counsel shall be selected
as provided in this Section&nbsp;8(<i>l</i>). The
Independent Counsel shall be selected by the Board and the Board shall provide written notice to the Indemnitee of the identity of the
Independent Counsel so selected.&nbsp; Indemnitee may, within ten (10) days after such written notice of selection shall have been received,
deliver to the Corporation a written objection to such selection; <u>provided</u>, <u>however</u>, that such objection may be asserted
only on the ground that the Independent Counsel so selected does not meet the requirements of “Independent Counsel” as defined
in Section&nbsp;8(p) of these Bylaws, and the objection shall set forth with particularity the factual basis of such assertion.&nbsp;
Absent a proper and timely objection, the person so selected shall act as Independent Counsel. If a written objection is so made and substantiated,
the Independent Counsel so selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court of competent
jurisdiction has determined that such objection is without merit. If, within twenty (20) days after submission by Indemnitee of a written
request for indemnification pursuant to Section 8(<i>l</i>) hereof, no Independent Counsel shall have been selected and not objected to,
either the Corporation or Indemnitee may petition a court of competent jurisdiction for resolution of any objection which shall have been
made by the Indemnitee to the Corporation’s selection of Independent Counsel and/or for the appointment as Independent Counsel of
a person selected by the Court or by such other person as the Court shall designate, and the person with respect to whom all objections
are so resolved or the person so appointed shall act as Independent Counsel under this Section 8(<i>l</i>). Upon the due commencement
of any judicial proceeding or arbitration pursuant to Section&nbsp;8(n) of these Bylaws, Independent Counsel shall be discharged and relieved
of any further responsibility in such capacity (subject to the applicable standards of professional conduct then prevailing). The Corporation
shall pay all reasonable fees and expenses incident to the procedures of this Section&nbsp;8(<i>l</i>), regardless of the manner in which
such Independent Counsel was selected or appointed.</font></td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.5pt 0pt 5.75pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(m)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font></font><font style="background-color: white"><u>Presumptions and Effect of Certain Proceedings</u>.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">i.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">In making a determination with respect to
entitlement to indemnification hereunder, the person or persons or entity making such determination shall presume that Indemnitee is entitled
to indemnification under these Bylaws if Indemnitee has submitted a notice and a request for indemnification in accordance with Section&nbsp;8(k)
of these Bylaws. Anyone seeking to overcome this presumption shall have the burden of proof and the burden of persuasion by clear and
convincing evidence. Neither the failure of the Corporation (including by the Board) or of Independent Counsel to have made a determination
prior to the commencement.</font></td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: left; text-indent: 0in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">ii.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">If the person, persons or entity empowered
or selected under Section&nbsp;8(m) of these Bylaws to determine whether Indemnitee is entitled to indemnification shall not have made
a determination within sixty (60) days after receipt by the Corporation of Indemnitee’s written request for indemnification pursuant
to Section&nbsp;8(k) of these Bylaws, the requisite determination of entitlement to indemnification shall be deemed to have been made
and Indemnitee shall be entitled to such indemnification, absent (i) a misstatement by Indemnitee of a material fact, or an omission of
a material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the request for indemnification,
or (ii) a prohibition of such indemnification under applicable law; <u>provided</u>, <u>however</u>, that such 60-day period may be extended
for a reasonable time, not to exceed an additional thirty (30) days, if the person, persons or entity making the determination with respect
to entitlement to indemnification in good faith requires such additional time for the obtaining or evaluating of documentation and/or
information relating thereto.</font></td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: left; text-indent: 0in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">iii.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">The termination of any Proceeding or of any
claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of <i>nolo contendere </i>or its equivalent,
shall not (except as otherwise expressly provided in these Bylaws) of itself adversely affect the right of Indemnitee to indemnification
or create a presumption that Indemnitee did not act in good faith and in a manner which Indemnitee reasonably believed to be in or not
opposed to the best interests of the Corporation or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to
believe that Indemnitee’s conduct was unlawful.</font></td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 6pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(n)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font></font><font style="background-color: white"><u>Remedies of Indemnitee</u>.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">i.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">In the event that (i) a determination is made
pursuant to Section&nbsp;8(<i>l</i>) of these Bylaws that Indemnitee is not entitled to indemnification under these Bylaws, (ii) advancement
of Expenses is not timely made pursuant to Section 8(h) or 8(<i>l</i>) of these Bylaws, (iii) payment of indemnification is not made pursuant
to Section 8(c), 8(d), 8(e) or the last sentence of Section 8(<i>l</i>) of these Bylaws within ten (10) days after receipt by the Corporation
of a written request therefor, or (iv)&nbsp;payment of indemnification pursuant to Section 8(a) or 8(b) of these Bylaws is not made within
ten (10) days after a determination has been made that Indemnitee is entitled to indemnification, or (v)&nbsp;Indemnitee determines in
its sole discretion that such action is appropriate or desirable, Indemnitee shall be entitled to seek an adjudication by a court of competent
jurisdiction as to Indemnitee’s entitlement to such indemnification or advancement of Expenses.&nbsp; Alternatively, Indemnitee,
at Indemnitee’s option, may seek an award in arbitration to be conducted by a single arbitrator pursuant to the Commercial Arbitration
Rules of the American Arbitration Association. The Corporation shall not oppose Indemnitee’s right to seek any such adjudication
or award in arbitration.</font></td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 91; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">ii.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">In the event that a determination shall have
been made pursuant to Section 8(l) of these Bylaws that Indemnitee is not entitled to indemnification, any judicial proceeding or arbitration,
commenced pursuant to this Section 8(n), shall be conducted in all respects as a de novo trial, or arbitration, on the merits, and Indemnitee
shall not be prejudiced by reason of that adverse determination.&nbsp; In any judicial proceeding or arbitration commenced pursuant to
this Section 8(n), in the event that the person, persons or entity empowered or selected under Section 8(l) of these Bylaws to determine
whether Indemnitee is entitled to indemnification has not made such a determination within the time period provided for under Section
8(m) of these Bylaws, the Corporation shall stipulate and may not contest that Indemnitee acted in good faith and in a manner Indemnitee
reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect to any criminal action or Proceeding,
had no reasonable cause to believe Indemnitee’s conduct was unlawful.</font></td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: left; text-indent: 0in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">iii.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">If a determination shall have been made pursuant
to Section 8(l of these Bylaws that Indemnitee is entitled to indemnification, the Corporation shall be bound by such determination in
any judicial proceeding or arbitration commenced pursuant to this Section 8(n), absent (i) a misstatement by Indemnitee of a material
fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the
request for indemnification, or (ii) a prohibition of such indemnification under applicable law.</font></td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: left; text-indent: 0in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">iv.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">In the event that Indemnitee is a party to
a judicial proceeding or arbitration pursuant to this Section 8(n) concerning Indemnitee’s rights under, or to recover damages for
breach of, these Bylaws, Indemnitee shall be entitled to recover from the Corporation, and shall be indemnified by the Corporation against,
any and all Expenses actually and reasonably incurred by him in such judicial adjudication or arbitration.&nbsp; If it shall be determined
in said judicial adjudication or arbitration that Indemnitee is entitled to receive part but not all of the indemnification or advancement
of Expenses sought, Indemnitee shall be entitled to recover from the Corporation (who shall be liable therefor), and shall be indemnified
by the Corporation against, any and all Expenses reasonably incurred by Indemnitee in connection with such judicial adjudication or arbitration.</font></td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: left; text-indent: 0in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">v.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">The Corporation shall be precluded from asserting
in any judicial proceeding or arbitration commenced pursuant to this Section&nbsp;8(n) that the procedures and presumptions of these Bylaws
are not valid, binding and enforceable and shall stipulate in any such court or before any such arbitrator that the Corporation is bound
by all the provisions of these Bylaws. The Corporation shall be liable to indemnify Indemnitee against any and all Expenses and, if requested
by Indemnitee, shall (within ten (10) days after receipt by the Corporation of a written request therefor) advance such Expenses to Indemnitee
that are incurred by Indemnitee in connection with any judicial adjudication or arbitration involving Indemnitee for indemnification or
advancement of Expenses from the Corporation under these Bylaws or under any directors’ and officers’ liability insurance
policies maintained by the Corporation, regardless of whether Indemnitee ultimately is determined to be entitled to such indemnification,
advancement of Expenses or insurance recovery, as the case may be.</font></td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: left; text-indent: 0in"></p>

<!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 6pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(o)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font></font><font style="background-color: white"><u>Contribution</u>. To the fullest extent permissible under applicable law, if the
indemnification provided for in these Bylaws is unavailable to Indemnitee for any reason whatsoever, the Corporation, in lieu of indemnifying
Indemnitee, shall contribute to the amount incurred by Indemnitee, whether for judgments, fines, penalties, excise taxes, amounts paid
or to be paid in settlement and/or for Expenses, in connection with any claim relating to an indemnifiable event under these Bylaws, in
such proportion in order to reflect (i) the relative benefits received by the Corporation and Indemnitee as a result of the event(s) and/or
transaction(s) giving cause to such Proceeding; and/or (ii) the relative fault of the Corporation (and its directors, officer, employees
and agents) and Indemnitee in connection with such event(s) and/or transaction(s).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 78pt; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 6pt; text-align: justify; text-indent: 1in"><font style="color: #010000">(p)<font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font></font><font style="background-color: white"><u>Definitions as used in this Section 8</u>.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">i.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">“<i>Board</i>” means the Board
of Directors of the Corporation.</font></td></tr></tbody></table>

<p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td>&nbsp;</td><td>&nbsp;</td><td style="text-align: justify; padding-right: 6.3pt">&nbsp;</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">ii.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">“<i>Change of Control</i>” means
(1) any “person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act), becomes the “Beneficial Owner”
(as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Corporation representing more than fifty
percent (50%) of the total voting power represented by the Corporation’s then outstanding voting securities (excluding for this
purpose any such voting securities held by the Corporation, or any parent or subsidiary of the Corporation or any employee benefit plan
of the Corporation) pursuant to a transaction or a series of transactions which the Board does not approve; (2) &nbsp;&nbsp;a merger or
consolidation of the Corporation, whether or not approved by the Board, which results in the holders of voting securities of the Corporation
outstanding immediately prior thereto failing to continue to represent (either by remaining outstanding or by being converted into voting
securities of the surviving entity) at least fifty percent (50%) of the combined voting power of the voting securities of the Corporation
or such surviving entity outstanding immediately after such merger or consolidation;
(3) the sale or disposition of all or substantially all of the Corporation’s assets (or consummation of any transaction having similar
effect) provided that the sale or disposition is of more than two-thirds (2/3) of the assets of the Corporation; or (4) the date a majority
of members of the Board is replaced during any twelve (12) month period by directors whose appointment or election is not endorsed by
a majority of the members of the Board before the date of such appointment or election; (5) In any case, a Change of Control under this
Section 2(a) must also meet the requirements of a change in ownership or effective control, or a sale of a substantial portion of the
Corporation’s assets in accordance with Section 409A(a)(2)(A)(v) of the Internal Revenue Code of 1986, as amended, and the applicable
provisions of Treasury Regulation § 1.409A-3.</font></td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: justify"></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td>&nbsp;</td><td>&nbsp;</td><td style="text-align: justify; padding-right: 6.3pt">&nbsp;</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">iii.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">“<i>Corporate Status</i>” describes
the status of a person who is or was a director, officer, employee, agent or fiduciary of the Corporation or of any other Enterprise.</font></td></tr></tbody></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td>&nbsp;</td><td>&nbsp;</td><td style="text-align: justify; padding-right: 6.3pt">&nbsp;</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">iv.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">“<i>Disinterested Director</i>”
means a director of the Corporation who is not and was not a party to the Proceeding in respect of which indemnification is sought by
Indemnitee.</font></td></tr></tbody></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td>&nbsp;</td><td>&nbsp;</td><td style="text-align: justify; padding-right: 6.3pt">&nbsp;</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">v.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">“<i>Enterprise</i>” means (i)
the Corporation, (ii) any other corporation, partnership, limited liability Corporation, joint venture, trust, employee benefit plan or
other enterprise which is an affiliate or wholly or partially owned subsidiary of the Corporation and of which Indemnitee is or was serving
as a director, trustee, general partner, managing member, officer, employee, agent or fiduciary and (iii) any other corporation, partnership,
limited liability Corporation, joint venture, trust, employee benefit plan or other enterprise of which Indemnitee is or was serving at
the request of the Corporation.</font></td></tr></tbody></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td>&nbsp;</td><td>&nbsp;</td><td style="text-align: justify; padding-right: 6.3pt">&nbsp;</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">vi.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">“<i>Exchange Act</i>” means the
Securities Exchange Act of 1934, as amended.</font></td></tr></tbody></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td>&nbsp;</td><td>&nbsp;</td><td style="text-align: justify; padding-right: 6.3pt">&nbsp;</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">vii.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">“<i>Expenses</i>” includes all
reasonable attorneys’ fees, retainers, court costs, transcript costs, fees of experts, witness fees, travel expenses, duplicating
costs, printing and binding costs, telephone charges, postage, delivery service fees, and all other disbursements or expenses of the types
customarily incurred in connection with prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to
be a witness in, or otherwise participating in, a Proceeding.&nbsp; Expenses shall include such fees and expenses, and costs incurred
in connection with any appeal resulting from any Proceeding, including without limitation the premium, security for, and other costs relating
to any cost bond, supersedeas bond, or other appeal bond or its equivalent. Expenses, however, shall not include amounts paid in settlement
by Indemnitee or the amount of judgments or fines against Indemnitee.</font></td></tr></tbody></table>

<p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></font></p>

<!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0"><font style="font: 10pt Times New Roman, Times, Serif">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">viii.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">“<i>Independent Counsel</i>” means,
at any time, any law firm, or a member of a law firm, that (i) is experienced in matters of corporation law and (ii) is not, at such time,
or has not been in the five years prior to such time,
retained to represent: (1) the Corporation or Indemnitee in any matter material to either such party (other than with respect to matters
concerning Indemnitee under these Bylaws, or of other indemnities under similar indemnification agreements), or (2) any other party to
the Proceeding giving rise to a claim for indemnification hereunder.&nbsp; Notwithstanding the foregoing, the term “Independent
Counsel” shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a
conflict of interest in representing either the Corporation or Indemnitee in an action to determine Indemnitee’s rights under these
Bylaws.&nbsp; The Corporation agrees to pay the reasonable fees and expenses of the Independent Counsel referred to above and to fully
indemnify such counsel against any and all Expenses, claims, liabilities and damages arising out of or relating to these Bylaws or its
engagement pursuant hereto and to be jointly and severally liable therefor.</font></td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 149.1pt; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td>&nbsp;</td><td>&nbsp;</td><td style="text-align: justify; padding-right: 6.3pt">&nbsp;</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td style="width: 108.8pt"></td><td style="width: 40.3pt">ix.</td><td style="text-align: justify; padding-right: 6.3pt"><font style="background-color: white">“<i>Proceeding</i>” includes any
threatened, pending or completed action, suit, arbitration, mediation, alternate dispute resolution mechanism, investigation, inquiry,
administrative hearing or any other actual, threatened or completed proceeding, whether brought by or in the right of the Corporation
or otherwise and whether of a civil, criminal, administrative or investigative nature, including without limitation any such proceeding
pending as of the date of these Bylaws, in which Indemnitee was, is or will be involved as a party or otherwise by reason of the fact
that Indemnitee is or was an officer or director of the Corporation, by reason of ny action taken by Indemnitee or of any action on Indemnitee’s
part while acting as director or officer of the Corporation, or by reason of the fact that Indemnitee is or was serving as a director,
trustee, general partner, managing member, officer, employee, agent or fiduciary of any other Enterprise, in each case whether or not
serving in such capacity at the time any Expense, judgment, fine or amount paid in settlement is incurred for which indemnification, reimbursement,
or advancement of Expenses can be provided under these Bylaws.</font></td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 121.7pt 0pt 1.65in; text-align: center"><font style="color: #010000">SECTION
9 -</font> AMENDMENTS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 20.2pt 0pt 5.95pt; text-indent: 0.5in">These bylaws may be altered, amended
or repealed in accordance with the certificate of incorporation of the Corporation.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-variant: small-caps"><b>ANNEX
I</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-variant: small-caps"><b>CONDITIONS
TO THE OFFER</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The capitalized terms used
in this <u>Annex I</u> shall have the meanings set forth in the Agreement and Plan of Merger to which this <u>Annex I</u> is attached
(the “<u>Agreement</u>”) unless specifically defined in this <u>Annex I</u>. The obligation of Purchaser to accept for payment
and pay for Shares validly tendered (and not withdrawn) pursuant to the Offer is subject to the satisfaction of the conditions set forth
in clauses (a)&nbsp;through (h)&nbsp;below. Accordingly, notwithstanding any other provision of the Offer or this Agreement to the contrary,
Purchaser shall not be required to accept for payment or (subject to any applicable rules&nbsp;and regulations of the SEC, including Rule&nbsp;14e-1(c)&nbsp;under
the Exchange Act) pay for, and may delay the acceptance for payment of, or (subject to any such rules&nbsp;and regulations) the payment
for, any tendered Shares, and, to the extent permitted by the Agreement, may terminate the Offer: (i)&nbsp;upon termination of the Agreement;
and (ii)&nbsp;at any scheduled Expiration Date (subject to any extensions of the Offer pursuant to <u>Section&nbsp;2.1(c)</u>&nbsp;of
the Agreement) or amend the Offer as otherwise permitted by the Agreement, if: (A)&nbsp;the Minimum Condition shall not be satisfied as
of one (1)&nbsp;minute following 11:59 p.m.&nbsp;Eastern Time on the Expiration Date of the Offer or (B)&nbsp;any of the additional conditions
set forth in clauses (b)&nbsp;through (h)&nbsp;below shall not be satisfied or waived (to the extent permitted by the Agreement and applicable
Law) in writing by Parent:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
number of Shares validly tendered (and not properly withdrawn) prior to the time that the Offer expires (but excluding Shares tendered
pursuant to guaranteed delivery procedures that have not yet been “received”, as defined by Section&nbsp;251(h)(6)(f)&nbsp;of
the DGCL by the “depository” (as such term is defined in Section&nbsp;251(h)(6)(c)&nbsp;of the DGCL)), together with the Shares
then owned by Purchaser and its “affiliates” (as such term is defined in Section&nbsp;251(h)(6)(a)&nbsp;of the DGCL), represent
at least one (1)&nbsp;Share more than 50% of the then-issued and outstanding Shares (the “<u>Minimum Condition</u>”);</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;the
representations and warranties of the Company set forth in <u>Section&nbsp;4.4(a)</u>&nbsp;and the first sentence of <u>Section&nbsp;4.4(c)</u>&nbsp;(<i>Capitalization,
Etc.</i>) of the Agreement shall have been accurate in all respects other than <i>de minimis</i> inaccuracies as of the date of this Agreement
and at and as of the Offer Acceptance Time as if made on and as of such time (except representations and warranties that by their terms
speak specifically as of another date or time, in which case as of such other date or time);</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
representations and warranties of the Company set forth in <u>Section&nbsp;4.1</u> (<i>Due Organization; Subsidiaries, Etc.</i>), <u>Section&nbsp;4.3</u>
(<i>Authority; Binding Nature of Agreement</i>), <u>Section&nbsp;4.4</u> (<i>Capitalization, Etc.</i>) (other than <u>Section&nbsp;4.4(a)</u>&nbsp;and
the first sentence of <u>Section&nbsp;4.4(c)</u>), and <u>Section&nbsp;4.26</u> (<i>Brokers and Other Advisors</i>) of the Agreement shall
have been accurate (disregarding for this purpose all “Material Adverse Effect” and “materiality” qualifications
contained in such representations and warranties) in all material respects as of the date of this Agreement and at and as of the Offer
Acceptance Time as if made on and as of such time (except representations and warranties that by their terms speak specifically as of
another date or time, in which case as of such other date or time);</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
representations and warranties of the Company set forth in <u>Section&nbsp;4.7(a)</u>&nbsp;(<i>Absence of Changes</i>) and <u>Section&nbsp;4.24</u>
(<i>Merger Approval</i>) shall have been accurate in all respects;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 95 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">I-1</font></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
of the other representations and warranties of the Company set forth in the Agreement (other than those referred to in clauses (b)(i),
(b)(ii)&nbsp;or (b)(iii)&nbsp;above) shall have been accurate (disregarding for this purpose all “Material Adverse Effect”
and “materiality” qualifications contained in such representations and warranties) in all respects as of the date of this
Agreement and as of the Offer Acceptance Time as if made on and as of such time (except representations and warranties that by their terms
speak specifically as of another date or time, in which case as of such other date or time), except where any failure of any representation
or warranty to be so accurate has not had, and would not reasonably be expected to have, a Material Adverse Effect;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company shall have complied with or performed in all material respects all of the Company’s covenants and agreements it is required
to comply with or perform at or prior to the Offer Acceptance Time;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;since
the Agreement Date, there shall not have been any Material Adverse Effect that shall be continuing as of the Offer Acceptance Time;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
waiting period (or any extension thereof) applicable to the Offer under the HSR Act shall have expired or been terminated;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Parent
and Purchaser shall have received a certificate executed on behalf of the Company by its Chief Executive Officer or its Chief Financial
Officer confirming that the conditions set forth in clauses (b), (c)&nbsp;and (d)&nbsp;of this <u>Annex I</u> have been duly satisfied;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;there
shall not have been issued by any court of competent jurisdiction and remain in effect any temporary, preliminary or permanent Order preventing
the acquisition of or payment for Shares pursuant to the Offer or the consummation of the Merger, nor shall any Law (other than any Antitrust
Law) or Order have been promulgated, entered, enforced, enacted, issued or deemed applicable to the Offer or the Merger by any Governmental
Body of competent jurisdiction and remain in effect that directly or indirectly prohibits, or makes illegal, the acquisition of or payment
for Shares pursuant to the Offer or the consummation of the Merger; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this
Agreement shall not have been terminated in accordance with its terms (the “<u>Termination Condition</u>”).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing conditions are for the sole benefit
of Parent and Purchaser and may be waived (but solely to the extent permitted by the Agreement and applicable Law) by Parent and Purchaser,
in whole or in part at any time and from time to time, in the sole discretion of Parent and Purchaser.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 96 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">I-2</font></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ANNEX
II</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONTINGENT VALUE RIGHTS AGREEMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS CONTINGENT VALUE RIGHTS
AGREEMENT, dated as of [&#9679;], 2021 (this “<u>Agreement</u>”), is entered into by and between Supernus Pharmaceuticals,&nbsp;Inc.,
a Delaware corporation (“<u>Parent</u>”), and [&#9679;] (the “<u>Rights Agent</u>”).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>RECITALS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, Parent, Supernus
Reef,&nbsp;Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“<u>Purchaser</u>”), and Adamas Pharmaceuticals,&nbsp;Inc,,
a Delaware corporation (the “<u>Company</u>”), have entered into an Agreement and Plan of Merger dated as of October&nbsp;10,
2021 (as it may be amended or supplemented from time to time pursuant to the terms thereof, the “<u>Merger Agreement</u>”),
pursuant to which Purchaser (a)&nbsp;has agreed to commence a tender offer (as it may be extended and amended from time to time as permitted
under the Merger Agreement, the “<u>Offer</u>”) to acquire all of the outstanding shares of the common stock, par value $0.001
per share, of the Company (“<u>Shares</u>”) and (b)&nbsp;following the consummation of the Offer, will merge with and into
the Company (the “<u>Merger</u>”), with the Company surviving the Merger as a wholly owned subsidiary of Parent, in accordance
with Section&nbsp;251(h)&nbsp;of the DGCL and on the terms and subject to the conditions set forth in the Merger Agreement; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, pursuant to the Merger
Agreement, (a)&nbsp;in each of the Offer and the Merger, Parent has agreed to provide to the holders of Shares (other than holders of
Excluded Shares and Dissenting Shares) that are outstanding as of immediately prior to the Effective Time and (b)&nbsp;in the Merger,
Parent has agreed to provide to holders of Company Options that have an exercise price per Share that is less than the Cash Amount and
holders of Company RSU Awards, in each case, that are outstanding as of immediately prior to the Effective Time (such Company Options
and the Company RSU Awards, collectively, the “<u>Covered Equity Awards</u>”), in the case of each of clauses (a)&nbsp;and
(b), the right to receive two (2)&nbsp;contingent cash payments, one (1)&nbsp;with respect to Milestone&nbsp;2024 and one (1)&nbsp;with
respect to Milestone&nbsp;2025, as hereinafter described.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the foregoing and the consummation of the transactions referred to above, Parent and the Rights Agent agree, for the equal and proportionate
benefit of all Holders, as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><font style="font-size: 10pt">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><b>DEFINITIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">1.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Definitions</u>.
Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Merger Agreement. As used in this
Agreement, the following terms shall have the following meanings:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">“<u>Acting Holders</u>”
means, at the time of determination, Holders of at least 10% of the outstanding CVRs as set forth on the CVR Register.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>Assignee</u>”
has the meaning set forth in <u>Section&nbsp;7.3</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>Change of Control</u>”
means (a)&nbsp;a sale or other disposition of all or substantially all of the assets of Parent on a consolidated basis (other than to
any Subsidiary (direct or indirect) of Parent), (b)&nbsp;a merger or consolidation involving Parent in which Parent is not the surviving
entity, (c)&nbsp;any other transaction involving Parent in which Parent is the surviving or continuing entity but in which the stockholders
of Parent immediately prior to such transaction own less than 50% of Parent’s voting power immediately after the transaction or
(d)&nbsp;any Disposition of Parent’s or its Subsidiaries’ respective rights in and to a Product to a third-party.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 97 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>Covered Equity Awards</u>”
has the meaning set forth in the Recitals.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>Covered Milestone
Payments</u>” has the meaning set forth in <u>Section&nbsp;2.4(f)</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>CVRs</u>”
means the rights of Holders to receive contingent cash payments with respect to Milestone&nbsp;2024 and Milestone&nbsp;2025 pursuant to
the Merger Agreement and this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>CVR Register</u>”
has the meaning set forth in <u>Section&nbsp;2.3(b)</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>Diligent Efforts</u>”
means, with respect to a particular task or obligation, the efforts required to carry out such task in a good faith, diligent and sustained
manner without undue interruption, pause or delay and expenditure of resources that is consistent with commercially reasonable practices,
in each case which level is at least commensurate with the level of efforts that a pharmaceutical company of comparable size and resources
as those of Parent and its Affiliates would devote to a product, taking into account issues of safety and efficacy, product profile, the
competitiveness of other products in development and in the marketplace, the proprietary position of the Product (including with respect
to patent or regulatory exclusivity), the regulatory structure involved, the profitability of the Product (including pricing and reimbursement
<i>but excluding</i>, in respect of the Product, the obligation to make Milestone Payments under this Agreement), market potential, and
other relevant technical, legal, scientific or medical factors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>Disposition</u>”
means any, direct or indirect, sale or swap of assets or other rights, merger, reorganization, joint venture, lease, exclusive license
(or another licensing arrangement or arrangements involving Intellectual Property that operate to transfer a substantial portion of the
value of such Intellectual Property) or any other transaction or arrangement or series of related transactions or arrangements entered
into by Parent or any of its Subsidiaries (including the Surviving Corporation) to sell, transfer, convey, lease, exclusively license
(or license pursuant to another licensing arrangement or arrangements involving Intellectual Property that operate to transfer a substantial
portion of the value of such Intellectual Property) or otherwise dispose of its or their respective rights in and to the applicable assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>DTC</u>” means
The Depository Trust Company or any successor thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">“<u>Event
of Default</u></font>” has the meaning set forth in <u>Section&nbsp;6.1</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>Fiscal Quarter</u>”
means a fiscal quarter of any fiscal year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>Holder</u>”
means a Person in whose name a CVR is registered in the CVR Register at the applicable time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>ICC</u>” has
the meaning set forth in <u>Section&nbsp;7.6</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>Milestone 2024</u>”
means the first occurrence of the achievement of aggregate worldwide Net Sales of the Product in excess of $150,000,000 during a Rolling
Period ending on or before December&nbsp;31, 2024. For the avoidance of doubt, Milestone 2024 may only be achieved one time, regardless
of the number of times such Milestone 2024 is achieved during the term of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>Milestone 2025</u>”
means the first occurrence of the achievement of aggregate worldwide Net Sales of the Product in excess of $225,000,000 during a Rolling
Period ending on or before December&nbsp;31, 2025. For the avoidance of doubt, Milestone 2025 may only be achieved one time, regardless
of the number of times such Milestone 2025 achieved during the term of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>Milestones</u>”
means Milestone 2024 and Milestone 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 98; Options: NewSection; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">II-2-</font></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>Milestone Notice</u>”
has the meaning set forth in <u>Section&nbsp;2.4(a)</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>Milestone Payment</u>”
means $0.50 with respect to Milestone 2024 and $0.50 with respect to Milestone 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>Milestone Payment
Amount</u>” means, for a given Holder, the product of (a)&nbsp;the applicable Milestone Payment and (b)&nbsp;the number of CVRs
with respect to such applicable Milestone held by such Holder as reflected on the CVR Register as of the close of business on the date
of the Milestone Notice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">“<u>Net
Sales</u>” means:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><font style="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>the
gross amount invoiced by or on behalf of the relevant Selling Entity for the Product sold to third parties, <i>less</i> the Permitted
Deductions to the extent actually taken or incurred and separately accounted for in the invoice with respect to such sale, all calculated
on an accrual basis, as determined in accordance with the applicable Selling Entity’s usual and customary accounting methods consistent
with the treatment of other branded prescription products commercialized by the applicable Selling Entity, which shall be in accordance
with GAAP as of the applicable time;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><font style="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>in
the case of any sale of the Product between or among the Company, its Affiliates and Sublicensees, for resale, Net Sales shall be calculated
as above only on the value charged or invoiced on the first <i>bona fide</i> arm’s-length sale thereafter to a third party;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><font style="font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>for
the avoidance of doubt, in the case of any sale of the Product between or among the Company, its Affiliates and Sublicensees where such
Affiliate or Sublicensee is an end-user of, and does not further sell, the Product, Net Sales shall be calculated on the value charged
or invoiced to such Affiliate or Sublicensee;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><font style="font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>in
the case of any sale for value other than exclusively for money (but excluding any compassionate use, early access, indigent patient and
patient assistance or discount programs) on <i>bona fide</i> arm’s&nbsp;length terms (which has the effect of reducing the invoiced
amount below what it would have been in the absence of such non-monetary consideration), Net Sales shall be calculated at the average
Net Sales price charged to third parties for cash sales of the Product in the jurisdiction of sale during the relevant reporting period
unless such sales in the jurisdiction during the relevant period were only <i>de minimis</i> cash sales, in which case at the fair market
value as determined by comparable markets;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><font style="font-size: 10pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>all
Net Sales shall be computed in Dollars, and where any Net Sales are calculated in a currency other than Dollars, they shall be translated
into Dollars in accordance with GAAP; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><font style="font-size: 10pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>for
clarity, no deductions will be made for sales commissions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 99 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">II-3-</font></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white">Despite the
foregoing, in the event that (x)&nbsp;Parent or any Subsidiary of Parent (including the Surviving Corporation), directly or indirectly,
by a sale or swap of assets or other rights, merger, reorganization, joint venture, lease, license or any other transaction or arrangement,
sells, transfers, conveys, licenses or otherwise disposes of their respective rights in and to the Product that would generate Net Sales
after the Closing Date and prior to December&nbsp;31, 2025 and (y)&nbsp;such transaction or arrangement does not constitute a Change of
Control, then the total fair market value of all cash, securities and other property paid or payable, directly or indirectly, by a purchaser
to Parent or its Subsidiaries in connection with such transaction or arrangement shall be included in Net Sales.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>Net Sales Statement</u>”
means a written statement of Parent, certified by the chief financial officer of Parent, setting forth in reasonable detail the calculation
of Net Sales for each Rolling Period that is associated with the potential attainment of a Milestone, which shall include (a)&nbsp;an
itemized calculation of the gross amounts invoiced by the Selling Entities for the Product sold to third parties, (b)&nbsp;an itemized
calculation of the Permitted Deductions, and (c)&nbsp;to the extent that sales for the Product are recorded in currencies other than United
States dollars, the exchange rates used for conversion of such foreign currency into United States dollars. The Net Sales Statement shall
be calculated in accordance with GAAP and shall be derived from the financial statements of Parent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>Officer’s
Certificate</u>” means a certificate signed by the chief executive officer, president, chief financial officer, any vice president,
the controller, the treasurer or the secretary, in each case of Parent, in his or her capacity as such an officer, and delivered to the
Rights Agent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>Permitted Deductions</u>”
means:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><font style="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>customary
trade, cash and quantity discounts given to customers;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><font style="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>amounts
repaid, reimbursed or credited by reasons of defects, recalls, withdrawals, returns, rebates or allowances of goods or because of retroactive
price reductions or billing corrections specifically identifiable to the Product;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><font style="font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>chargebacks,
discounts, co-payment assistance programs for patients with commercial insurance, credits, rebates (or the equivalent thereof) and
other amounts paid on sale of the Product, including such payments mandated by programs of a Governmental Body;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><font style="font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>government-mandated
rebates, credits and adjustments paid or deducted; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><font style="font-size: 10pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>reasonable,
customary and separately itemized and invoiced freight, shipping, insurance and other transportation expenses, if borne by the applicable
Selling Entity without reimbursement from any third party.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>Permitted Transfer</u>”
means a transfer of CVRs (a)&nbsp;upon death of a Holder by will or intestacy; (b)&nbsp;pursuant to a court order; (c)&nbsp;by operation
of law (including by consolidation or merger) or without consideration in connection with the dissolution, liquidation or termination
of any corporation, limited liability company, partnership or other entity; (d)&nbsp;in the case of CVRs held in book-entry or other
similar nominee form, from a nominee to a beneficial owner and, if applicable, through an intermediary, as allowable by DTC; (e)&nbsp;if
the Holder is a partnership or limited liability company, a distribution by the transferring partnership or limited liability company
to its partners or members, as applicable; or (f)&nbsp;as provided in <u>Section&nbsp;2.6</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>Product</u>”
means (a)&nbsp;GOCOVRI (amantadine), (b)&nbsp;any pharmaceutical preparation sold under NDA&nbsp;No.&nbsp;208944 (or its foreign equivalents),
and (c)&nbsp;any pharmaceutical preparation sold under an approval that references or relies in whole or in part on the clinical data
submitted in support of NDA&nbsp;No.&nbsp;208944 (or its foreign equivalents), except that “<u>Product</u>” shall not include
any pharmaceutical preparation approved pursuant to 21&nbsp;U.S.C.&nbsp;§&nbsp;355(j)&nbsp;in reliance in whole or in part on NDA&nbsp;No.&nbsp;208944
(or through reference to the clinical data submitted in support of NDA&nbsp;No.&nbsp;208944) unless such pharmaceutical preparation is
licensed, manufactured or authorized by any Selling Entity, or purchased through a supply chain or sold through a distribution chain that
includes any Selling Entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 100 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">II-4-</font></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<!-- Field: Split-Segment; Name: 7 -->
 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">“<u>Rights
Agent</u>”</font> means the Rights Agent named in the preamble of this Agreement, until a successor Rights Agent becomes such pursuant
to the applicable provisions of this Agreement, and thereafter “Rights Agent” shall mean such successor Rights Agent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>Rolling Period</u>”
means, as of the date that is one (1)&nbsp;day after the end of the applicable Fiscal Quarter, the four Fiscal Quarters immediately preceding
such date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>Selling Entity</u>”
means Parent, any Assignee, and each of their controlled Affiliates (including, from and after the Effective Time, the Company) and Sublicensees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">“<u>Sublicensee</u>”
shall mean an authorized or permitted licensee or sublicensee of rights to the Product.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Rules&nbsp;of
Construction</u>. For purposes of this Agreement, the parties hereto agree that: (a)&nbsp;whenever the context requires, the singular
number shall include the plural, and vice versa; (b)&nbsp;the masculine gender shall include the feminine and neuter genders; the feminine
gender shall include the masculine and neuter genders; and the neuter gender shall include masculine and feminine genders; (c)&nbsp;the
word “extent” in the phrase “to the extent” means the degree to which a subject or other thing extends, and does
not simply mean “if”; (d)&nbsp;the words “include” and “including,” and variations thereof, shall
not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words “without limitation;” (e)&nbsp;the
meaning assigned to each capitalized term defined and used in this Agreement is equally applicable to both the singular and the plural
forms of such term, and words denoting any gender include all genders; (f)&nbsp;where a word or phrase is defined in this Agreement, each
of its other grammatical forms has a corresponding meaning unless the context otherwise requires; (g)&nbsp;a reference to any specific
Law or to any provision of any Law includes any amendment to, and any modification, re-enactment or successor thereof, any legislative
provision substituted therefor and all rules, regulations and statutory instruments issued thereunder or pursuant thereto; (h)&nbsp;references
to any agreement or Contract are to that agreement or Contract as amended, modified or supplemented; (i)&nbsp;they have been represented
by legal counsel during the negotiation and execution and delivery of this Agreement and therefore waive the application of any Law, holding
or rule&nbsp;of construction providing that ambiguities in an agreement or other document will be construed against the party drafting
such agreement or document; and (j)&nbsp;the word “or” shall not be exclusive (<i>i.e.</i>, “or” shall be deemed
to mean “and/or”) unless the subjects of the conjunction are mutually exclusive. The headings contained in this Agreement
are for convenience of reference only, shall not be deemed to be a part of this Agreement and shall not be referred to in connection with
the construction or interpretation of this Agreement. All references to “Dollars” or “$” are to United States
Dollars, unless expressly stated otherwise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><font style="font-size: 10pt">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><b>CONTINGENT
VALUE RIGHTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>CVRs</u>.
The CVRs represent the contractual rights of Holders to receive contingent cash payments pursuant to the Merger Agreement and this Agreement.
The initial Holders shall be determined pursuant to the terms of the Merger Agreement and this Agreement, and a list of the initial Holders
shall be furnished to the Rights Agent by or on behalf of Parent in accordance with <u>Section&nbsp;4.1</u> hereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Non-transferable</u>.
The CVRs may not be sold, assigned, transferred, pledged, encumbered or in any other manner transferred or disposed of, in whole or in
part, other than through a Permitted Transfer. Any such sale, assignment, transfer, pledge, encumbrance or disposition of a CVR that is
not a Permitted Transfer shall be null and void.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 101; Options: NewSection; Value: 5 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">2.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>No
Certificate; Registration; Registration of Transfer; Change of Address</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>The
CVRs shall not be evidenced by a certificate or other instrument.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>The
Rights Agent shall keep a register (the “<u>CVR Register</u>”) for the purpose of identifying the Holders of CVRs, registering
CVRs and Permitted Transfers of CVRs as herein provided. The CVR Register will initially show one position for Cede&nbsp;&amp; Co. representing
all of the CVRs that are issued to the holders of Shares held by DTC on behalf of the street holders of the Shares tendered by such holders
in the Offer or held by such holders as of immediately prior to the Effective Time. The Rights Agent will have no responsibility whatsoever
directly to the street name holders or DTC participants with respect to transfers of CVRs. With respect to any payments to be made under
<u>Section&nbsp;2.4</u>, the Rights Agent will accomplish the payment to any former street name holders of the Shares by sending a lump
payment to DTC. The Rights Agent will have no responsibilities whatsoever with regard to the distribution of payments by DTC to such street
name holders. In the case of CVRs to be received by the holders of Covered Equity Awards pursuant to the Merger Agreement, such CVRs shall
initially be registered in the name and address of the holder of such Covered Equity Awards as set forth in the records of the Company
at the Effective Time and in a denomination equal to the number of shares of Company Common Stock subject to such Covered Equity Awards
cancelled in connection with the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Subject
to the restrictions on transferability set forth in <u>Section&nbsp;2.2</u>, every request made to transfer the CVRs must be in
writing and accompanied by a written instrument of transfer and other documentation reasonably requested by the Rights Agent in form
reasonably satisfactory to the Rights Agent pursuant to its guidelines, duly executed by the Holder thereof, the Holder’s
attorney duly authorized in writing, the Holder’s personal representative or the Holder’s survivor, as applicable, and
setting forth in reasonable detail the circumstances relating to the transfer. Upon receipt of such written notice, the Rights Agent
shall, subject to its reasonable determination that the transfer instrument is in proper form and the transfer otherwise complies
with the other terms and conditions of this Agreement (including the provisions of <u>Section&nbsp;2.2</u>), register the transfer
of the CVRs in the CVR Register and notify the Parent of the same. No service charge shall be made for any registration of transfer
of a CVR, but Parent and the Rights Agent may require payment of a sum sufficient to cover any stamp or other Tax or charge that is
imposed in connection with any such registration of transfer. The Rights Agent shall have no duty or obligation to take any action
under any section of this Agreement that requires the payment of applicable Taxes or charges unless and until the Rights Agent is
satisfied that all such Taxes or charges have been paid. All duly transferred CVRs registered in the CVR Register shall be the valid
obligations of Parent and shall entitle the transferee to the same benefits and rights under this Agreement as those held
immediately prior to the transfer by the transferor. No transfer of a CVR shall be valid unless and until registered in the CVR
Register.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>A
Holder may make a written request to the Rights Agent to change such Holder’s address of record in the CVR Register. The written
request must be duly executed by the Holder. Upon receipt of such written request, the Rights Agent is hereby authorized to, and shall
promptly, record the change of address in the CVR Register.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">2.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Payment
Procedures</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>In
the event that a Milestone is attained or there is an Event of Default that is subject to <u>Section&nbsp;6.2</u>, then, in each case,
(x)&nbsp;on a date that is within sixty (60) days following the last day of such Fiscal Quarter in which such Milestone is attained or
(y)&nbsp;solely, in the case <u>Section&nbsp;6.2</u>, promptly following the Event of Default, Parent shall deliver to the Rights Agent
(i)&nbsp;a written notice (the “<u>Milestone Notice</u>”) indicating which Milestone was attained (or indicating both Milestones
were attained) and an Officer’s Certificate certifying the date of such achievement(s)&nbsp;and (ii)&nbsp;cash, by wire transfer
of immediately available funds to an account specified by the Rights Agent, equal to the aggregate amount necessary to pay the applicable
Milestone Payment Amount to all Holders pursuant to <u>Section&nbsp;4.2</u>, along with any letter of instruction reasonably required
by the Rights Agent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 102; Value: 5 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>The
Rights Agent shall promptly, and in any event within ten (10)&nbsp;Business Days of receipt of a Milestone Notice and cash, by wire transfer
of immediately available funds, equal to the aggregate amount necessary to pay the applicable Milestone Payment Amount to all Holders
pursuant to <u>Section&nbsp;4.2</u> as well as any letter of instruction reasonably required by the Rights Agent, send each Holder at
its registered address a copy of such Milestone Notice. If a Milestone Payment is payable to the Holders, then at the time the Rights
Agent sends a copy of the Milestone Notice to the Holders, the Rights Agent shall also pay the Milestone Payment Amount to each of the
Holders in accordance with the corresponding letter of instruction (i)&nbsp;by check mailed to the address of such Holder reflected in
the CVR Register as of 5:00&nbsp;p.m.&nbsp;<font style="font-size: 10pt">Eastern Time</font> on the date of the Milestone Notice or (ii)&nbsp;with
respect to any such Holder that is due an amount in excess of $[100,000] in the aggregate who has provided the Rights Agent wiring instructions
in writing as of the close of business on the date of the Milestone Notice, by wire transfer of immediately available funds to the account
specified on such instructions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: white"><font style="font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Parent
shall be entitled to deduct or withhold, or cause the Rights Agent to deduct or withhold, from any payments made pursuant to this Agreement
such amounts as are required to be deducted or withheld therefrom under the Code, the U.S. Treasury Regulations thereunder, or any other
applicable Tax Law, as may be determined by Parent and communicated to the Rights Agent in writing. Prior to making any such Tax withholdings
or causing any such Tax withholdings to be made with respect to any Holder (other than ordinary course payroll withholding and reporting
on the Covered Milestone Payments) Parent shall instruct the Rights Agent to solicit from such Holder an IRS Form&nbsp;W-9 or other
applicable Tax form within a reasonable amount of time in order to provide the opportunity for the Holder to provide any necessary Tax
forms (including an IRS Form&nbsp;W-9 or an applicable IRS Form&nbsp;W-8) in order to avoid or reduce such withholding amounts.
To the extent any such amounts are so deducted or withheld, such amounts shall be treated for all purposes under this Agreement and the
Merger Agreement as having been paid to the Holder to whom such amounts would otherwise have been paid, and, to the extent required by
applicable Law, Parent shall deliver (or shall cause the Rights Agent to deliver) to the Holder to whom such amounts would otherwise have
been paid an IRS Form&nbsp;1099, an IRS Form&nbsp;W-2 or other reasonably acceptable evidence of such withholding. To the extent such
amounts are so deducted or withheld from the Covered Milestone Payments, the Rights Agent shall, as soon as reasonably practicable, deliver
such amounts to Parent for the purposes of remitting such amounts to the IRS. In no event shall the Rights Agent have any duty, obligation
or responsibility for wage or Form&nbsp;W-2 reporting with respect to Milestone Payments (including Covered Milestone Payments) made
to the Holders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>If
any funds delivered to the Rights Agent for payment to Holders as Milestone Payment Amounts remain undistributed to the Holders on the
date that is twelve (12) months after the date of the applicable Milestone Notice, Parent shall be entitled to require the Rights Agent
to deliver to Parent or its designee any funds which had been made available to the Rights Agent in connection with such Milestone Payment
Amounts and not disbursed to the Holders (including, all interest and other income received by the Rights Agent in respect of all funds
made available to it), and, thereafter, such Holders shall be entitled to look to Parent (subject to abandoned property, escheat and other
similar Laws) only as general unsecured creditors thereof with respect to the Milestone Payment Amounts that may be payable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Neither
Parent, the Rights Agent nor any of their Affiliates shall be liable to any Holder for any Milestone Payment Amounts delivered to a public
official pursuant to any abandoned property, escheat or other similar Laws. If, despite Parent’s and the Rights Agent’s commercially
reasonable efforts to deliver a Milestone Payment Amount to the applicable Holder, such Milestone Payment Amount has not been paid immediately
prior to the date on which such Milestone Payment Amount would otherwise escheat to or become property of any Governmental Body, such
Milestone Payment Amount shall become, to the extent permitted by applicable Laws, the property of Parent or its designee, free and clear
of all claims or interest of any Person previously entitled thereto. In addition to and not in limitation of any other indemnity obligation
herein, Parent agrees to indemnify and hold harmless the Rights Agent with respect to any liability, penalty, cost or expense the Rights
Agent may incur or be subject to in connection with transferring such property to Parent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 103; Value: 5 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Except
to the extent any portion of any Milestone Payment Amount is required to be treated as imputed interest pursuant to applicable Law, the
parties hereto intend to treat (i)&nbsp;the CVRs received with respect to the Shares pursuant to the Merger Agreement for all U.S. federal
and applicable state and local income Tax purposes as additional consideration paid at the Effective Time for the Shares pursuant to the
Merger Agreement, (ii)&nbsp;any Milestone Payment Amounts received in respect of such CVRs as amounts realized on the disposition of the
CVRs with respect to Milestone&nbsp;2024 or Milestone&nbsp;2025, as applicable, and (iii)&nbsp;Milestone Payment Amounts paid in respect
of CVRs received with respect to Covered Equity Awards pursuant to the Merger Agreement (the “<u>Covered Milestone Payments</u>”),
for all U.S. federal and applicable state and local income Tax purposes, as wages in the year in which the applicable Milestone Payment
Amount is made. Notwithstanding the foregoing, Parent may, and may cause the Surviving Corporation to, report imputed interest on the
CVRs and Milestone Payment Amounts pursuant to Section&nbsp;483 of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">2.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>No
Voting, Dividends or Interest; No Equity or Ownership Interest</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>The
CVRs shall not have any voting or dividend rights, and interest shall not accrue on any amounts payable on the CVRs to any Holder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>The
CVRs shall not represent any equity or ownership interest in Parent or in any constituent company to the Merger or any of their respective
Subsidiaries or Affiliates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Neither
Parent and its directors and officers nor Purchaser and its directors and officers will be deemed to have any fiduciary or similar duties
to any Holders by virtue of this Agreement or the CVRs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: white"><font style="font-size: 10pt">2.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Ability
to Abandon CVR</u>. A Holder may at any time, at such Holder’s option, abandon all of such Holder’s remaining rights in such
Holder’s CVRs by transferring such CVRs to Parent or any of its Affiliates without consideration therefor, which a Holder may effect
via delivery of a written abandonment notice to Parent. Nothing in this Agreement shall prohibit Parent or any of its Affiliates from
offering to acquire or acquiring any CVRs for consideration from the Holders, in private transactions or otherwise, in its sole discretion.
Any CVRs acquired by Parent or any of its Affiliates shall be automatically deemed extinguished and no longer outstanding for purposes
of the definition of Acting Holders and <u>Article&nbsp;5</u> and <u>Article&nbsp;6</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><font style="font-size: 10pt">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><b>THE
RIGHTS AGENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Certain
Duties and Responsibilities</u>. Prior to the occurrence of an Event of Default, and after the curing or waiving of all such Events of
Default which may have occurred, the Rights Agent shall not have any liability for any actions taken, suffered or omitted to be taken
in connection with this Agreement, except to the extent of its gross negligence, bad faith or willful or intentional misconduct. If an
Event of Default has occurred (which has not been cured or waived), the Rights Agent shall exercise such of the rights and powers vested
in it by this Agreement, and use the same degree of care and skill in their exercise, as a reasonably prudent person would exercise or
use under the circumstances in the conduct of his or her own affairs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 104; Value: 5 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Certain
Rights of the Rights Agent</u>. The Rights Agent undertakes to perform such duties and only such duties as are specifically set forth
in this Agreement, and no implied covenants or obligations shall be read into this Agreement against the Rights Agent. In addition:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>the
Rights Agent may rely and shall be protected and held harmless by Parent in acting or refraining from acting upon any resolution, certificate,
statement, instrument, opinion, report, notice, request, direction, consent, order or other paper or document believed by it in good faith
to be genuine and to have been signed or presented by the proper party or parties;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>whenever
the Rights Agent shall deem it desirable that a matter be proved or established prior to taking, suffering or omitting any action hereunder,
the Rights Agent may rely upon an Officer’s Certificate, which certificate shall be full authorization and protection to the Rights
Agent, and the Rights Agent shall, in the absence of gross negligence, bad faith or willful or intentional misconduct on its part, incur
no liability and be held harmless by Parent for or in respect of any action taken, suffered or omitted to be taken by it under the provisions
of this Agreement in reliance upon such certificate;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>the
Rights Agent may engage and consult with counsel of its selection and the written advice of such counsel or any opinion of counsel shall
be full and complete authorization and protection and shall be held harmless by Parent in respect of any action taken, suffered or omitted
by it hereunder in good faith and in reliance thereon;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>in
the event of litigation, the Rights Agent may engage and consult with regulatory experts, drug development experts and other experts and
third parties that it, in its sole and absolute discretion, deems appropriate or necessary to enable it to discharge its duties hereunder;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>the
permissive rights of the Rights Agent to do things enumerated in this Agreement shall not be construed as a duty;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>the
Rights Agent shall not be required to give any note or surety in respect of the execution of such powers or otherwise in respect of the
premises;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>the
Rights Agent shall not be liable for or by reason of, and shall be held harmless by Parent with respect to any of the statements of fact
or recitals contained in this Agreement or be required to verify the same, but all such statements and recitals are and shall be deemed
to have been made by Parent only;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>the
Rights Agent shall have no liability and shall be held harmless by Parent in respect of the validity of this Agreement or the execution
and delivery hereof (except the due execution and delivery hereof by the Rights Agent and the enforceability of this Agreement against
the Rights Agent assuming the due execution and delivery hereof by Parent); nor shall it be responsible for any breach by Parent of any
covenant or condition contained in this Agreement;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Parent
agrees to indemnify the Rights Agent for, and hold the Rights Agent harmless against, any loss, liability, claim, demands, suits or expense
arising out of or in connection with Rights Agent’s duties under this Agreement, including the reasonable out-of-pocket costs and
expenses of defending Rights Agent against any claims, charges, demands, suits or loss, unless such loss has been determined by a court
of competent jurisdiction to be a result of Rights Agent’s gross negligence, bad faith or willful or intentional misconduct;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 105; Value: 5 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>The
Rights Agent shall not be liable for consequential damages under any provision of this Agreement or for any consequential damages arising
out of any act or failure to act hereunder in the absence of gross negligence, bad faith or willful or intentional misconduct on its part;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Parent
agrees (i)&nbsp;to pay the fees and expenses of the Rights Agent in connection with this Agreement as agreed upon in writing by the
Rights Agent and Parent on or prior to the date hereof (which shall not exceed $[__] per year), and (ii)&nbsp;to reimburse the
Rights Agent for all Taxes and governmental charges, reasonable out-of-pocket expenses and other charges of any kind and nature
incurred by the Rights Agent in the execution of this Agreement (other than Taxes imposed on or measured by the Rights Agent’s
net income and franchise or similar Taxes imposed on it (in lieu of net income Taxes)). The Rights Agent shall also be entitled to
reimbursement from Parent for all reasonable, documented and necessary out-of-pocket expenses paid or incurred by it in
connection with the administration by the Rights Agent of its duties hereunder; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>No
provision of this Agreement shall require the Rights Agent to expend or risk its own funds or otherwise incur any financial liability
in the performance of any of its duties hereunder or in the exercise of its rights if there shall be reasonable grounds for believing
that repayment of such funds or adequate indemnification against such risk or liability is not reasonably assured to it.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">3.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Resignation
and Removal; Appointment of Successor</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>The
Rights Agent may resign at any time by giving written notice thereof to Parent specifying a date when such resignation shall take effect,
which notice shall be sent at least sixty (60) days prior to the date so specified but in no event shall such resignation become effective
until a successor Rights Agent has been appointed and accepted such appointment in accordance with <u>Section&nbsp;3.4</u>. Parent has
the right to remove the Rights Agent at any time by specifying a date when such removal shall take effect but no such removal shall become
effective until a successor Rights Agent has been appointed and accepted such appointment in accordance with <u>Section&nbsp;3.4</u>.
Notice of such removal shall be given by Parent to the Rights Agent, which notice shall be sent at least sixty (60) days prior to the
date so specified.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>If
the Rights Agent provides notice of its intent to resign, is removed or becomes incapable of acting, Parent shall, as soon as is reasonably
practicable, appoint a qualified successor Rights Agent who shall be a stock transfer agent of national reputation or the corporate trust
department of a commercial bank. Notwithstanding the foregoing, if Parent shall fail to make such appointment within a period of sixty
(60) days after giving notice of such removal or after it has received notice in writing (in accordance with the provisions hereof) of
such resignation or incapacity by the resigning or incapacitated Rights Agent, then the incumbent Rights Agent may apply to any court
of competent jurisdiction for the appointment of a new Rights Agent. The successor Rights Agent so appointed shall, forthwith upon its
acceptance of such appointment in accordance with <u>Section&nbsp;3.4</u>, become the successor Rights Agent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Parent
shall give notice of each resignation and each removal of a Rights Agent and each appointment of a successor Rights Agent by mailing written
notice of such event by first-class mail to the Holders as their names and addresses appear in the CVR Register. Each notice shall include
the name and address of the successor Rights Agent. If Parent fails to send such notice within ten (10)&nbsp;Business Days after acceptance
of appointment by a successor Rights Agent, the successor Rights Agent shall cause the notice to be mailed at the expense of Parent. Failure
to give any notice provided for in this <u>Section&nbsp;3.3</u>, however, shall not affect the legality or validity of the resignation
or removal of the Rights Agent or the appointment of the successor Rights Agent, as the case may be.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 106; Value: 5 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>The
Rights Agent will cooperate with Parent and any successor Rights Agent as reasonably requested in connection with the transition of
the duties and responsibilities of the Rights Agent to the successor Rights Agent, including transferring the CVR Register to the
successor Rights Agent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">3.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Acceptance
of Appointment by Successor</u>. Every successor Rights Agent appointed hereunder shall execute, acknowledge and deliver to Parent and
to the retiring Rights Agent an instrument accepting such appointment and a counterpart of this Agreement, and thereupon such successor
Rights Agent, without any further act, deed or conveyance, shall become vested with all the rights, powers, trusts and duties of the retiring
Rights Agent. On request of Parent or the successor Rights Agent, the retiring Rights Agent shall execute and deliver an instrument transferring
to the successor Rights Agent all the rights, powers, trusts and duties of the retiring Rights Agent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><font style="font-size: 10pt">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><b>COVENANTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>List
of Holders</u>. Parent or the Surviving Corporation shall furnish or cause to be furnished to the Rights Agent, in a form reasonably satisfactory
to the Rights Agent, and received from Parent’s Depository Agent in the Offer, Parent’s Paying Agent in the Merger, and in
the case of Holders who held Covered Equity Awards, the Company, the names and addresses of the Holders of such securities within thirty
(30) days after the Effective Time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">4.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Payment
of Milestone Payments</u>. If a Milestone has been achieved in accordance with this Agreement, Parent shall, promptly (but in any event
no later than five (5)&nbsp;Business Days) following the delivery of the Milestone Notice, deposit with the Rights Agent, for payment
to the Holders in accordance with <u>Section&nbsp;2.4</u>, the aggregate amount necessary to pay the Milestone Payment Amounts to all
Holders. For the avoidance of doubt, the maximum aggregate potential amount payable under this Agreement shall be (i)&nbsp;$0.50 with
respect to Milestone&nbsp;2024 and (ii)&nbsp;$0.50 with respect to Milestone&nbsp;2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">4.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Books
and Records</u>. Parent shall, and shall cause its subsidiaries to, keep true, complete and accurate records in sufficient detail to enable
the Holders and their consultants or professional advisors to determine the amounts payable hereunder (including books and records in
sufficient detail to enable the calculation of Net Sales in any applicable Rolling Period).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">4.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Further
Assurances</u>. Parent agrees that it will perform, execute, acknowledge and deliver or cause to be performed, executed,
acknowledged and delivered, all such further and other acts, instruments and assurances as may reasonably be required by the Rights
Agent for the carrying out or performing by the Rights Agent of the provisions of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: white"><font style="font-size: 10pt">4.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Diligent
Efforts</u>. Commencing upon the Closing, Parent shall, and shall cause its Affiliates and any Sublicensees to, use Diligent Efforts to
achieve each Milestone; provided, that the use of Diligent Efforts does not guarantee that Parent will achieve any Milestone. Without
limiting the foregoing, neither Parent nor any of its Affiliates shall act in bad faith for the purpose of avoiding achievement of the
Milestone or the payment of the Milestone Payment or Milestone Payment Amounts. As of the date hereof, Parent acknowledges and agrees
that there is no restriction applicable to it pursuant to applicable Law or Contract that would prohibit or materially interfere with
Parent’s Diligent Efforts to achieve each Milestone (any such prohibition or material interface a, “<u>Prohibition</u>”).
However, in the event that a Prohibition arises and the circumstances or facts giving rise to such Prohibition which were known by (or
should have known by) Parent or were reasonably foreseeable, then Parent will be deemed to be in material default of this <u>Section&nbsp;4.5</u>
(a “<u>Specified Default</u>”).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 107; Value: 5 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: white"><font style="font-size: 10pt">4.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Audit
Rights</u>. If a Milestone has not been attained by the expiry of such Milestone, Parent shall deliver to the Rights Agent, on a date
that is within sixty (60) days following the last day of such Fiscal Quarter in which such Milestone expires, a written notice (the “<u>Expiry
Notice</u>”) indicating which Milestone was not attained and an Officer’s Certificate certifying that such Milestone was not
attained and is not payable to the Holders of such CVR. Until December&nbsp;31, 2027, (i)&nbsp;once after such time as Milestone&nbsp;2024
expires and Parent has delivered an Expiry Notice with respect thereto and (ii)&nbsp;once after such time as Milestone&nbsp;2025 expires
and Parent has delivered an Expiry Notice with respect thereto, upon reasonable advance written notice from the Acting Holders, Parent
shall permit one (1)&nbsp;independent certified public accounting firm of nationally recognized standing selected by such Acting Holders
and reasonably acceptable to Parent (the “<u>Independent Accountant</u>”) to have access at reasonable times during normal
business hours to the books and records of Parent and its Affiliates as may be reasonably necessary to evaluate and verify Parent’s
calculation of Net Sales hereunder, including the Net Sales Statements; <i>provided</i> that (x)&nbsp;such Acting Holders (and the Independent
Accountant) enter into customary confidentiality agreements reasonably satisfactory to Parent with respect to the confidential information
of Parent or its Affiliates to be furnished pursuant to this <u>Section&nbsp;4.6</u> and (y)&nbsp;such access does not unreasonably interfere
with the conduct of the business of Parent or any of its Affiliates. The Independent Accountant shall provide Parent with a copy of all
disclosures made to the Acting Holders. Parent shall not enter into any transaction constituting a Change of Control unless such agreement
contains provisions that would permit such Independent Accountant with such access to the records of the other party in such Change of
Control, if and to the extent as are reasonably necessary to ensure compliance with this <u>Section&nbsp;4.6</u>. The audit rights set
forth in this <u>Section&nbsp;4.6</u> may not be exercised by the Acting Holders more than twice during the pendency of this Agreement,
in accordance with the first sentence of this <u>Section&nbsp;4.6</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: white">&nbsp;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: white"><font style="font-size: 10pt">4.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Net
Sales Statements</u>. Within sixty (60) days of the end of each Fiscal Quarter, Parent shall have compiled a Net Sales Statement for the
Rolling Period ending on the last day of such Fiscal Quarter. Parent shall keep each such Net Sales Statement in its books and records.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: white"><font style="font-size: 10pt">4.8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Change
of Control</u>. In the event that Parent desires to consummate a Change of Control prior to December&nbsp;31, 2025, Parent or the Surviving
Corporation, as applicable depending upon the structure of the Change of Control, will cause the Person acquiring Parent to assume Parent’s
and the Surviving Corporation’s (as applicable depending upon the structure of the Change of Control) obligations, duties and covenants
under this Agreement. No later than five (5)&nbsp;Business Days prior to the consummation of any Change of Control, Parent will deliver
to the Rights Agent an Officer’s Certificate, stating that such Change of Control complies with this <u>Section&nbsp;4.8</u> and
that all conditions precedent herein relating to such transaction have been complied with.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><font style="font-size: 10pt">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><b>AMENDMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">5.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Amendments
without Consent of Holders</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Without
the consent of any Holders or the Rights Agent, Parent at any time and from time to time, may enter into one or more amendments hereto,
for any of the following purposes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><font style="font-size: 10pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>to
evidence the succession of another Person as a successor Rights Agent and the assumption by any such successor of the covenants and obligations
of the Rights Agent herein;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><font style="font-size: 10pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>to
add to the covenants of Parent such further covenants, restrictions, conditions or provisions as Parent shall consider to be for the protection
of the Holders; <i>provided</i> that, in each case, such provisions do not adversely affect the interests of the Holders;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><font style="font-size: 10pt">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>to
cure any ambiguity, to correct or supplement any provision herein that may be defective or inconsistent with any other provision herein
or in the Merger Agreement, or to make any other provisions with respect to matters or questions arising under this Agreement; <i>provided</i>
that, in each case, such provisions do not adversely affect the interests of the Holders;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 108; Value: 5 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><font style="font-size: 10pt">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>as
may be necessary or appropriate to ensure that the CVRs are not subject to registration under the Securities Act, the Exchange Act, any
applicable state securities or “blue sky” laws or any laws outside the United States;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><font style="font-size: 10pt">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>to
evidence the assignment of this Agreement by Parent as provided in <u>Section&nbsp;7.3</u>; or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><font style="font-size: 10pt">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>any
other amendments hereto for the purpose of adding, eliminating or changing any provisions of this Agreement, unless such addition, elimination
or change is adverse to the interests of the Holders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: white"><font style="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Without
the consent of any Holders, Parent and the Rights Agent, at any time and from time to time, may enter into one or more amendments thereto
to reduce the number of CVRs, in the event any Holder agrees to renounce such Holder’s rights under this Agreement in accordance
with <u>Section&nbsp;7.4</u> or to transfer CVRs to Parent pursuant to <u>Section&nbsp;2.6</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Promptly
after the execution by Parent and/or the Rights Agent of any amendment pursuant to the provisions of this <u>Section&nbsp;5.1</u>, Parent
shall mail (or cause the Rights Agent to mail) a notice thereof by first class mail to the Holders at their addresses as they appear on
the CVR Register, setting forth such amendment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">5.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Amendments
with Consent of Holders</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Subject
to <u>Section&nbsp;5.1</u> (which amendments pursuant to <u>Section&nbsp;5.1</u> may be made without the consent of any Holder), with
the consent of the Holders of not less than a majority of the outstanding CVRs as set forth in the CVR Register, whether evidenced in
writing or taken at a meeting of the Holders, Parent and the Rights Agent may enter into one or more amendments hereto for the purpose
of adding, eliminating or changing any provisions of this Agreement, even if such addition, elimination or change is materially adverse
to the interest of the Holders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Promptly
after the execution by Parent and the Rights Agent of any amendment pursuant to the provisions of this <u>Section&nbsp;5.2</u>, Parent
shall mail (or cause the Rights Agent to mail) a notice thereof by first class mail to the Holders at their addresses as they appear on
the CVR Register, setting forth such amendment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">5.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Execution
of Amendments</u>. Prior to executing any amendment permitted by this <u>Article&nbsp;5</u>, the Rights Agent shall be entitled to
receive, and shall be fully protected in relying upon, an opinion of counsel selected by Parent stating that the execution of such
amendment is authorized or permitted by this Agreement. The Rights Agent may, but is not obligated to, enter into any such amendment
that affects the Rights Agent’s own rights, powers, trusts or duties under this Agreement or otherwise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">5.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Effect
of Amendments</u>. Upon the execution of any amendment under this <u>Section&nbsp;5</u>, this Agreement shall be modified in accordance
therewith, such amendment shall form a part of this Agreement for all purposes and every Holder shall be bound thereby.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 109; Value: 5 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><font style="font-size: 10pt">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><b>REMEDIES
OF THE HOLDERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="font-size: 10pt">6.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Event
of Default</u>. An “<u>Event of Default</u>” with respect to the CVRs, means each one of the following events which shall
have occurred and be continuing (whatever the reason for such Event of Default and whether it shall be voluntary or involuntary or be
effected by operation of Law or pursuant to any judgment, decree or order of any court or any order, rule&nbsp;or regulation of any Governmental
Body):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>default
in the payment by Parent pursuant to the terms of this Agreement of all or any part of the Milestone Payment Amount after a period of
ten (10)&nbsp;Business Days after the Milestone Payment Amount shall become due and payable&#894;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>material
default in the performance, or breach in any material respect, of any covenant or warranty of Parent hereunder (other than a default in
whose performance or whose breach is elsewhere in this <u>Section&nbsp;6.1</u> specifically dealt with), and continuance of such default
or breach for a period of ninety (90) days after a written notice specifying such default or breach and requiring it to be remedied is
given, which written notice states that it is a “Notice of Default” hereunder and is sent by registered or certified mail
to Parent by the Rights Agent or to Parent and the Rights Agent by the Acting Holders; or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>the
occurrence of a Specified Default.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="font-size: 10pt">Subject
to <u>Section&nbsp;6.2</u>, if an Event of Default described above occurs and is continuing (and</font> has not been cured or
waived), then, and in each and every such case, (i)&nbsp;the Rights Agent by notice in writing to Parent or (ii)&nbsp;the Rights
Agent upon the written request of the Acting Holders by notice in writing to Parent (and to the Rights Agent if given by the Acting
Holders), shall commence a legal proceeding to protect the rights of the Holders, including to obtain damages or payment for any
amounts then due and payable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
foregoing provisions of this <u>Section&nbsp;6.1</u>, however, are subject to the condition that if, at any time after the Rights Agent
shall have commenced such proceeding, and before any award shall have been obtained, Parent shall pay or shall deposit with the Rights
Agent a sum sufficient to pay all amounts which shall have become due and such amount as shall be sufficient to cover reasonable compensation
to the Rights Agent, its agents, attorneys and counsel, and all Events of Default under this Agreement shall have been cured, waived or
otherwise remedied as provided herein, then and in every such case the Acting Holders, by written notice to Parent and to the Rights Agent,
may waive all defaults that are the subject of such proceeding, but no such waiver or rescission and annulment shall extend to or shall
affect any subsequent default.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="font-size: 10pt">6.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Specified
Defaults/Payment Due</u>. In the event an Event of Default set forth in <u>Section&nbsp;6.1(c)</u>&nbsp;occurs, then each Milestone that
has not been attained shall be, without any further action by any Person, deemed to have been attained for all purposes under this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="font-size: 10pt">6.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Enforcement</u>.
If an Event of Default has occurred, has not been waived and is continuing, the Rights Agent may in its discretion proceed to protect
and enforce the rights vested in it by this Agreement by commencing a legal proceeding in accordance with <u>Section&nbsp;7.6</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="font-size: 10pt">6.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Limitations
on Suits by Holders</u>. Subject to the last sentence of this <u>Section&nbsp;6.4</u>, no Holder of any CVR shall have any right under
this Agreement to commence proceedings under or with respect to this Agreement, or for the appointment of a Rights Agent, receiver, liquidator,
custodian or other similar official, for any other remedy hereunder, unless (i)&nbsp;such Holder previously shall have given to the Rights
Agent written notice of default, (ii)&nbsp;the Acting Holders shall have made written request upon the Rights Agent to commence such proceeding
in its own name as Rights Agent hereunder and shall have offered to the Rights Agent such reasonable indemnity as it may require against
the costs, expenses and liabilities to be incurred therein or thereby and (iii)&nbsp;the Rights Agent for fifteen (15) days after its
receipt of such notice, request and offer of indemnity shall have failed to commence any such proceeding and no direction inconsistent
with such written request shall have been given to the Rights Agent pursuant to <u>Section&nbsp;6.5</u>. Notwithstanding any other provision
in this Agreement, the right of any Holder of any CVR to receive payment of the amounts that a Milestone Notice indicates are payable
in respect of such CVR on or after the applicable due date, or to commence proceedings for the enforcement of any such payment on or after
such due date, shall not be impaired or affected without the consent of such Holder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 110; Value: 5 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="font-size: 10pt">6.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Control
by Acting Holders.</u> Subject to the last sentence of this <u>Section&nbsp;6.5</u>, the Acting Holders shall have the right to direct
the time, method and place of conducting any proceeding for any remedy available to the Rights Agent under this Agreement, or exercising
any power conferred on the Rights Agent by this Agreement&#894; <i>provided</i> that such direction shall not be otherwise than in accordance
with Law and the provisions of this Agreement&#894; <i>provided</i>, <i>further</i> that (subject to the provisions of <u>Section&nbsp;3.1</u>)
the Rights Agent shall have the right to decline to follow any such direction if the Rights Agent, being advised by counsel, shall determine
that the action or proceeding so directed may not lawfully be taken or if the Rights Agent (acting in good faith through its board of
directors, the executive committee, or a committee of directors of the Rights Agent) shall determine that the action or proceedings so
directed would involve the Rights Agent in personal liability or if the Rights Agent in good faith shall so determine that the actions
or forbearances specified in or pursuant to such direction would be unduly prejudicial to the interests of Holders not joining in the
giving of said direction. Nothing in this Agreement shall impair the right of the Rights Agent in its discretion to take any action deemed
proper by the Rights Agent and which is not inconsistent with such direction or directions by the Acting Holders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><font style="font-size: 10pt">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><b>OTHER
PROVISIONS OF GENERAL APPLICATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="font-size: 10pt">7.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Notices
to the Rights Agent and Parent</u>. Any notice or other communication required or permitted to be delivered to Parent or the Rights Agent
under this Agreement shall be in writing and shall be deemed properly delivered, given and received (a)&nbsp;upon receipt when delivered
by hand, (b)&nbsp;two (2)&nbsp;Business Days after being sent by registered mail or by courier or express delivery service, (c)&nbsp;if
sent by email transmission prior to 5:00 p.m.&nbsp;recipient’s local time, upon transmission thereof (provided that no bounceback
or similar “undeliverable” message is received by such sender) or (d)&nbsp;if sent by email transmission after 5:00 p.m.&nbsp;recipient’s
local time, the Business Day following the date of transmission (provided that no bounceback or similar “undeliverable” message
is received by such sender); <i>provided</i> that in each case the notice or other communication is sent to the physical address or email
address, as applicable, set forth beneath the name of such party below (or to such other physical address or email address as such party
shall have specified in a written notice given to the other party):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">If to the Rights Agent:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">[&#9679;]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">With a copy to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">[&#9679;]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 111; Value: 5 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; background-color: white">if to Parent:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white"><font style="font-size: 10pt">Supernus
Pharmaceuticals,&nbsp;Inc.<br>
9715 Key West Ave<br>
Rockville MD, 20850<br>
Attention:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Jack A. Khattar<br>
Email:<font style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>jkhattar@supernus.com</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; background-color: white">with a copy to (which shall not constitute
notice):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white"><font style="font-size: 10pt">Saul
Ewing Arnstein&nbsp;&amp; Lehr LLP<br>
1919 Pennsylvania Avenue, N.W., Suite&nbsp;550<br>
Washington, DC 20006-3434<br>
Attention:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Mark I. Gruhin<br>
Facsimile:<font style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>(202) 295-6719<br>
Email:<font style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>mark.gruhin@saul.com</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Rights Agent or Parent
may specify a different address, facsimile number or email address by giving notice in accordance with this <u>Section&nbsp;7.1</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">7.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Notice
to Holders</u>. Where this Agreement provides for notice to Holders, such notice shall be sufficiently given (unless otherwise herein
expressly provided) if in writing and mailed, first-class postage prepaid, to each Holder affected by such event, at the Holder’s
address as it appears in the CVR Register, not later than the latest date, and not earlier than the earliest date, if any, prescribed
for the giving of such notice. In any case where notice to Holders is given by mail, neither the failure to mail such notice, nor any
defect in any notice so mailed, to any particular Holder shall affect the sufficiency of such notice with respect to other Holders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">7.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Parent
Successors and Assigns</u>. Parent may assign, in its sole discretion and without the consent of any other Person, any or all of its
rights, interests and obligations hereunder (i)&nbsp;to one or more direct or indirect wholly-owned subsidiaries of Parent,
(ii)&nbsp;to any purchaser, licensee or sublicensee of substantial rights to the Product that is a company in the pharmaceutical
industry or (iii)&nbsp;otherwise with the prior written consent of the Acting Holders, to any other person (each, an
 “<u>Assignee</u>”); <i>provided</i> that the Assignee agrees to assume and be bound by all of the terms and conditions
of this Agreement. Any such Assignee may thereafter assign, in its sole discretion and without the consent of any other party, any
or all of its rights, interests and obligations hereunder to one or more additional Assignees which agree to assume and be bound by
all of the terms and conditions of this Agreement; <i>provided</i>, <i>however</i>, that in connection with any assignment to an
Assignee pursuant to clause (i)&nbsp;of the first sentence of this <u>Section&nbsp;7.3 </u>if the Assignee does not have net assets
of at least $500,000,000 as shown on its most recently prepared financial statements, and clause&nbsp;(ii)&nbsp;of the first
sentence of this <u>Section&nbsp;7.3</u>, the assignor shall agree to remain liable for the performance by the Assignee of all
duties, covenants, agreements and obligations of Parent hereunder, with such Assignee substituted for Parent under this Agreement.
This Agreement will be binding upon, inure to the benefit of and be enforceable by Parent’s successors and each Assignee.
Subject to compliance with the requirements set forth in this <u>Section&nbsp;7.3 </u>relating to assignments, this Agreement shall
not restrict Parent’s, any Assignee’s or any of their respective successors’ ability to merge or consolidate with,
or sell, issue, license or dispose of its stock or other equity interests or assets to, any other Person, or spin-off or split-off.
Each of Parent’s successors and each Assignee shall, by a supplemental contingent consideration payment agreement or other
acknowledgement executed and delivered to the Rights Agent, expressly assume the due and punctual payment of the CVRs and the due
and punctual performance of every duty, obligation, agreement and covenant of this Agreement on the part of Parent to be performed
or observed by Parent. The Rights Agent may not assign this Agreement without Parent’s written consent. Any attempted
assignment of this Agreement or any such rights in violation of this <u>Section&nbsp;7.3</u> shall be void and of no effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 112; Value: 5 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">7.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>No
Third Party Beneficiaries</u>. Nothing in this Agreement, express or implied, shall give to any Person (other than Parent’s successors
and Assignees, each of whom is intended to be, and is, a third party beneficiary hereunder; <i>provided</i> that the Holders shall be
considered third party beneficiaries solely to the extent set forth in <u>Article&nbsp;6</u>) any benefit or any legal or equitable right,
remedy or claim under this Agreement or under any covenant or provision herein contained, all such covenants and provisions being for
the sole benefit of the Rights Agent, Parent, Parent’s successors and Assignees, and the Holders (solely to the extent set forth
in <u>Article&nbsp;6)</u>. The Holders shall have no rights except the contractual rights as are expressly set forth in this Agreement.
Notwithstanding anything to the contrary contained herein, any Holder may at any time agree to renounce, in whole or in part, whether
or not for consideration, such Holder’s rights under this Agreement by written notice to the Rights Agent and Parent, which notice,
if given, shall be irrevocable, and Parent may, in its sole discretion, at any time offer consideration to Holders in exchange for their
agreement to irrevocably renounce their rights, in whole or in part, hereunder. Except for the rights of the Rights Agent set forth herein,
the Acting Holders will have the sole right, on behalf of all Holders, by virtue of or under any provision of this Agreement, to institute
any action or proceeding with respect to this Agreement, and no individual Holder or other group of Holders will be entitled to exercise
such rights. Reasonable expenditures incurred by such Acting Holders in connection with any enforcement action hereunder may be deducted
from any damages or settlement obtained prior to the distribution of any remainder to Holders generally. Acting Holders acting pursuant
to this provision on behalf of all Holders shall have no liability to the other Holders for such actions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">7.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Governing
Law</u>. This Agreement, the CVRs and all actions arising under or in connection herewith and therewith (whether sounding in
contract, tort or otherwise) shall be governed by and construed in accordance with the laws of the State of Delaware, regardless of
the laws that might otherwise govern under applicable principles of conflicts of laws thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">7.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Jurisdiction,
WAIVER OF JURY TRIAL</u>. In any action or proceeding arising out of or relating to this Agreement or any of the matters contemplated
hereby: (i)&nbsp;each of Parent, the Rights Agent and the Holders irrevocably and unconditionally consents and submits to the exclusive
jurisdiction and venue of the Court of Chancery of the State of Delaware and any state appellate court therefrom or, if such court lacks
subject matter jurisdiction, the United States District Court sitting in New Castle County in the State of Delaware (it being agreed that
the consents to jurisdiction and venue set forth in this <u>Section&nbsp;7.6</u> shall not constitute general consents to service of process
in the State of Delaware and shall have no effect for any purpose except as provided in this paragraph and shall not be deemed to confer
rights on any Person other than Parent, the Rights Agent and the Holders); and (ii)&nbsp;each of Parent, the Rights Agent and the Holders
irrevocably consents to service of process by first class certified mail, return receipt requested, postage prepaid, to the address at
which such Party is to receive notice in accordance with <u>Section&nbsp;7.1</u> or <u>Section&nbsp;7.2</u>, as applicable. Each of Parent,
the Rights Agent and the Holders hereby irrevocably and unconditionally waives any objection to the laying of venue of any action, suit
or proceeding arising out of this Agreement or the matters contemplated hereby in the Court of Chancery of the State of Delaware and any
state appellate court therefrom or, if such court lacks subject matter jurisdiction, the United States District Court sitting in New Castle
County in the State of Delaware, and hereby further irrevocably and unconditionally waives and agrees not to plead or claim in any such
court that any such action, suit or proceeding brought in any such court has been brought in an inconvenient forum (including, any claim
based on the doctrine of <i>forum non conveniens</i> or any similar doctrine). Parent, the Rights Agent and the Holders agree that a final
judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in
any other manner provided by applicable Laws; <i>provided</i>, <i>however</i>, that nothing in the foregoing shall restrict any Person’s
rights to seek any post-judgment relief regarding, or any appeal from, such final trial court judgment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES
ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING BETWEEN THE PARTIES (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE),&nbsp;INCLUDING
ANY COUNTERCLAIM, ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THE ACTIONS OF ANY PARTY IN
THE NEGOTIATION, ADMINISTRATION, PERFORMANCE AND ENFORCEMENT THEREOF. EACH PARTY HERETO (A)&nbsp;MAKES THIS WAIVER VOLUNTARILY AND (B)&nbsp;ACKNOWLEDGES
THAT SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS CONTAINED IN THIS <u>SECTION&nbsp;7.6</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 113; Value: 5 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">7.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Severability</u>.
In the event that any provision of this Agreement, or the application thereof, becomes or is declared by a court of competent jurisdiction
to be illegal, void or unenforceable, the remainder of this Agreement shall continue in full force and effect and the application of such
provision to other Persons or circumstances shall be interpreted so as reasonably to effect the intent of the parties. The parties further
agree to replace such void or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the
extent possible, the economic, business and other purposes of such void or unenforceable provision.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">7.8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Termination</u>.
This Agreement will be terminated and of no force or effect, the parties hereto will have no liability hereunder (other than with respect
to monies due and owing by Parent to the Rights Agent), and no payments will be required to be made, upon the earliest to occur of (a)&nbsp;the
payment by the Rights Agent to each Holder of the Milestone Payment with respect to Milestone&nbsp;2024 and the Milestone Payment with
respect to Milestone&nbsp;2025, such amounts not to exceed an aggregate value of $1.00 (inclusive of any payments received with respect
to such CVRs by the permitted transferor of each CVR held by such Holder) as reflected on the CVR Register as of the close of business
on the date of the Milestone Notice, (b)&nbsp;the delivery of a written notice of termination duly executed by Parent and the Acting Holders,
and (c)&nbsp;January&nbsp;1, 2028.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">7.9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Obligation
of Parent</u>. Parent shall cause Purchaser, the Surviving Corporation and each Selling Entity that is controlled by Parent and its Affiliates
to duly perform, satisfy and discharge each of the covenants, obligations and liabilities applicable to Purchaser, the Surviving Corporation
or such Selling Entity under this Agreement, and Parent shall be jointly and severally liable with Purchaser and the Surviving Corporation
for the performance and satisfaction of each of said covenants, obligations and liabilities. References to Purchaser herein apply to the
Surviving Corporation from and after the Effective Time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">7.10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><u>Entire
Agreement; Counterparts</u>. This Agreement and the Merger Agreement constitute the entire agreement and supersede all contemporaneous
and prior agreements and understandings, both written and oral, among or between any of the Parties, with respect to the subject matter
hereof and thereof. If and to the extent that any provision of this Agreement is inconsistent or conflicts with the Merger Agreement,
this Agreement govern and be controlling. This Agreement may be executed in counterparts, each of which shall be deemed an original and
all of which shall constitute one and the same instrument. The exchange of a fully executed Agreement (in counterparts or otherwise) by
PDF shall be sufficient to bind the Parties to the terms and conditions of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<i>REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</i>]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 114; Value: 5 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, each of
the parties has caused this Agreement to be executed on its behalf by its duly authorized officers as of the day and year first above
written.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td></td><td colspan="2" style="text-align: left"><b>SUPERNUS PHARMACEUTICALS,&nbsp;INC.</b></td>
</tr><tr style="vertical-align: top; text-align: justify">
<td style="width: 50%">&nbsp;</td><td style="text-align: left; width: 5%">&nbsp;</td><td style="text-align: justify; width: 45%">&nbsp;</td></tr>
     <tr style="vertical-align: top; text-align: justify">
<td>&nbsp;</td><td style="text-align: left">By:</td><td style="border-bottom: Black 1pt solid; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td></tr>
     <tr style="vertical-align: top; text-align: justify">
<td>&nbsp;</td><td style="text-align: left">Name:</td><td style="text-align: justify">&nbsp;</td></tr>
     <tr style="vertical-align: top; text-align: justify">
<td>&nbsp;</td><td style="text-align: left">Title:</td><td style="text-align: justify">&nbsp;</td></tr>
     <tr style="vertical-align: top; text-align: justify">
<td>&nbsp;</td><td style="text-align: left">&nbsp;</td><td style="text-align: justify">&nbsp;</td></tr>
     <tr style="vertical-align: top; text-align: justify">
<td>&nbsp;</td><td colspan="2" style="text-align: left"><b>[<font style="text-transform: uppercase">Rights Agent</font>]</b></td></tr>
     <tr style="vertical-align: top; text-align: justify">
<td>&nbsp;</td><td style="text-align: left">&nbsp;</td><td style="text-align: justify">&nbsp;</td></tr>
     <tr style="vertical-align: top; text-align: justify">
<td>&nbsp;</td><td style="text-align: left">By:</td><td style="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</td></tr>
     <tr style="vertical-align: top; text-align: justify">
<td>&nbsp;</td><td style="text-align: left">Name:</td><td style="text-align: justify">&nbsp;</td></tr>
     <tr style="vertical-align: top; text-align: justify">
<td>&nbsp;</td><td style="text-align: left">Title:</td><td style="text-align: justify">&nbsp;</td></tr>
     </tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[<i>Signature Page to Contingent
Value Rights Agreement</i>]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 115; Options: Last -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>



</text>
</description></filename></sequence></type></document>
<script src="data:text/javascript;base64,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"></script></body><grammarly-desktop-integration data-grammarly-shadow-root="true"><template shadowrootmode="open"><style>
      div.grammarly-desktop-integration {
        position: absolute;
        width: 1px;
        height: 1px;
        padding: 0;
        margin: -1px;
        overflow: hidden;
        clip: rect(0, 0, 0, 0);
        white-space: nowrap;
        border: 0;
        -moz-user-select: none;
        -webkit-user-select: none;
        -ms-user-select:none;
        user-select:none;
      }

      div.grammarly-desktop-integration:before {
        content: attr(data-content);
      }
    </style><div aria-label="grammarly-integration" role="group" tabindex="-1" class="grammarly-desktop-integration" data-content="{&quot;mode&quot;:&quot;limited&quot;,&quot;isActive&quot;:false,&quot;isUserDisabled&quot;:false}"></div></template></grammarly-desktop-integration></html>